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Theoretical Part
 1 
1. Introduction 
 
 
1. 1. Haloperoxidases and Natural Organohalogen Compounds 
 
Halogens are abundant constitutive elements of the biosphere particularly in marine 
environment. Ocean water is approximately 0.5 M in chloride, 1 mM in bromide and 
1 M in iodide. Thus it is not surprising that halogens are incorporated into a number 
of natural organic compounds. More than 3,800 natural organohalogen compounds 
have been isolated and characterized to date,[1] which range in structural intricacy 
from the ubiquitous fungal and plant metabolite chloromethane to the complex life-
saving antibiotic vancomycin.[1, 2] The biological functions of most natural 
organohalogens are important for many organisms, such as in chemical defense, in 
food gathering or as regulatory hormones. In many cases these compounds are also of 
pharmacological interest due to antifungal, antibacterial, antineoplastic, antiviral (e.g., 
anti-HIV), anti-inflammatory, and other action.[3, 4] 
 
The main enzymes responsible for the incorporation of halogen atoms in organic 
compounds in nature are haloperoxidases (HPOs), which catalyze the formation of 
halogenated organic compounds at the expense of hydrogen peroxide according to Eq. 
(1), where RH is organic substrate; X- is chloride, bromide or iodide ion; and RX is 
the halogenated product. 
 
RH + H2O2 + H+ + X-  RX + 2H2O                         (1) 
 
Without suitable organic substrate, the two-electron oxidation of a halide may turn to 
produce singlet oxygen, see Eq. (2) and (3) .[5-7]  
 
H2O2 + H+ + X-  HOX + H2O                                  (2) 
 
HOX + H2O2  1O2 + X- + H+ + H2O                         (3) 
 
Since Hager’s group purified the first chlorinating enzyme from Caldariomyces 
fumago in 1961,[8] more and more HPOs have been found in a broad range of 
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organisms, including mammals, molds, bacteria, algae, ferns, and higher plants.[5-7] 
The historical nomenclature convention of HPO is based on the most electronegative 
halide that the enzyme can oxidize (i.e., the chloroperoxidases (CPO) can oxidize 
both Cl- and Br- and bromoperoxidases (BPO) can oxidize Br-). HPO does not have 
the driving force to oxidize the fluoride, however a fluorinating enzyme, fluorinase, 
has recently been isolated and is proposed to act by an SN2 mechanism.[9, 10] 
 
On the basis of their cofactor requirement HPOs are classified into the following three 
groups: heme-containing, vanadium-containing[11] and “metal-free” 
haloperoxidases.[12] Among them, vanadium Haloperoxidase (V-HPO) appears to be 
the most prevalent.[11, 13] 
 
The catalytic ability of HPOs attracts broad interest of industry for biotransformations 
and as bleaching enzymes for laundering. The use of heme-containing enzymes in this 
application has the disadvantage of unsatisfactory stability due to rapid oxidation and 
cleavage of the prosthetic heme ligand and low substrate specificity.[14] Therefore, the 
remarkably high stability of V-HPO against high concentration of organic solvents 
and elevated temperature[15, 16] and their availability from large-scale process or 
expression systems afford greater potential for industrial application.[17] 
 
 
1. 2. Vanadium Haloperoxidase 
 
Evidence of the involvement of vanadium ions in the vanadium-dependent 
haloperoxidase enzymes was first discovered by Vilter in 1984.[17, 18] The 
bromoperoxidase isolated from Ascophyllum nodosum was inactivated by dialysis in 
pH 3.8 citrate-phosphate buffer containing EDTA and was slowly reactivated by 
vanadate in suitable buffers.[17, 18] V-HPO have now been isolated from a number of 
marine algae[11] and also from some lichens[19] and fungi.[20] The vanadium iodo- and 
bromoperoxidases (V-IPO and V-BPO) are predominantly found in marine 
organisms,[21] while vanadium chloroperoxidases (V-CPO) originate mainly from 
terrestrial fungi.[22] 
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All the vanadium haloperoxidases isolated to date share some common features[23]: 
they are composed of one or more subunits of around 67 kDa; they can be inactivated 
by dialysis against EDTA at low pH; their activity is only restored by addition of 
vanadium (as vanadate) and they seem to have similar coordination of vanadium in 
the active site. 
 
V-HPOs have been studied in great detail using a variety of biophysical techniques 
including 51V NMR,[24] extended X-ray absorption fine structure[25, 26] and electron 
spin echo modulation.[27, 28] Yet, only limited structural information had been obtained 
from these experiments until the first X-ray structure was resolved. 
 
 
1. 2. 1. X-ray Structures of V-HPOs 
 
1. 2. 1. 1. Structure of V-CPO from Curvularia inaequalis 
 
Concerning the V-HPO family, the vanadium chloroperoxidase from the pathogenic 
fungus Curvularia inaequalis has been most thoroughly investigated. The X-ray 
structure of its azide-substituted form was the first of this family to be solved.[29] 
Thereafter, the  native form, the peroxide forms[30], the apo-form (metal-free form) 
and  the tungstate-substituted form[31] also became available. Moreover, the 
determination of the four active site mutants structures (H404A, H496A, D292A and 
R360A)[32] shed light on the characteristics of the active site and the mechanism of the 
enzyme.[29-33]  
 
 
1. 2. 1. 1. 1. Overall Structure of V-CPO 
 
The protein contains 609 amino acids with a calculated molecular mass of 67,488 Da, 
and the gene has been cloned and sequenced.[34] Determination of the crystal structure 
of this enzyme revealed a molecule with an overall cylindrical shape measuring about 
80 × 50 Å. The secondary structure is mainly -helical with two four-helix bundles as 
main structural motifs (Fig. 1). The active site of the enzyme is located on top of the 
second four-helix bundle.[29-33] It should be noted that the overall protein structure of 
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V-CPO is rather rigid and remains nearly unchanged in all of the different forms 
compared with the native V-CPO.[30-32] 
 
 
Figure 1. The 2.03Å crystal structure of V-CPO from Curvularia inaequalis (PDB ID: 
1IDQ).[30] The figure was prepared with the program WebLab ViewerLite. 
 
 
1. 2. 1. 1. 2. The Structure of Native Form of V-CPO 
 
There are three positively charged groups at the active site: two guanidiniums from 
Arg 490, Arg 360 and one ammonium from Lys 353, all of which bind the cofactor 
hydrogen orthovanadate (HVO42-) through electrostatic interaction (Fig. 2). Since 
charged groups of these residues are also good H-bond donors, they form, together 
with several amide–NH groups, a hydrogen bond network to the oxygen atoms of 
HVO42-. The nitrogen (N 2) of His 496 coordinates to vanadium and hence is the only 
direct bond from the protein to the metal center, generating a trigonal-bipyramidal 
geometry for the cofactor HVO42-: a hydroxide and His 496 in the axial positions and 
three oxo moieties in the equatorial plane. The three equatorial V-O bonds  are about 
1.65 Å long, while the apical V-O bond length is 1.93 Å and the V-N bond is 1.96 Å 
(Fig. 2).[30, 31] Accordingly Coulomb interactions, H-bonds and coordination generate 
a highly organized receptor displaying a high affinity to HVO42- with Kd ~ 100 nM.[35] 
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The active site forms a very rigid matrix designed for selective oxyanion binding, 
with relative affinities for HVO42- >HPO42- >SO42-. The differences in the affinities 
for these oxyanions could results primarily from their capabilities to coordinate with 
the active site His 496, and further from the distribution of hydrogen bond donors in 
the protein in relation to the protonation state of the oxyanion.[32] From the ability to 
bind tungstate,[31] one may predict it to bond molybdate, as was shown for the V-
BPO.[28] 
 
Figure 2. The active site of V-CPO from Curvularia inaequalis in the native form (PDB ID: 
1IDQ).[30] The figure was prepared with the program WebLab ViewerLite. 
 
 
1. 2. 1. 1. 3. The Structure of Peroxide Form of the V-CPO 
 
The peroxide form was obtained by soaking the crystals in mother liquor containing 
20nM H2O2. In the resulting 2.24 Å crystal structure (R = 17.7%), the peroxide is 
bound to the V in an 2-fashion after the release of the apical oxygen ligand of the 
native state, thus vanadium is coordinated by four non-protein oxygen atoms and one 
nitrogen (N 2) from His 496. The coordination geometry around the vanadium is a 
distorted tetragonal pyramid with the two peroxide oxygens O2 and O4 (bond lengths: 
V-O2 and V-O4 about 1.87 Å; O2-O4, 1.47 Å), one oxygen O3 (bondlength V-O3 
1.93 Å) and the nitrogen (bond length V-N 2.19 Å ) in the basal plane and one oxygen 
(V-O1, bond length 1.60 Å) in the apical position (Fig. 3).[30]  It has been shown 
recently that the protein has a higher affinity to pervanadate than to vanadate.[36] 
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Figure 3. The active site of V-CPO from Curvularia inaequalis in the peroxide form (PDB ID: 
1IDU) .[30] The figure was prepared with the program WebLab ViewerLite. 
 
 
1. 2. 1. 2. Structural Comparison with other V-HPO enzymes 
 
The X-ray structures of V-BPO from brown algae Ascophyllum nodosum(A-V-
BPO)[14] in the native form and V-BPO from red algae Corallina officinalis (C-V-
BPO) in the phosphate substituted form[37, 38] also became available recently. All the 
structures share a four–helix bundle motif known from V-CPO. Unlike V-CPO from 
Curvularia inaequalis crystallized as a monomer,[29] A-V-BPO shows a homo-dimeric 
structure[14] and C-V-BPO exists as a dodecameric form in solid state.[37] Although the 
sequence alignment among them show only very low similarity (21.5% sequence 
identity between V-CPO from Curvularia inaequalis and A-V-BPO,[14] 33% sequence 
identity between A-V-BPO and C-V-BPO[37]), the active sites are highly conserved in 
all three structures (Fig. 4), suggesting a common reaction mechanism. 
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                              (A)                                                              (B) 
Figure 4. (A) The superposition of A-V-BPO and V-CPO structure near the active site. A-V-
BPO residues in atom colors, V-CPO in cyan;[14] (B) The superposition of the active sites of 
the C-V-BPO enzyme (in red) and the V-CPO (in black).  
 
 
1. 2. 2. The Proposed Mechanism of V-HPO 
 
Since the vanadium (4+) or (3+) states have not been observed by EPR or K-edge X-
ray studies in the presence of substrates or during turn over, and the reduced enzyme 
is inactive, apparently the redox state of the metal remains (5+) and does not change 
during the catalytic turnover. Hence it is believed that the vanadium ion plays the role 
of a strong Lewis acid with respect to the primary oxidant, H2O2.[28]  
 
Mechanistic investigations have involved product analysis, kinetics, and have 
included studies of both the enzyme and the model systems. A general consensus 
currently exists for the mechanism for both the V-BPO and V-CPO catalyzed 
reactions and is described in Scheme 1.[39] The reaction proceeds initially by H2O2 
addition, which is followed by protonation of the bound peroxide and addition of the 
halide, successively. Apart from direct evidence from the X-ray structure,[30] 
spectroscopic evidence for the enzymatic VO2-O2 intermediate was obtained using 
17O NMR spectroscopy.[40] There is no evidence however for an intermediate in which 
the halide binds to the vanadium atom.[41] The rate-determining step in the catalytic 
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cycle is the nucleophilic attack of the halide on the protonated protein-peroxide 
complex, generating a ("X+") species, which immediately reacts with organic 
substrates and halogenates them. This step will generate singlet oxygen in the absence 
of RH, and has been investigated in detail with Cl-, Br-, and I-. 
V
V
O
O
N(His496)
O
O
O
OH
H
N(His404)
V
N(His496)
O
O
O
OH
H
N(His404)
H
-OOH
O
(His496)N
O
X -
V O
O
O
(His496)N
O H
N(His404)
H
XOH
HOX
H+, H2O
X -
- 2H2O
H2O2
 
Scheme 1. Proposed mechanism of V-HPO catalysis.  
 
Site-directed mutagenesis experiments (alanine scanning) have elucidated the relative 
importance of various active-site residues in catalytic activity.[42] His 496 is the 
primary chemical anchor for vanadium, and its replacement with Ala results in 
complete loss of activity. Substitution of the positively charged residues Lys 353, Arg 
360, and Arg 490 revealed less severe effects, but of these mutants, the largest 
decrease in activity is observed for K353A. In fact, Lys 353 is the only residue which 
interacts with the peroxo-bound moiety directly. It has been suggested that it plays a 
role in polarizing the peroxo bond, making it more susceptible to nucleophilic 
attack.[30] The crystal structures indicate that Arg 490 is involved in two hydrogen 
bonds with oxygen atoms of the cofactor, both in the native and the peroxo forms, 
whereas Arg 360 donates only one hydrogen bond.[30] This difference agrees with a 
smaller catalytic efficiency of K353A and R490A as compared to the R360A mutant. 
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1. 2. 3. The Reactivity and Selectivity of the Reactions Catalyzed by V-HPO 
 
Halogenation of monochlorodimedone (MCD) represents the standard assay for V-
HPO, which was first developed to analysis the activity of heme-containing HPO.[43] 
The reaction is followed spectrophotometrically at 290 nm, monitoring the loss of 
MCD in the enol form (  = 20,000 M-1cm-1).[11]  In addition, phenol red is also used as 
a substrate to analyze the halogenation activity.[44] 
 
O
Cl
OH
+ X- + H2O2 + H+
O OHaloperoxidase
X = Br-, Cl-
Cl X
MCD
 
Scheme 2. Halogenation of MCD catalyzed by HPO. 
 
However, the high reactivity of both substrates makes it impossible to distinguish 
whether the nature of the oxidized halogen intermediate is enzyme-trapped, enzyme-
bound, or freely diffusible. Initial investigations into the reactivity of V-BPOs with 
various substrates, such as anisole or prochiral aromatic compounds failed to 
demonstrate any regio- or stereoselectivity upon bromination.[13, 45, 46] The apparent 
lack of selectivity at that time was interpreted to mean that V-BPO produces a 
diffusible oxidized bromine intermediate such as hypobromite, bromine or tribromide 
which would then carry out a molecular bromination reaction.[47] More recently, 
however, since more and more substrates have been tested, the chemo-, regio- and 
stereo-selectivity have been achieved to varying degrees and the selectivity seems to 
depend on the nature of the organic substrate.[13] 
The competitive kinetic studies comparing the bromination of indole substrates by the 
V-BPO/H2O2/Br– system to bromination by aqueous bromine (i.e., the equilibrium 
mixture of HOBr ⇌ Br2 ⇌ Br3–) under identical reaction conditions, showed that V-
BPO-catalyzed reactions were not consistent with a freely diffusible brominating 
intermediate.[13, 48, 49] A competition experiment revealed that vanadium 
bromoperoxidase catalyzed preferentially the bromination and oxidation of indole 
derivatives over phenol red or MCD (equimolar mixtures). In contrast, the same 
reactions performed with aqueous bromine showed the simultaneous bromination of 
all substrates present in solution.[48-50] 
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The first regiospecific bromoperoxidative oxidation was reported by the group of 
Butler.[51] Both V-BPO enzymes from the marine algae Ascophyllum nodosum and 
Corallina officinalis catalyze the regiospecific oxidation of 1,3-di-tert-butylindole in a 
reaction requiring both H2O2 and Br- as substrates, producing 1,3-di-tert-butyl-2-
indolinone product nearly quantitatively. Although the product is unbrominated, a  
regioselective brominated intermediate is certainly involved (Scheme 3). By contrast, 
reactions with the controlled addition of aqueous bromine solution (HOBr = Br2 = 
Br3-) produce three monobromo- and one dibromo-2-indolinone products, all of which 
differ from the V-BPO catalyzed product (Scheme 3).[48] Bromination and cyclization 
of terpenes is also reported by the same group.[52] 
 
N N
Br+
N
OV-BrPO
H2O2, Br
V-BrPO
H2O
N
Aqueous  Bromine
N
O
Br
N
O
Br
Br
+
 
Scheme 3. V-BPO catalyzed regiospecific bromination of 1,3-di-tert-butylindole[51]. 
 
The only reported stereoselective reaction catalyzed by V-HPO is the oxidation of 
sulfides to sulfoxides in the absence of halides.[53-56] Depending on the substrate, up to 
91% ee could be achieved, and different enzymes may produce different enantiomers 
from the same substrate (Scheme 4). However, the selectivity of sulfoxidation is 
exclusive to the marine algal V-BPOs, since V-CPO catalyzes the formation of a 
racemic mixture of the sulfoxide.[53-56] The reactivity of V-BPO (A. nodosum and C. 
pilulifera) to produce different enantiomers suggests that subtle differences in the 
substrate channel near the vanadium-binding site of these enzymes.[13]  
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Scheme 4. V-BPO catalyzed enantioselective sulfoxidation. 
 
 
1. 3.  From V-HPOs to Acid Phosphatases 
 
1. 3.  1. Structural Similarity 
 
Interestingly, the amino acid sequence of the active site of vanadium haloperoxidase 
is conserved in a completely different group of enzymes, the acid phosphatases. 
Sequence motifs are shared between V-CPO and several lipid phosphatases, the 
mammalian glucose-6-phosphatase, bacterial nonspecific acid phosphatases and the 
Drosophila development protein Wunen.[57-59] The sequence alignment of several V-
HPOs and acid phosphatases are shown in Fig. 5 A, from which a  dendrogram can be 
drawn (Fig. 5 B).[57] 
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Figure 5. (A) Alignment of V-CPO of C. inaequalis with the enzymes proposed to contain a 
structurally similar active site. The residues contributing to the active site of V-CPO are given 
underneath the alignment together with the secondary structure elements in which they are 
present. ■ , Residue hydrogen-bonded to vanadate in V-CPO; ♦ , histidine proposed to be the 
acid-base group of -CPO. ● , histidine coordinated to vanadate in V-CPO; ✫, residue shown to 
be essential for glucose-6-phosphatase (G-6-Pase) activity; ,α -helix; ➪, β -sheet; ━, loop. 
(B) A dendrogram based on the alignment. The group of membrane-bound phosphatases is 
marked with an M, and the group of soluble phosphatases is marked with an S.[57]   
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 The structural similarity of the active sites of V-HPOs and acid phosphatases is also 
reflected by the fact that phosphate inhibits or inactivates VHPOs and vanadate 
inhibits the phosphatases.[60-62] This similarity has been confirmed by structural 
determination of an acid phosphatase from Escherichia blattae[63] and its structural 
comparison with V-CPO (Fig. 6).[61]  Striking similarities are also observed from the 
X-ray structure of the rat prostatic acid phosphatase which has been co-crystallized 
with a vanadate at its active site.[64, 65] 
 
 
Figure 6.  Structure of the active site of (A) vanadium chloroperoxidase from C. inaequalis 
(PDB ID: 1 IDQ) and (B) the acid phosphatase from E. blattae (PDB ID:1D2T). The 
phosphatase cocrystallized with sulfate.[66] 
 
 
1. 3.  2. Dual Functions 
 
V-HPOs and phosphatases have different biological functions. The former catalyze 
the oxidation of halide, whereas the later catalyze the hydrolysis of phosphoester and 
phosphor anhydride bond. As previously described, since these two different types of 
enzymes share the same supramolecular environment at their active sites, hence it is 
reasonable to assume that both of them may exhibit the dual activities. Indeed, as 
Wever et al. showed that phosphatase activity can be observed using the apo-protein 
of V-CPO isolated from C. inaequalis;[36, 57, 62, 67] kinetic data, however, indicates that 
the active site of this V-CPO is not optimized for phosphatase activity. The possibility 
that peroxidase activity could be observed for vanadate-incorporated phosphatases has 
been investigated for several systems. The first observation of chloroperoxidase 
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activity was reported with phytase, added vanadate and H2O2.[68] Since then reports 
have been made demonstrating that other phosphatases can be converted to 
peroxidases in the presence of vanadate and H2O2.[61, 68-72] Thus, at this time the 
analogy between these classes of enzymes includes both structural and catalytic 
aspects. However, the detailed structural requirement for these two reactions is still 
slightly different. As shown by mutation study of V-CPO, the mutant H404A can still 
oxidize bromide but phosphatase activity is completely lost.[36]  
 
A major issue at the present time (and in the future) is whether the dual activity of 
these enzymes observed in vitro extends to the function and role of these enzymes in 
vivo.[73] 
 
 
1.  4. Vanadate as Phosphate Analogy 
Phosphate esters and anhydrides dominate the living world. DNA and RNA are 
phosphodiesters; most of the coenzymes are esters of phosphoric or pyrophosphoric 
acid; the principal reservoir of biochemical energy is adenosine triphosphate (ATP); 
phosphorylation and de-phosphorylation is most important means of signal 
transduction; many intermediary metabolites are phosphate esters, and phosphates or 
pyrophosphate are essential intermediates in biosynthesis and degradation.[74] 
Vanadate has long been recognized as a structural and electronic analogue of 
phosphate, encompassing the tetrahedral ground state and the penta-coordinated 
excited state, which is the chemical base of the wide range of vanadate biological 
activities.[73] 
 
1.  4.  1.  Comparison of Tetrahedral Form: the Ground State Analogy 
Vanadate and phosphate analogy is most evident in the tetrahedral trianionic forms 
(VO43- and PO43-) as demonstrated by their similar protonation reactions (Eq. 4-6).[75, 
76]
  However, the similarities of the pKa values for vanadate (3.5, 7.8, and 12.5)[77] 
with those of phosphate (2.1, 7.2, and 12.7) document that the analogy also extends 
from structural to the electronic properties of these species.[62, 73, 75, 76] 
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H3VO4 + H2O H2VO4- + H3O+     pKa  3.5                  (4)
H2VO4- + H2O HVO42- + H3O+     pKa  7.8                  (5)
HVO42- + OH- VO43- + H2O         pKa  12.7                 (6)
 
Given the central role of phosphate and phosphates in biology, a wide range of effects 
of two classes of V-compounds, vanadate anhydrides and vanadate esters, can be 
envisioned.  
1.  4.  1.  1. Vanadate Anhydrides as Structural Analogues of Condensed 
Phosphates 
In aqueous solution, vanadate undergoes a number of hydrolytic and self-
condensation reactions. The equilibria within the various vanadate species (Fig. 7) are 
very sensitive to pH, concentration and ionic strength (Fig. 8). Around neutral pH, 
H2VO4- and HVO42- oligomerize to form dimeric, tetrameric, and pentameric 
species.[78-80] These vanadate anhydrides are analogues of pyrophosphate, oligomeric, 
and polymeric phosphate anhydride. They readily undergo exchange in aqueous 
solution,[81, 82] whereas pyrophosphate and the corresponding oligomeric phosphate 
derivatives are stable and kinetically inert.  
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Figure 7.  Aqueous structures for the major vanadate species. 
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Figure 8.  Phase diagram showing the distribution of vanadate species as a function of pH 
and total Vanadium concentration. 
The tetrameric and pentameric vanadates are cyclic in solution and fail to show a 
structural analogy with the biologically interesting linear phosphates. The linear 
trivanadate V3O105- has been observed in solution by 51V NMR spectroscopy in the 
pH window of 8.8 to 9.2 at high ionic strength.[83] However, importantly a linear 
vanadate trimer was recently reported binding to phosphatase PhoE from Bacillus 
stearothermophilus.[84] Prior to this report, the structural analogy of these 
homovanadates were limited to the analogy between pyrophosphate and the vanadate 
dimer in purely inorganic systems.[85] No information is currently available on 
systems that support four-coordinate vanadium in a basic O3POVO3 unit. 
The most important anhydrides analogues are those of ADP, ATP, and other 
nucleotides. Although a range of ADP and ATP analogues have been prepared in 
aqueous solution and spectroscopically observed, the most useful analogues are 
AMPV and ADPV. Applications of both these analogues as probes have been met 
with some success, particularly when the analogue is binding in allosteric sites.[86-88] 
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1.  4.  1.  2. Vanadate Esters: Functional Analogues of Phosphate Esters 
Vanadate esters form readily in aqueous solution and are found to be enzyme 
substrates for a range of phosphate-involving enzymes including dehydrogenases, 
isomerases, and aldolases. One example of vanadate ester formation is the reaction 
between D-glucose and vanadate. D-Glucose contains one primary and several 
secondary hydroxyl groups that can form vanadate esters. Indeed, many species form 
in such solutions as indicated by 1H and 13C NMR spectroscopy (data not shown). 
However, as was shown first by Gresser, the small amount of glucose-6-vanadate that 
forms is recognized by glucose-6-phosphate dehydrogenase.[89, 90] In Scheme 5, the 
proposed conversions are shown, explaining the rapid oxidation of D-glucose to D-
gluconate that does not take place at an appreciable rate in the absence of the vanadate 
unit. 
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Scheme 5. Reaction of D-glucose with vanadate to form D-glucose-6-vanadate, a 
substrate for glucose-6-phosphate dehydrogenase. The oxidation of D-glucose catalyzed by 
glucose-6-phosphate dehydrogenase is shown next, followed by the hydrolysis of the 
vanadate ester.  
 
1.  4.  1.  3. Differences 
One difference between vanadate and phosphate is that near neutral pH the vanadate 
monomer exists primarily as a monoanion (H2VO4-), while phosphate exists primarily 
as a dianion (HPO42-). In contrast to the high stability of H3PO4, the existence of 
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H3VO4, although occasionally inferred, has not been documented,[78-80] presumably 
reflecting the conversion to VO2+, which is the major species of aqueous vanadate 
solutions at pH 1. Thermodynamic evidence has now been provided suggesting that 
the high stability of VO2+ is due to the increased coordination number of the hydrated 
form as compared to H3VO4.[91]  
Another difference lies in the fact that, under physiological conditions, vanadates can 
undergo redox chemistry[92] while phosphates do not. The most important difference, 
however, is that penta-coordinated phosphate is thermodynamically unstable and are 
only inferred as high-energy intermediates, whereas vanadate can accommodate a 
higher stable coordination number, which accounts for the notion that penta-
coordinated vanadates are analogues of penta-coordinated phosphate transition 
state.[93] 
 
1.  4. 2.  Penta-Coordinated Vanadate:Transation State Analogy of Phosphate 
A large variety of phosphate-metabolizing enzymes including phosphatases, mutases, 
ATPases, kinases, lyases, synthases and some ribonucleases, catalyze phosphoryl 
transfer reactions, and share the same mechanism involving the formation of penta-
coordinated phosphate as high-energy transition state. In general, these enzymes are 
potently inhibited by vanadate due to the chemical similarities between vanadate and 
phosphate combined with the ability of vanadate to readily undergo changes in 
coordination geometry (Fig. 9).[73, 94, 95]  
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Figure 9.  Schematic representation of penta-coordinated phosphate transition state and its 
vanadate analogy. 
This unique feature of vanadate was first proposed more than 30 years ago,[96] and has 
been confirmed by structural determination of a broad variety of enzymes which have 
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been co-crystallized with a vanadate. 39 structures including protein-vanadate 
complexes are available from the Protein Data Bank till September 7, 2004. Twenty 
one of them have been classified as representing transition state. All of the vanadate 
complexes classified as transition state mimics exhibit trigonal bipyramidal or 
distorted trigonal bipyramidal geometry at vanadium, and at least one bond between 
the vanadium atom and atoms of the enzyme or substrate molecules.[94] The incoming 
“nucleophile” normally occupies one of the two apical positions of the trigonal 
bipyramidal vanadium complex. Based on the different electron donor in the active 
site, these enzymes therefore will show some variation in their interaction with the V-
compounds (Fig. 10). For example, the alkaline phosphatase has a nucleophilic serine 
residue in the active site whereas some other protein phosphatases have a cysteine 
residue as nucleophile, and the acid phosphatases contain a histidine residue in the 
active site which bond vanadate similarly as VHPOs, which was described in part 1.3. 
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Figure 10.  Schematic representation of different types of penta-coordinated vanadate as 
transition state analogue of different phosphate metabolizing enzymes. 
 
1.  5.  Coordinating Bond or Covalent Bond: Implication from X-ray Structures 
The bond characteristic of the unique V-N linkage between the nitrogen (N 2) of His-
496 and vanadate at the active center of V-CPO was assigned as a covalent bond,[14, 29, 
30, 32]
 although the original X-ray data may not exclude a more likely interpretation, 
that this is a coordinating bond. Actually, due to its special electronic property, 
histidine is often chosen by nature as a bio-ligand to bind metals at various enzyme 
active sites, via coordinating bond, such as that in the hemoglobin.[97, 98] The only 
confirmed covalent his-metal bond appeared in the biological system is the copper-
zinc superoxide dismutase (CuZnSOD) enzyme, where a deprotonated histidine is 
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bound to a zinc and a copper ions simultaneously. However, two close metal ions is 
essentially required to form such a covalent bridge as shown in Fig. 11.[99-102] 
NN
CuII ZnII
 
Figure 11.  Schematic representation of “bridging imidazolate” of cupric form of CuZnSOD. 
The comparison of the V-N bond of V-CPOs with other enzyme-trapped penta-
coordinated vanadate should lead to a better understanding of the nature of this bond, 
since they are all formed from tetrahedral vanadium(5+) by accepting a fifth ligand 
without changing the oxidation state. If this newly formed bond is coordinating, the 
original V=O double bond should remain at one of the equatorial position, as shown 
in Fig. 12 (Type 1); otherwise, all the five bonds are single bonds if the newly formed 
fifth bond is covalent bond (see Fig 12,Type 2).  The bond order is visualized by the 
bond lengths as listed in Table 1. The length of the equatorial bonds of all available 
structures belonging to V-HPOs family (all type 1 in Table 1) is significantly shorter 
than that of type 2, reflecting there is one double bond exists for type 1, which may be 
averagely delocalized within the 3 equatorial bonds. Therefore, we suggest the V-N 
bond of V-CPO is a coordinating bond. 
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Figure 12.  The schematic view of two different type penta-coordinated vanadate 
depending on the different nature of the fifth bond (marked in red). 
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Name/Type PDB Resol. 
Nu 
d1 (Å) d2 (Å) d3 (Å) d4 (Å) d5 (Å) Ref. 
VCPOs Native/1 1IDQ 2.03 Å 
 
His 2,075 1,881 1,600 1,653 1,608 [30] 
VCPOs 
Recombinant/1 1VNI 
 
2.15 Å 
 
His 1,940 2,147 1,600 1,600 1,608 [32] 
VCPOs 
H404A/1 1VNG 2.20 Å 
 
His 1,956 2,002 1,592 1,598 1,590 [32] 
VCPOs 
R360A/1 1VNF 2.35 Å 
 
His 2,006 1,774 1,585 1,609 1,622 [32] 
VCPOs 
D292A/1 1VNE 2.15 Å 
 
His 1,974 2,196 1,590 1,604 1,601 [32] 
VBPO- 
Dimer-A/1 1QI9 2.05 Å 
 
His 2,111 1,771 1,690 1,517 1,604 [14] 
VBPO- 
Dimer-B/1 1QI10 2.05 Å 
 
His 2,111 1,772 1,543 1,590 1,575 [14] 
VCPO-N3/1 1VNC 2.10 Å 
 
His 2,249 1,982 1,535 1,641 1,667 [29] 
Alkaline- 
Phosphatase/2 1B8J 1.90 Å 
 
Ser 1,721 1,921 1,771 1,719 1,721 [103] 
Estrogen- 
Sul-transferase/2 1BO6 2.10 Å 
5’-phosphate 
of PAP 2,079 1,990 1,662 1,691 1,676 [104] 
Phospho- 
Glucomutase/2 1C4G 2.70 Å 
 
Ser 1,880 2,007 1,731 1,738 1,714 [105] 
Yersinia 
PTPase/2 (a) 2.2 Å 
 
Cys 2.520 1.940 1.61 1.68 1.71 [106] 
BovineLow 
MwPTPase/2 (b)  2.20 Å 
 
Cys 2,160 1,720 1,600 1,620 1,620 [107] 
Table 1.  The statistic bond-length on the different 2 types penta-coordinated vanadate in 
enzyme.(a) Data from personal communication with Prof. Mark A. Saper at University of 
Michigan; (b) Data of bond length from the original publication; structural data of both (a)  and (b) 
are not available at PDB. 
 
1.  6.  Synthetic Models of V-HPOs 
Evidence of the involvement of vanadium ions in V-HPOs and its particular activity 
have stimulated interest in synthesizing biomimetic structural and functional 
models.[39, 73, 108-111] A structural model allows deduction of site characteristics by 
possessing sufficiently high adherence to the indicated features via spectroscopic 
comparison, which is especially valuable to reveal possible coordination 
characteristics at the active site before the high resolution crystal structure of the 
enzyme is available. A functional model sustains a stoichiometric, or better, a 
catalytic reaction which transforms substrate to product as does the enzyme, albeit at a 
different rate and not necessarily with the natural substrate specificity. A functional 
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model is not ineluctably a structural model, but, ideally, a high-fidelity structural and 
functional model will certainly leads to the ultimate goal of bioinorganic research: 
definition of function in terms of structure. [112, 113] 
 
1.  6.  1.  Structural Models of V-HPOs 
Two general categories of complexes have been described as structural model 
complexes for haloperoxidase enzymes. The first class is defined as compounds 
containing V (5+) and even (4+) bound to ligands with O and N donors and almost all 
of them contain V-O-R covalent bonds as vanadate ester or mixed vanadate-
carboxylic anhydrate; some examples are shown in Fig. 13. The largest group within 
this class of compounds is the Schiff base complexes. More than 200 crystal 
structures of V-containing Schiff bases can be found in a search of the 
crystallographic database and document the widespread interest in these types of 
compounds.[39, 114, 115]  
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Figure 13.  The selected vanadium complexes with O and N donors supposed to be 
structural models of V-HPOs. 
The second class of model complexes includes peroxovanadium complexes. These 
complexes are of interest because vanadium peroxide is involved as an intermediate in 
the catalytic cycle of the VHPO reaction, and the peroxide form of V-CPO has been 
confirmed by crystal structure determination.[30] A wide range of peroxovanadium 
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complexes have been reported, and several reviews are dedicated to the discussion of 
the structure and chemistry of these systems. [73, 116, 117]  
Combined methods using 51V NMR spectroscopy, potentiometric data (glass 
electrode), electro spray ionization-mass spectrometry (ESI-MS), and ab initio 
calculations have been found to be excellent tools for obtaining direct information 
about the structure and chemistry of peroxovanadates in solution.[117-121] The number 
of peroxo groups and the auxiliary ligand that are coordinated to the vanadium atoms 
dictate the structures (and reactivity) of the peroxovanadium complexes. The peroxo 
group is bound side-on to the V(V) atom with V-O bond lengths on the order of 1.85 
Å and O-O bond lengths of about 1.4 Å. Complexes are known with one, two, three, 
and four peroxo groups, although only the two former classes of complexes are found 
under the conditions required of functional mimics. Coordination numbers around the 
vanadium are generally 6 or 7, and the elaborate dimeric structures often fall apart 
upon dissolution of the compounds. However, detailed speciation has been 
characterized for a few simple systems, and this area has been recently reviewed.[122] 
It is worth to note that there is one example in which the intramolecular hydrogen 
bond was taken into the consideration for the design of structural model.[123] However, 
the stability of the overall complex is still mainly contributed from the covalent bonds 
between vanadate oxygen and ligands, as shown in Fig. 14. 
 
 
Figure 14.  The ORTEP view of [VO(O2)(BrNH2pyg2)]-. Hydrogen bonds in dashed lines. All 
protons have been omitted for clarity. [123] 
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The structural information regarding the haloperoxidases active sites have now shown 
that these complexes are poor structural model systems.[39, 73] 
 
1.  6.  2.  Functional Models of V-HPOs  
Initial studies on functional mimics of V-HPO were driven by the lack of 
spectroscopic techniques capable of observation of the vanadium site in the enzyme. 
Nevertheless, effective modeling of the V-BPO activity was obtained for cis-
dioxovanadium (VO2+) in acidic aqueous solution by Butler and co-workers.[124, 125] 
Previously,  oxidation of iodide under similar condition had been reported.[126] With 
this system, a detailed mechanism involving H2O2 binding to V, followed by bromide 
oxidation was proposed, similar to V-HPOs. Two important differences between this 
system and V-HPO are that a dinuclear species, V2O2(O2)3, was implicated as the 
active catalyst and strongly acidic conditions are required for activity (pH  2). The 
identification of dimeric active species was based on the fact that (1) the rate of halide 
oxidation showed clear second order dependence on [V], and (2) a maximum rate was 
observed under pH and H2O2 concentrations where VO(O2)+ and VO(O2)- were equal, 
and thus, the concentration of the dimeric V2O2(O2)3 is maximized,  Eq. 7-9. The 
proposed mechanism for this reaction is outlined in Scheme 6. 
VO2+ + H2O2  VO(O2)+ + H2O        K1                                (7) 
VO(O2)+ + H2O2   VO(O2)- + 2H+   K2                                (8) 
VO(O2)+ + VO(O2)-  V2O2(O2)3       K3                                (9) 
VO2+ VO(O2)+ VO(O2)2-
(VO)2(O2)3
K1
K3
K2
Br-
HOBr = Br2 = Br3-
 
Scheme 6.  Proposed mechanism of halide oxidation by V2O2(O2)3.[127] 
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While the structure of V2O2(O2)3 is not known, Pecoraro proposed the structure of the 
active V2O2(O2)3 to have an asymmetrically bridging peroxide of the form shown in 
Fig. 15 (B),[128]based on the 51V-NMR study in acetonitrile[129] and the crystal 
structure of tetraperoxo dimmer (Fig. 15 (A))[130]. In Fig. 15B, the second vanadium 
could very well function as a “giant proton”, activating the diperoxovanadate complex 
toward nucleophilic attack by the halide, comparable to the proton in the monomeric 
complexes, as suggested for V-HPOs.[128] 
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Figure 15.  Drawing of (A) V2O2(O2)42- and (B) proposed coordination of V2O2(O2)3. 
Conte and co-workers designed a two-phase system (H2O-CHCl3 or H2O-CH2Cl2); 
products analysis, ESI-MS and ab initio calculations were carried out to provide 
evidence for the hypobromite-like V-complex.[131-133]  
These studies importantly demonstrated that not only do systems exist that mimic the 
enzyme reaction, but if the simple ion can catalyze this reaction, complexing ligands 
should be able to enhance and/or retard this reaction. Since then, a range of systems 
have been reported competent to carry out this reaction.[39, 73, 108, 114, 115, 117, 134] These 
complexes include the first monomeric complexes LVO(OEt)(EtOH) (L = N-(2-
hydroxyphenyl)salicylideneamine or N-(2-carboxyphenyl)salicylideneamine) (Fig. 16) 
reported by Butler and co-workers, which showed that the bromination of the organic 
substrates proceeded exclusively via an electrophilic mechanism and involved no 
radical intermediates.[135] 
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Figure 16.  Drawing of LVO(OEt)(EtOH)[135] 
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Pecoraro and co-workers designed a model system with ligands which completed the 
coordination sphere of an oxoperoxovanadium unit.[128, 136-138] These most completely 
studied model compounds have been with tetradentate tertiary amine complexes 
containing different combinations of carboxylate, amine, alcohol, amide, or pyridyl 
donors (Fig. 17). The most efficient complex of this class, [VO(O2)Hheida]- , in the 
presence of excess acid and peroxide, up to 10 turnovers were accomplished within 3 
min, and thus increased the rate of reaction by at least an order of magnitude greater 
than that observed for Butler’s systems. The starting dioxovanadate complexes 
(VO2L’, L’= tetradentate ligand) and oxoperoxovanadate complex (VO(O)2L’) (Fig. 
17) have been isolated and structurally characterized. In addition, the kinetics of 
peroxide binding to the complex[136] and the kinetics of subsequent halide 
oxidation[137, 138] have been measured and a detailed mechanism proposed. These 
systems also catalyze O2 formation in the absence of an organic substrate, similar to 
enzymes. Studies with H218O2 showed persuasively that the oxidation of bromide 
produced O2, which was completely labeled with 18O and thus indicated that peroxide 
is oxidized without oxygen-oxygen bond cleavage.[137] One key point with the kinetic 
studies of the VO2L’ complexes is that the reactions were run in acetonitrile. This less 
polar solvent was vital, since chloride, bromide and iodide oxidation were not 
observed under any aqueous conditions. Both bromide and iodide can be oxidized in 
acetonitrile, but chloride oxidation was not achieved in water or acetonitrile.  
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Figure 17.  Oxoperoxovanadate complex (VO(O)2L’) and the abbreviation (H2heida = N-(2-
hydroxyethyl)iminodiacetic acid; H2ada = N-(2-amidomethyl)iminodiacetic acid; H3nta = 
nitrilotriacetic acid; Hbpg = N,N-bis(2-pyridylmethyl)glycine.) of the ligand. 
The kinetics of peroxide binding to the VO2L’ complexes to form the oxoperoxo 
complex, VO(O2)L’, are first order in VO2L’. In the absence of acid, Michaelis-
Menton behavior was observed upon H2O2 addition, indicating the formation of a 
reversible VO2L’ H2O2 intermediate. Upon addition of acid, the Michaelis-Menton 
behavior is greatly diminished or disappears completely (depending on ligand and 
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acid concentration), and a first order dependence on H2O2 concentration is observed. 
The proposed mechanism for peroxide binding is summarized in Scheme 7.[136]  
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Scheme 7.  Proposed mechanism for peroxovanadium complex formation.[136]  
The kinetics of halide (Br-, I-) oxidation are first order in peroxovanadate complex and 
halide. Based on kinetic, UV-vis and NMR analysis, there is no evidence of halide 
binding to the complexes at any point during the reaction. One very important factor 
for achieving halide oxidation in acetonitrile is the need for one equivalent of acid. In 
the absence of acid, no reaction occurs. These results suggest that the complexes must 
be protonated (presumably at the peroxide) to become active. By studying the rate 
dependence on acid, estimated pKa’s for the protonated peroxovanadate complexes in 
acetonitrile have been obtained and range from 5.5-6.0, depending on the ligand. For 
comparison, the pKa’s of HI and HBr in acetonitrile are also in this range, while the 
pKa of HCl is ca.9. Thus, Pecoraro provided an explanation for the lack of chloride 
oxidation in acetonitrile is that the chloride buffers the reaction, preventing the 
formation of the active protonated peroxovanadate complex.[137, 138]  
Based on these studies, the mechanism in Scheme 8, has been proposed for the 
Pecoraro’s model complexes. This mechanism is also consistent with enzymatic 
studies, where it was shown that the halide oxidation step proceeds faster at lower pH 
where protonation of the peroxide is favored[47]. In addition, His-404 and Lys-353 are 
both located near the vanadium binding site and may participate in activating the 
complex through hydrogen bonding interaction.[29, 30] With regard to the other model 
studies, no evidence for complex protonation was provided, but the reactions were all 
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run under acidic conditions because of the need for protons to drive the net 
reaction.[124] 
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Scheme 8.  Proposed mechanism of Pecoraro’s model. 
Although much progress has been made in recent years toward achieving bromide 
oxidation with model complexes, Cl- oxidation has remained relatively elusive. It has 
been observed with V2O2(O2)3 in aqueous solution but no rates were reported, 
presumably because the rates were too slow to measure.[124] Chloride oxidation has 
been achieved by using mixed water/acetonitrile solvent. By adjusting water 
concentration in acetonitrile, vanadate has been shown to catalyze chloride oxidation, 
with a mximum rate occurring in 6% H2O/94% CH3CN.[128, 129] Presumably, this 
water concentration represents conditions where the concentration of the active 
protonated peroxovanadate species is at a maximum. Unfortunately, 51V NMR shows 
that the equilibrium under these conditions is very complex, and the active 
peroxovanadate species has not yet been identified. Approximate first order 
dependence of the rate of halide oxidation on [V] strongly supports a monomeric 
complex as the active species. The rate dependence on Cl- concentration has not been 
determined because Cl- acts as both a substrate and an inhibitor.[128] 
 
Although success was obtained to some extents with several functional model systems, 
the lack of the structural similarity, especially concerning the hydrogen bond net work 
and positively charged donor sites of V-HPO active pocket, the significance for 
mechanism comparison between models and enzyme, is limited. 
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2. Aim of this Work 
Vanadium haloperoxidase (V-HPO) are one of the few natural occurring enzymes 
found that catalyze the halogenation of organic substrates. According to X-ray 
structure analysis of vanadium chloroperoxidase (V-CPO), the co-factor of the 
enzyme is a monovanadate HVO42- bound to the protein in a unique supramolecular 
fashion, i.e. via H-bonding to the positively charged amino acids (Arg 360, Arg 490 
and Lys 353) and via a single V-N bond to the nitrogen (N 2) of His 496.  
The enzyme works at slightly low pH and employs H2O2 and X- (Br- and Cl-) which 
take part in the catalytic cycle. It is believed that the reaction mechanism passes 
through a peroxovanadate [Enzyme-VO2(O2)-].  which is then protonated, and 
subsequently attacked by X-. This X- is then oxidized  to X+ for further electrophilic 
reactions. 
Many details of the reaction pathway are uncertain and no enzyme model has been 
prepared which contain the unique cofactor-binding –mode of the native enzyme.  
Therefore, the aim of this work has been the preparation of the receptors that (1) bind 
vanadate (and its structural analogue phosphate) in a enzyme like fashion and (2) 
catalyze the halogenation of organic substrates. 
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3. Results and Discussions 
 
3. 1. Tris(2-guanidinium-ethyl)amine (TGEA), the First Supramolecular 
Receptor of Orthovanadate and a Spectroscopic Model of V-HPO 
3. 1. 1. Design and Synthesis 
Binding of anions through non-covalent interactions is a common structural motif of 
many enzymes[139] inter alia of proteins such as phosphatase and V-HPO. The 
development of supramolecular receptors for phosphate has been extensively 
studied,[140-145] while its structural analogues, such as vanadate, and other transitional 
metal anions, have been rarely investigated. From the conventional view of 
supramolecular chemistry or “host-guest” chemistry, the vanadate behaves like a dual 
property “guest”: it accepts hydrogen bonds and Coulomb interactions via the oxygen 
atoms as a typical anionic “guest”, while vanadium center maintains the capability to 
coordinate to ligands with lone pairs. In particular, this feature requires ligands to 
selectively bind vanadate that are different from those designed for phosphate. 
To obtain a supramolecular receptor that binds vanadate in an enzyme-like fashion, 
we chose the tripodal ligand Tris(2-guanidinium-ethyl)amine (1, structure see Scheme 
9), of which binding of phosphate has been already studied.[146] 1 contains three 
guanidinium subunits flexibly connected to a central nitrogen. It is important to note 
that this central nitrogen could bind to vanadium, i.e. mimicking the histidine N of the 
active site coordination in the enzyme. Further, the high pKa value (pKa=13.5 for 
guanidinium in water)[147] of the three guanidiniums, which replace two arginines and 
one lysine in the active site of V-CPO, ensures protonation in a broad pH window 
providing positive charges and several hydrogen bond donor sites. The charge 
repulsive effect adjusts a low pKBH value of the central nitrogen atom preventing 
protonation down to pH 2.48[146] and hence providing a lone pair to coordinate with 
vanadium at experimental conditions, vide infra. 
It is worth to note that the guanidinium group is widely adopted for binding of anions 
either in biological systems[148] or in synthetic receptors because of its high pKa value 
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and directional hydrogen bond donor ability.[149, 150] For other guanidinium receptors 
see references.[141, 142, 146, 150-169] 
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Scheme 9.  Synthesis of TGEA (1) and proposed structure after binding of vanadate. 
1 was conveniently synthesized in one step from 2 and 3 in the presence of 3 
equivalents of diisopropyl-ethyle-amine (DIEA) under ultrasonic conditions (Scheme 
9), and purified by crystallization from methanol/CH2Cl2 as the tris-HCl salt which 
co-crystallized with one molecule of methanol. 
 
Figure 18. X-ray structure of 1. The cocrystallized methanol molecule, another two chloride 
anions and the CH2 hydrogen atoms are omitted for clarity. Hydrogen bonds are in dotted line 
with figures of the distances marked (Å). The figure was prepared with the program WebLab 
ViewerLite.  
The crystal structure of 1 exhibits a basket shape (Fig. 18), binding one chloride anion 
inside the basket, by forming six hydrogen bonds with two NH hydrogen atoms of 
each of the three guanidinium groups, that are pointing towards the central axis of the 
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basket. The two nitrogen atoms of N-CH2CH2-N(G) adopt a gauche conformation and 
the central nitrogen atom has an endo- configuration, with its lonepair inside the 
basket. This special arrangement seems to be suitable to bind vanadate. Further, 
molecular modeling indicates that the three arms have a certain flexibility and hence 
the chloride shown in the crystal structure of 1 can be replaced by HVO42- to give a 
complex as 5 (Scheme 9). 
 
3. 1. 2. Binding of HVO42- to TGEA, NMR Titration and ESI-MS 
The formation of a complex between 1 and 4 causes the change of chemical shifts for 
both 1H and 51V nuclei, facilitating the binding study by NMR titration. 51V NMR has 
been an indispensable technique in characterizing vanadium (5+) complexes[170]. 
Although nuclei with spin 7/2 usually give broad peaks in NMR spectroscopy, the 
unusually small absolute quadruple moment ( 0.037×10-28 m2), the relatively large 
magnetogyric ratio (  = 7.0453×107 rad T-1S-1), and the high natural abundance make 
the 51V one of the most favored nuclei for NMR with a relative sensitivity 
approximately 2000 times greater than 13C[83, 86, 129, 170, 171]. 
To investigate the binding of vanadate 4 to ligand 1 the following important aspects 
have to be considered. Depending on concentration and pH, vanadate forms 
equilibrium mixtures of monomeric and oligomeric vanadates; thus, to facilitate NMR 
titration experiments conditions for the presence of only monovanadate (HVO42-) 
should be used. The use of buffers can be abandoned since many of the possible ions 
bind to vanadate[172, 173] and/or to 1. Further, according to earlier studies[122] the 
chemical shift of 51V is extremely pH dependent. For these reasons a stock solution of 
HVO42- (Bu4N+ as counter cation) was prepared in water, pH 10.2, for which HVO42- 
is >90% the dominant species. This solution was titrated with 1 at constant pH 10.2. 
The titration was followed by 51V NMR and 1H NMR (Fig. 19). The 51V resonance 
shifts from −536 ppm (4)[122] to −544 ppm (5) and protons at C adjacent to the central 
nitrogen shift from 2.77 ppm (1) to 2.65 ppm (5). Both NMR methods, using a 
nonlinear least-squares fitting reveal that the 1:1 complex 5 is formed and that 4 binds 
1 with Ka = 1.1 × 103 M−1.  
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Figure 19.  1H-NMR(A)- and 51V-NMR(B)-titration curves of binding 4 to 1 in aqueous 
solution;  pH was kept at 10.2 with (n-Bu4N+OH-)/HCl, and total vanadate concentration is 
constant at 2 mmol/l to avoid concentration dependent 51V chemical shift change. 51V 
chemical shifts relative to VOCl3 (0 ppm). 
The binding of 1 and 4 is highly pH dependent. The titration performed at pH 12.01 
showed a big difference on the tendency curve both of 1H- (not shown) and 51V- 
chemical shifts (Fig 20). Job plot[174, 175] displays a maximum at vanadate fraction 
([4]total/([4]total+[1]total) of 1/3, indicating the formation of 2:1 complex between 1 and 
4, which can be explained by changing of protonation states at higher pH: the positive 
charge number of 1 decrease and negative charge number of 4 increase due to 
deprotonation of both species. 
 
Figure 20.  Comparison of 51V-NMR titration curves of binding 4 to 1 at pH 10.2 and 12.01. 
Inlet is the Job plot at pH 12.01. 
1H-NMR titration was performed under identical condition to study the binding of 1 
to phosphate, and the resulting highly similar titration curve reflects the structural 
analogy of HPO42- and 4 (Fig. 21). However, the 31P chemical shift of phosphate is 
not sensitive enough to facilitate accurate titration. 
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Figure 21.  Comparison of 51V-NMR titration curves of 1 binding vanadate and phosphate. 
Further evidence for the formation of 5 was obtained by ESI-MS which showed a 
prominent peak at 391.2 (391.17, calculated).  
 
3. 1. 3. V-N bond characterization: UV and TD-DFT study 
The coordination of the nitrogen (N 2) of His 496 of V-CPO of Curvularia inaequalis 
has been related to a particular UV absorbance at 312 nm.[67]  It is interesting to note 
that the UV difference spectrum of 4 and 5 reveales the same characteristic displaying 
λmax= 307nm (Fig. 22). 
 
Figure 22.  Difference spectrum of 5 and vanadate 4 in DMSO with total vanadate 
concentration of 0.2 mmol/l.  
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For in depth understanding of the relationship between the excitation and the structure, 
ab initio calculations were carried out with the GAUSSIAN98 suite of programs.[176] 
In all calculations the total wavefunction was converged to 10-7 at the 6-
31G**/B3LYP (for closed shell) or 6-31G**/UB3LYP (for open shell) level. For the 
electronic spectra time-dependent density functional theory (DFT) was used. The 
starting structure for the partial optimizations was the X-ray structure of vanadium 
chloroperoxidase (V-CPOs, PDB code 1IDQ) with the Lys 353, Arg 360, His 404 side 
chains constrained to their respective positions in the crystal.[30] Subsequently, the 
structure of the His496-HVO42- system was optimized (Fig. 23A). With time-
dependent DFT calculations the positions and intensities of the electronic absorption 
bands were determined on this optimized structure. The continuous spectrum was 
derived from converting the stick spectrum with a Gaussian lineshape with full width 
at half maximum of 7.5 nm centered around the calculated frequency and with peak 
intensity from the electronic structure calculation. For comparison, the electronic 
spectrum of isolated HVO42- was also determined at its respective optimized structure 
(Fig. 23B). 
 
Figure 23.  (A) Model system for the active site of 1IDQ. Position of H atoms were 
optimized while heavy atoms of the protein fragments were kept at their X-ray positions. (B) 
The calculated UV spectra of HVO42-(trace 1 below) and after adding subunits of the enzyme-
like micro-environment. Abbreviations: W: H2O; protein: Lys 353, His 404, Arg 490. 
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The calculated UV spectra of HVO42- and HVO42--His-protein, are shown in Figure 3. 
In good agreement with experiments the main absorptions of isolated HVO42- are 
below 300nm (trace 1 in Fig. 23B). Approaching N 2-histidine to vanadium of 
HVO42- changes the geometry of V-coordination and leads to a V-N distance-
dependent absorption above 300nm. When the V-N distance is set at 2.07 Angstrom, 
the distance found in enzyme (see also Figure 3A) the bands below 300 nm almost 
entirely disappear (trace 2 in Fig. 23B). Keeping the V-N distance constant the 
binding of water to the apical OH of HVO42- (trace 3 in Fig. 23B), further H-bonding 
by His 404 to the same oxygen and Arg 490 and Lys 353 interactions to equatorial 
oxygen atoms of HVO42- (trace 4 in Fig. 23B) qualitatively give the same picture: 
significant UV absorptions between 300 and 350 nm. The UV absorptions between 
300 and 350 nm remain though their intensities are modulated depending upon the 
number of H-bonds. These results support the interpretation of the UV-difference 
spectrum of V-CPO from Curvularia inaequalis relating the observed absorbance to a 
V-N interaction. 
Similar calculations were also performed for the model system 5 (Scheme 9). The 
proposed structure was partially minimized at the AM1 level. Then, the interatomic 
distances were further optimized by ab initio calculations using the methods and basis 
set described above. The flat potential energy surface along the coordination during 
optimization accounts for the flexibility of 5. Electronic absorption spectra were then 
calculated at a series of V-N distances, namely 2.55, 2.35, 2.25 and 2.00 Å to study its 
influence on absorption. The resulting maxima of the absorption band above 300 nm 
and the maximum intensities are shown in Fig. 20. Both of them increase significantly 
as the V-N distance becomes shorter suggesting a strong relationship between V-N 
distance and excitation. 
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Figure 24.  Change of intensity (solid line) and λ max (dashed line) of the absorption band 
above 300 nm as a function of the V–N distance in 5. For decreasing V–N bond length the 
maximum shifts further to the red and the intensity increases. The absorption is strongly 
dependent upon the V–N distance. Similar results were found for the model system for the 
active site of 1IDQ compound in Fig. 23A. 
 
3. 1. 4. Binding of Peroxovanadate to TGEA 1 
Whether peroxovanadate binds to 1 is of interest, because the mono-peroxide form is 
proposed as the key intermediate in the catalytical cycle of VHPO, which is 
confirmed by X-ray structure determination[30] (see chapter 1. 2. 1. 1. 3.). Although 
the vanadate readily forms adducts with hydrogen peroxide in solution, it is almost 
impossible to prepare a stock solution in which the mono-peroxovanadate is a 
predominant species to facilitate the NMR binding study, because the interaction 
between vanadate and hydrogen peroxide gives rise to a variety of species and 
equilibrium.[177] For example, in the neutral aqueous solution of H2O2/V at a ratio of 
1/1, mono-peroxovanadate is only a minor component, while di- and non-
peroxovanadate are dominant species. Upon addition of one equivalent of 1 to this 
solution, the 51V NMR peak of di-peroxovanadate shifted slightly to higher field 
(from -694ppm to -697ppm) and became a little broader indicating complexation of 1 
and diperoxovanadate may occur. However, the presence of 1 did not change the 
vanadate equilibrium and no evidence could be obtained whether the system catalyzes 
the oxidation of Br- to Br+. 
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3. 1. 5. Tris(3-guanidinium-Propyl)amine (TGPA) and Solvent Effect 
In order to study the influence of the length and flexibility of the linkers between the 
central nitrogen and the three guanidinium units, tris(3-guanidinium-Propyl)amine 
(TGPA, 6) was synthesized in a same way as for 1. However, the following NMR 
titration and UV study failed to demonstrate that the binding of vanadate to 6 occurred, 
presumably because 6 is too flexible and the charge repulsive effect of the 
guanidinium moieties favors a “dendrimeric” structure rather than a “basket”, and 
hence disfavors binding.  
N
N
H
HN
NH
NH2
H2N
NH2
NH2
H2N NH2
6, 3 Cl-
8, 3 BPh4-
 
The polar inter-molecular forces such as hydrogen bonding and electrostatic 
interactions will be enhanced in less polar solvent. To improve the solubility of 1 and 
6 in organic solvents, the Cl- counter anion of both 1 and 6 were exchanged to 
tetraphenylborate (BPh4-), via precipitation in water with NaBPh4. The resulting 
TGEA.3·BPh4- (7) and TGPA.3·BPh4- (8) are both highly soluble in acetonitrile. 
However, when 7 or 8 was titrated with vanadate in acetonitrile, a cloudy solid 
precipitated immediately and the solid could not be re dissolved in most of the organic 
solvents, not even in DMSO/H2O mixture. The IR spectrum (KBr) of the precipitate is 
significantly different from that of 6, the detailed assignment needs further 
investigation. 
 
3. 1. 6. Summary of part 3.1. 
In summary, NMR and UV spectroscopy of 5 revealed the structural similarity to the 
active site of V-HPO. DFT calculations identify V-N transitions as the origin of the 
observed UV spectra for both the enzyme V-CPO and its model 5. Since it is obvious 
that the central nitrogen in 5 forms a coordinative bond to vanadium our results 
indicate that the vanadium-N 2His 496 interaction in V-CPO is of the same nature. 
Accordingly 5 is a spectroscopic enzyme model of V-CPO. 
 39 
3. 2. Macrobicyclic Guanidinium-Cryptand: the Cage Shaped Receptor 
3. 2. 1. Design and Retro-synthetic Analysis 
Given the Ka of about 1×103 M- between 1 and vanadate, the 1:1 ratio of free and 
ligand bound vanadate (5) can be calculated for a solution containing 2M of each 1 
and HVO42-. The ratio of free vanadate will even increase if the total concentration 
decrease, hence to facilitate the study of catalytic activity, new receptors with higher 
affinity to vanadate are desired, such that most vanadate in solution is complexed and 
the activity from free vanadate can be eliminated to an acceptable extend. Inspired by 
the cryptand ligand, which was developed by Lehn over 30 years and achieved great 
success to tightly and selectively encapsulate cations[178-182] and anions,[180, 183] we 
designed the new macrobicyclic guanidinium receptors as shown below. 
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Figure 25.  Schematic representation of the designed guanidinium cryptands. 
These new receptors inherit the key structural features from the first generation 
receptor 1 which are needed to bind vanadate, namely, three guanidinium units linked 
to a central nitrogen by alkyl chains.  However, unlike their open-armed precursor 1, 
the other N-terminals of the three guanidiniums are tethered by another tripodal link, 
generating cage-shaped receptors. They should be conformationally more rigid than 1 
and the cavity is expected to encapsulate vanadate with higher affinity. In principle, 
the size and geometry of the cavity can be tuned by varying the length of alkyl chain 
at one or both sides, and additional one more positive charge can be introduced at the 
top central nitrogen, which should further expand the size of cavity due to the exo-
configuration of that nitrogen. 
To the best of our knowledge, only one paper reported the synthesis of guanidine 
cryptand with a low overall yield,[184] and the binding study to any guest molecule is 
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not published. However, our synthetic strategy is expected to be applicable to a 
variety of different multicyclic cage-shaped guanidinium receptors to meet the need 
of our design. With this main aim in mind, the following retro-synthetic strategy is 
proposed (Scheme 10). 
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Scheme 10.  The general retro-synthetic analysis of the guanidinium cryptands. 
The thiourea analogue is chosen as a key intermediate because this functional group is 
a common synthetic precursor of guanidine compounds and various efficient methods 
have been developed, even for solid phase transformation[185]. Another important 
reason is that thiourea is also a relatively strong hydrogen bond donor and structurally 
similar to the guanidinium group except for the absence of charges. Both moieties 
adopt a “Y” type planar conformation due to the mesomeric –character of the system, 
providing two hydrogen bond donor sites per unit. Indeed, thiourea has been 
extensively employed for the design of neutral anion receptors[186-204]. However, 
unlike guanidinium, thiourea is neutral, providing the chance to compare the influence 
of positive charges on the binding of vanadate. The thiourea intermediate can be 
obtained from the addition of the tris-amine (i.e. 2) to tris-isothiocyanate compounds 
(26, 27). This is a very fast and efficient reaction facilitating the high dilution reaction 
which favors the cyclization over polymerization. Notably, the tris-isothiocyanate can 
be obtained from the tris-amine compound. The benzyl is introduced at the top central 
nitrogen from the very beginning of synthesis, and should be able to be removed by 
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reductive debenzylation at any step of the following reactions if needed. Therefore, 
this synthetic strategy is flexible and allows us adjusting the size and geometry of the 
binding cavity of the target guanidinium cryptand without changing the synthetic 
pathway. 
 
3. 2. 2. Synthesis  
Starting from commercial available N-4-bromobutyl-phthalimide 9 or N-5-
bromopentyl-phthalimide 10, the tris-NH2 compounds with C4 (17) or C5 (18) alkyl 
chain were prepared according to the known procedures,[205, 206] respectively (steps a 
 d, Scheme 11), or through a slightly modified method: 9 and 10 were converted to 
their iodide derivatives (19, 20) first, then reacted with benzyl amine to give 
quaternary ammonium iodide salts 21 or 22, and the following stepwise cleavage of 
phthalimide and benzyl protecting group afforded the desired tris- NH2 17 and 18. 
One advantage of the modification is the central-N-benzylated derivatives (23, 24) 
could be obtained via the same route without removal of the benzyl group. The tris-
amine with shorter alkyl chains, see 2 and 25 are both commercial available. For 
practical purposes, only these two compounds were converted to their isothiocyanate 
derivatives 26 and 27 by reacting with CS2 and DCC, although in principle the tris-
NH2 with longer arms can also be transform to isothiocyanates and then cyclize with 
the smaller tris-NH2 counter partner, however is less convenient.  
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Scheme 11.  The overall synthetic pathways for guanidinium cryptands. Reagents and 
conditions: (a) Benzyl amine, KF/Celite® 545, CH3CN; (b) H2/Pd-C, EtOH; (c) 9 or 10, 
KF/Celite® 545, CH3CN; (d) hydrazine, EtOH, reflux; (e) KI, acetone; (f) Benzyl amine, 
KF/Celite® 545, CH3CN, reflux; (g) CS2, Et3N, DCC, THF; (h) high dilution, tris-amine or tris-
isothiocyanate, CHCl3; (i) high dilution, tris-isothiocyanate, CHCl3/DMF = 1 : 1; (j) MeI, then R-
NH2; (k) Muikaiyama reagent, R-NH2. 
Tris-NH2 compounds are readily cyclized with tris-isothiocyanate under high diluted 
conditions to form the thiourea cryptands as key intermediates. Depending on the 
length of the arms, yields are different. In general, the smaller the size, the higher the 
yield. The smallest thiourea cryptand 28 with three identical –(CH2)2- links at both 
sides was prepared quantitatively, while for 34, the largest one, only 24.4% yield 
could be obtained. DMF was chosen as solvent only when the solubility of the starting 
material is lower, such as for the ammonium salts tris-NH2 (23, 24), otherwise 
chloroform is more favorable. Compounds 28 and 29 have been crystallized and 
characterized by X-ray structure determination (Fig. 26). These two compounds 
exhibits certain conformational differences in the solid state, such as the thiourea 
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groups adopts Z,Z-conformation in 28, but Z,E-conformation in 29. Nevertheless, all 
the central nitrogen atoms are endo-oriented with the lone pair pointing into the cavity; 
accordingly both could coordinate to vanadium atom of the encapsulated vanadate. 
The broad NMR signals of all the thiourea cryptands suggest conformational 
equilibria existing in solution. 
 
 
Figure 26.  The ORTEP drawing of compound 28, top-left: viewing from side, top-right: 
viewing from top; and compound 29, bottom-left: viewing from side, bottom-right: viewing from 
top. All CH2 hydrogen atoms are omitted for clarity. 
Several methods had been tried to convert the different thiourea precursors to 
guanidinium cryptands. It has been found out that the feasibility of the method is 
depending on the structure. Mukaiyama reagent has been successfully used to 
synthesize the guanidinium 33 from the thiourea 30, through a carbodiimide 
intermediate[207, 208] following by condensation with benzyl amine in one pot (Method 
A, Scheme 12). However, this method was failed for substrates with –(CH2)2- linkers, 
such as compounds 29 and 34, though the formation of their carbodiimide 
intermediates had been determined by ESI-MS during the reaction. Finally an 
alternative method has been developed. These two compounds were converted to S-
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methyl-isothiourea intermediates, without purification they reacted with primary 
amine by nucleophilic substitution finally to afford the guanidinium macrocycles 32 
and 35 (Method B, Scheme 12). 
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Scheme 12.  The two methods applied to synthesize guanidinium cryptands. 
 
3. 2. 3. pKa of central nitrogen  
An unprotonated central nitrogen atom is needed to form V-N coordination. Therefore, 
the pKBH value of the nitrogen needs to be determined. Since the protonation of the 
central nitrogen is coupled with significant chemical shift change of related CH2 
signals, 1H-NMR titration was used. For example, the protonation of the central 
nitrogen of compound 35 causes significant change of chemical shift not only for the 
adjacent H-atoms, but also to most others located far away (Fig. 27), including the 
benzyl and even phenyl protons which are at the other side of maclocycle. This 
remote effect is presumably due to charge repulsion, i.e. ring enlargement is 
accomplished by a change of the configuration of the central N from endo to exo.  
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Figure 27.  The partial 1H-NMR spectra (left) of compound 35 indicating the chemical shift 
of the labled H-atoms (right) changes according the pH. The break point occurs at pH around 
to the pKa value of protonated 35. 
The determined pKa value of 3.2 for protonated 35 is in good agreement with that of 
compound 1, as well as those of polyamine cryptands, of which the charge repulsive 
effect shifts the basicity of the bridgehead nitrogen to a very low value for tertiary 
amine.[209] 
 
3. 2. 4. Binding of vanadate  
No significant changes of chemical shifts were observed from either 51V or 1H NMR 
when compound 33 (with C3 links at both sides) was titrated by vanadate in water. 
Molecular modeling suggests the cavity of this guanidinium cryptand is too small to 
accommodate vanadate. For the biggest guanidinium cryptand ever synthesized, 35, 
binding of vanadate leads to a 2 ppm 51V shift to higher field, too small to be suitable 
to determine the stoichiometry of the adduct. Further, the tendency curve of 1H 
chemical shift changes of the ligand (Fig. 28) suggests a stepwise formation of 
complexes of various compositions (similar phenomenon reported see reference[210]). 
These observations lead to the conclusion that 35 is a weaker receptor of vanadate 
than the open-armed 1, and binding is likely to occur outside of the cavity. 
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Figure 28.  1H-NMR titration curves of binding HVO42- to 35 in aqueous solution. The 
tendency curve of G–CH2-CH2N chemical shift change indicates multi steps binding behavior. 
 
3. 2. 5. Summary of part 3.2. 
To improve vanadate binding a number of novel guanidinium cryptands containing 
rigid cavities of different size and geometry were designed and synthesized according 
to a general strategy via thiourea intermediates. The pKBH value of the central 
bridgehead nitrogen was determined by NMR titration revealing a low basicity 
sufficient for V-N bond formation. It was, however, not possible to obtain evidence 
that vanadate binds inside these cages. NMR studies suggest that in general mixture of 
vanadate: cage adducts of undefined stoichiometry are found.  
From these experiences, it can be concluded that this preferred conformations of 
cages such as 28 and 29, see X-ray structures in Fig 26, do not bind HVO42-, and 
further, the activation energy to change these cages into suitable receptors is too high. 
Nevertheless the lesson from these experiments is that more flexibility of potential 
receptors is required to allow the binding site of the host to self-adjust to a certain 
extent for the best fit to the shape of the guest molecule. 
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3. 3. Tris-(2- (N’-pyren-1yl-methyl-guanidinium)-ethyl)- amine (TPGEA): From 
vanadate sensor to functional model. 
3. 3. 1. Design 
Introducing three pyrene moieties at the N’-terminal of guanidinium of compound 1 
leads to the modified receptor 36 (Tris-(2-(N’-pyren-1yl-methyl-guanidinium)-ethyl)- 
amine, TPGEA), as shown below:  
N
NH HN
NH
H2N
NH2
HN
HN NH2
HN
36
  
This modification seemed attractive for the the following reasons:  
(1) the pyrenes “close” the basket by -  stacking; 
(2) this preorganization is comparatively weaker than that of cryptand receptors, and 
the binding of vanadate could be accomplished through a low activation barrier; 
(3) the pyrenes are expected to increase solubility of the host in organic solvents in 
which naturally hydrogen bonding and Coulomb interactions are more fully expressed 
than in water; 
(4) the photophysical feature of pyrenes in particular the excimer fluorescence 
exhibited by adjacent pyrenes are expected to be useful for investigating vanadate 
binding; 
(5) the CH2 link between the guanidinium and pyrene is the most common spacer 
facilitating the Photoinduced Electron Transfer (PET),[211] which has been the most 
extensively used and effective strategy for developing fluorescent sensors for cations 
and anions. As the direct binding site, the anticipated complexation with vanadate will 
change the redox potential of the guanidinium, which can be intramolecularly 
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transmitted to the fluorophore via PET. Therefore, visualizing the binding events by 
means of fluorescent signal changing becomes possible and reasonable. 
3. 3. 2. Synthesis 
The synthetic strategy is aimed not only for the preparation of 36, but also to allow for 
the introduction of other functional groups at one arm, such as imidazole (see i.e., 
compound 52, Scheme 13), which can potentially mimic either His 496 or His 404 of 
the active site of V-CPO (see chapter 1. 2. 1. 1. 2.). 
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Scheme 13.  Attempts to synthesize TPGEA (36) and the histamine modified derivative 
(52) (pathway in gray). Reagents and conditions: (a) CHCl3, NEt3, recrystallized from 
CHCl3/Et2O; (b) DIC, CH2Cl2, and TAEA, reflux 30 h; (c) in one-pot of previous step, CS2 and 
second part DIC; (d) histamine, CH2Cl2. 
According to previous experience, the number of positive charges and the high pKa 
value render the poly guanidinium compounds very polar and hence difficult to purify.  
Therefore, N-benzoyl or ethoxy-carbonyl protecting group were used, which greatly 
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decrease the basicity of the guanidine and ease the purification. The addition of 1-
pyrene-methyl-amine (37) to benzoyl or ethyl-carbonyl isothiocyanate (38 or 39) 
quantitatively yields the protected thiourea (40 or 41). The resulting 40 or 41 were 
converted to carbodiimide 42 or 43 by DIC, which was reacted with TAEA in one pot 
to afford N-protected tris-guanidine (44 or 45). Varying the ratio between protected 
thiourea and TAEA from 3:1 to 2:1, a bis-guanylated 46 or 47 was obtained as the 
main product, of which the one remaining unreacted free amine could be transformed 
to the isothiocyanate within one pot since both step use DIC as reagent, followed by 
addition of histamine to yield 50 or 51. Benzoyl has been extensively used as a 
protecting group for guanidine which can be removed by hydrolysis under acidic 
condition[212-223]. Unexpectedly, the desired product 52/36 were not obtained under 
routine or even harsher acidic deprotecting condition.  Other debenzoylation methods 
such as basic hydrolysis, hydrazine or DIBAL[224] all failed to remove benzoyl 
protecting group from compound 44 or 50. Presumably, the conjugation of guanidine 
C=N double bond with the carbonyl enhanced the strength of amide bond, which is 
very difficult to be cleave under normal condition, while the harder condition caused 
the decomposition of the starting materials. The same problem was encountered for 
the removal of ethyl-carbamate protected guanidines 45 and 51. Even Me3SiBr, the 
reagent which was reported to specifically cleave ethyl-carbamate from protected 
guanidines[225], also failed. 
To avoid the problematic deprotecting step, a convenient strategy employing an 
alternative, flexible route was developed, see Scheme 14.  
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Scheme 14.  Synthesis of TPGEA (36). Reagents and conditions: (a) CS2, Et3N, DCC, 
THF; (b) DIPEA, CHCl3; (c) CH2Cl2/EtOH, aq. 55-58% HI; (d) MeI, 72 h, rt.; (e) in sealed tube 
with J. Young valve, 7 N ammonia in MeOH, 55 ˚C, 12 h. 
The starting material TAEA 2 was converted to tris-isothiocyanate 26 as described in 
Scheme 12. After the addition of pyrene-1-methyl amine to 26, compound 53 was 
obtained in 83.2% yield. As discussed in chapter 3. 2. 1. , this tris-thiourea 
intermediate is a structure analogy of 36. It has hydrogen bond donor sites with the 
similar geometry as 36, but without positive charge, which provide a good 
opportunity to study the influence of positive charges on anion binding. To avoid the 
obvious electrophilic attack at central nitrogen, the smallest protecting group, 
protonation, was used by formation of HI salt. The following reaction with methyl 
iodide, therefore only happened at S-atoms, almost quantitatively yielding the tris-S-
methyl-isothiourea derivative 55 as the tetra-HI salt. Without purification, it reacted 
directly with ammonia in methanol in a sealed tube. After separation and exchanging 
the counter anion to Cl- by ion-exchange resin, the final target compound 36 was 
obtained within only five steps totally.  
Notably, the synthetic strategy is also flexible and compatible, allowing the structural 
modification at one arm or even two to facilitate the synthesis of other desired model 
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compounds. For instance, varying the ratio between tris-isothiocyanate 26 and pyrene-
1-methy-amine 37 from 1:3 to 1:2, bis-thiourea compound 54 could be obtained as the 
main product, which contains an unreacted isothiocyanate group for introducing 
another desired functional moiety such as histamine. Following the same pathway for 
36, compound 56 was obtained as another potencial vanadate receptor. 
 
3. 3. 3. Pre-organization of 36: Fluorescent study 
Receptor 36 is well soluble in acetonitrile/water (1:1) mixture and only slightly 
soluble in any of the solvent alone. However, to maximize the polar interaction with 
vanadate, the fluorescence and UV titrations were performed in acetonitrile. Upon 
excitation at 343 nm, the acetonitrile solution of 36 exhibits emission bands at 376 
and 395 nm as typical fluorescence signals of pyrene monomer. However, the 
intensity of these monomer bands is rather low compared to another broad and 
structureless band at 478nm, which is assigned to the pyrene excimer (Fig. 29).[226]  
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Figure 29.  Emission spectrum of 36 (3.6 uM in acetonitrile, λ ex = 343 nm). 
Traditionally, an excimer can be defined as a complex formed by interaction of a 
fluorophore in the excited state with a fluorophore of the same structure in the ground 
state.[226] An important aspect is that the emission spectrum of the excimer is red-
shifted with respect to that of the monomer, and in many cases, the dual emission of 
the monomer and the excimer is observed. In general, it is assumed that flat highly -
delocalized systems show greater tendency to form excimers, such as anthracene and 
pyrene. A crucial requirement for excimer formation is that two monomers are in 
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close proximity in order to give stacking interactions and the molecular excimer state. 
Further, a long-lived excited fluorophore is required, since it has to approach its 
ground state partner within its lifetime. Pyrene has long singlet lifetime and readily 
form excimer. Therefore it has been extensively applied as a fluorescence probe for 
many purposes by means of the excimer signal formation.[226-229] 
The involvement of three pyrene moieties of 36 in excimer formation at low 
concentration suggests they are intramolecularly close to each other in space, which 
confirms the original design with respect to preorganization. According to earlier 
reported, two different types of excimer formation can be distinguished. The first type 
refer to two pyrenes that are sufficiently far apart from each other before excitation; 
only one is excited and then approaches its ground state partner by diffusion within its 
lifetime to form the excimer, which is termed as “dynamic excimer”. By contrast, 
another type refers to the situation that (pre)association between two pyrenes already 
occurs in ground state, which absorbs the light as a ground-state dimer and the 
resulting excimer is termed as a “static excimer”[226].  Obviously, the later case should 
be favored in a preorganized system such as 36. The existence of static excimer can 
be visualized by steady-state excitation spectrum. In contrast to monomer, the pre-
associated ground state dimer should exhibit red shift and broadening of peaks. The 
widths of the band can be related to the parameters Pm (for monomer) and Pe (for 
excimer), which refer to the ratio of the fluorescent intensity of the most intense band 
(Ip, intensity of peak) to that of the adjacent minimum (Iv, intensity of valley) at 
shorter wavelength. As shown in Fig. 30, receptor 36 indeed exhibits the 
characteristic of static excimer to a certain extent: 1 nm red shift ( ) was observed 
for excitation spectrum monitored for excimer ( em = 476 nm) relative to that for 
monomer ( em = 376 nm). Futher, the broadness parameters (Pm > Pe) qualitatively 
indicates that the excitation spectrum of the excimer is than that of monomer. 
Potential surfaces of both pyrene ground-state dimer and excimer had been calculated 
by Warshel and Huler in order to study the influence of distance between two pyrenes, 
revealing a minimum at the 3.44 Å distance between two ground state pyrenes and 
3.26 Å for that of excimer.[230] For receptor 36, the close proximity of pyrenes 
observed by fluorescent study is in good agreement with the solid state structure of its 
structural precursor 1 (Fig. 18). 
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Figure 30.  Normalized excitation spectra of 36 (3   M in acetonitrile), monitored at 376 nm 
(monomer, red solid line) and at 476 nm (excimer, blue dashed line). 
It is interesting to note that the thiourea analogy 53 also shows very similar 
fluorescence spectra, which strongly indicates the conformational similarity to 36.   
 
3. 3. 4. UV-vis and Fluorescent Titration: Sensor of Vanadate 
Using Bu4N+ as a counter cation makes the vanadate soluble in organic solvents. The 
5.4 mM stock solution in acetonitrile was prepared by dissolving 135 l of 0.2 M 
vanadate aqueous solution in 5 ml acetonitrile. As already described in chapter 3.1.2., 
the 0.2 M aqueous solution can be prepared by reaction of vanadium oxide (V2O5) 
with four equivalent Bu4N+OH- in water.  
Significant change were observed when 3 M of receptor 36 in acetonitrile was 
titrated with the vanadate solution (Fig. 31), indicating that complexation of vanadate 
by 36 occurred. Upon stepwise addition of vanadate, almost all characteristic bands of 
pyrene shift to red, i.e. the transition at 343 nm shows 6 nm red shift to 349 nm. 
Meanwhile, bands become much broader, which is qualitatively represented by the 
parameter Pa. Similar as Pm shown in Fig. 30, Pa is defined as the ratio of absorption 
intensity of a peak (AUp) to that of the adjacent valley (AUv) at shorter wavelength 
(Fig. 31). It is important to note that there is almost no change for the over all integral 
of the spectrum before and after adding vanadate. These observations strongly 
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indicate that the pyrene moieties are getting more packed upon the interaction with 
vanadate. Hence it is reasonable to assume that vanadate is bound within the three 
arms of 36 and pulls all three pyrenes closer to each other by electrostatic and 
hydrogen bonds with the guanidinium units. 
Notably, before two equivalents of vanadate (calculated for monomer, V1) are added, 
the changing of intensity at a specific wavelength of UV spectrums of 36 is almost 
proportional to the amount of vanadate used, while only very little change can be 
observed > 2 equivalents, which indicates the formation of 1:2 complex (36:V). 
Additionally, the clear isosbestic points suggest only one complex is generated 
between 36 and vanadate. However, the background absorption from vanadate itself 
interferes the accurate determination of association constants from UV titration, 
especially at high total vanadate concentration and at wavelength < 300 nm. 
 
Figure 31.  UV titration of 36 (12   M in acetonitrile) by vanadate. Bands became red 
shifted (represented by   λ ) and broader (qualitatively indicated by peak to valley ratio of 
intensity, Pa = AUp/AUe) upon the increasing ratio of vanadate. 
Fluorescence titration was also performed at the lower concentration than that for UV. 
The excitation wavelength of 345 nm was chosen from the isosbestic point of UV-vis 
spectra. Quenching of fluorescence was observed for both monomer and excimer 
emissions (Fig. 32) upon the portionwise addition of vanadate. The titration curve 
following the intensity at 474 nm against the ratio of vanadate/36 reveals almost 
 55 
linear quenching < 2 equivalents of vanadate (counted as V1), and the excimer 
emission is almost completely quenched at 2 equivalents of V1 (Fig 33 A). The sharp 
break point at V1/36 = 2 and the nearly linear tendency before and after this break 
point suggest that 36 very tightly forms a complex with vanadate dimer (V2), not 
monomer, which is compatible to the result from UV titration. Additionally, the Job 
plot gives the maximum at the molar fraction (  = [36]/([36]+[V])) of 1/3 if vanadate 
monomer is counted for vanadate concentration. In contrast, maximum at 1/2 can be 
obtained if using [V2] instead of [V1] (Fig. 33 B).  
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Figure 32.  Fluorescent spectra of 36 (3   M in acetonitrile) at diffirent ratio vanadate (λ ex = 
345 nm). Both monomer and excimer bands were quenched upon the increasing ratio of 
vanadate.  
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Figure 33. (A) The titration curve monitoring the fluorescent intensity at 474 nm against the 
ratio of V1/36. (B) Job plot according to vanadate monomer and dimmer (inlet). 
However, an accurate binding constant can not be deduced from the data of 
fluorescent titration because of two reasons. Firstly, all the vanadate species are 
involved in elusive equilibrium in acetonitrile, so it is not possible to determine the 
concentration of the species of interest since the concentration is too low to get 
meaningful 51V-NMR spectrum. Secondly, it is known that only when the 
concentration of the analyte is in the range of (1/(10Ka)) < [analyte] < (10/Ka),  the 
systematic error for calculation of binding constants Ka is acceptable.[174] In this case, 
the affinity of 36 to V2 is too high to be fitted, as one can see from the sharp break 
point. Nevertheless, it is obvious to judge that the Ka >> 10/[analyte]. Namely, the 
binding constant is much higher than 3 × 107 mol-1. 
The quenching observed with vanadate can be rationalized in terms of the change in 
redox properties of guanidinium (Fig. 34). Due to occupancy of the lone pair by 
protonation, the vanadate-free guanidinium has a relative lower HOMO level below 
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that of an excited pyrene (pyr.*); therefore its influence to fluorescent intensity is 
negligible. However, the formation of complex with vanadate by hydrogen bond 
weakens the N-H bonds of guanidinium; hence the HOMO level increases to be above 
that of pyr.* such that the electron transfer from the former to the half filled later one 
occurs, interrupting the fluorescence process of pyr.*. Consequently, the quenching of 
fluorescence is observed (Fig. 34).[227] 
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Figure 34. Principle of fluorescence quenching induced by anion recognition of fluorescent 
PET sensors. 
 
3. 3. 5. 51V-NMR Titration 
Due to the low solubility of the complex formed between 36 and vanadate, a mixture 
of D2O/DMSO-d6 (1:3) was finally chosen as solvent for the 51V-NMR titration. The 
0.5 mM vanadate stock solution alone shows three peaks at -546, -574 and -585 ppm, 
which can be assigned to V1, V2 and V4 respectively (structures see Fig. 35).[129] 
Upon the proportional addition of 36, the ratios of V1 and V4 peaks decreased while 
that of V2 (suggested from the stoichiometry of UV and fluorescence titration) 
increased and the peak significantly became broader (Fig. 35). The broadening of the 
V2 peak evidently suggests that complexation occurs. When the ratio of 
36/vanadatetotal reached 2:1, most of the V4 signal disappeared, and the V2 became 
predominant species (Fig. 35). The remaining small portion of V1 is tentatively 
assigned as VO43-, which can not be dimerized due to not being protonated, since the 
dimerization requires protons to eliminate one equivalent H2O, as shown in Eq. (10).    
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2 × HVO42-  V2O74- + H2O                                    (10) 
The result of 51V-NMR titration provides consistent evidence that 36 preferentially 
binds V2, which drive the equilibriums towards the formation of V2 over V1 and V4. 
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Figure 35. 36 preferentially binding V2 over V1 as indicated by 51V-NMR spectra of 0.5 mM 
vanadate in DMSO-d6/D2O (3:1) with different ratio of 36. The total concentration of vanadate 
is counted according to V1. 
1H-NMR spectra were also measured to follow the change of signals from 36 upon the 
binding with V2. All the 1H peaks became much broader with the increasing ratio of 
vanadate. The broadening of signals observed both from 1H and 51V NMR spectra 
suggest a slow exchanging process between free and complexed state due to tight 
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binding. In principle, measurement in lower temperature can further slow the 
exchanging rate down to NMR time scale to get information of different individual 
state. However, the high melting point of DMSO excludes the possibility to be cooled 
down to a meaningfully low level. 
 
3. 3. 6. Binding Inorganic Pyrophosphate (PPi) and Phosphate―Structural 
Analogues of Vanadates V2O74- and HVO42- 
It is reasonable to assume that 36 should bind pyrophosphate (PPi), the structural 
analogue of vanadate dimer in a similar fashion. In addition, unlike V2, which is 
involved in fast equilibrium with other vanadate species in solution, PPi is kinetically 
inert. Therefore it should be easier to characterize the stoichiometry and binding 
affinity between 36 and pyrophosphate than those between 36 and V2. 
Strikingly similar changes on UV spectra were observed when 36 was titrated with 
the solution of (nBu4N)3HP2O73- in acetonitrile (Fig. 36) as that from the titration with 
vanadate (see Fig. 32). Most of the bands are red shifted and became broader upon the 
stepwise addition of PPi till one equivalent PPi was added. Job plot shows a 
maximum at 0.5, revealing 1:1 binding mode. This UV change clearly indicates a 
similar binding mode of PPi and V2, respectively to 36.   
 
Figure 36.  UV titration of 36 (3   M in acetonitrile) by pyrophosphate and the related Job 
plot (inlet). 
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Similar fluorescence quenching was also observed (Fig. 37) both for excimer and 
monomer emission when 36 was titrated with PPi. However, the quenching efficiency 
of PPi is less than that of V2, consistent with 14% of the remaining intensity of 
excimer emission even after adding of 10 equivalents of PPi, while for V2, quenching 
is almost completed at 1 equivalent. In addition, the titration curve of PPi is less sharp 
than that of vanadate, indicates 36 binds V2 more tightly than PPi. 
 
Figure 37.  Fluorescent titration of 36 (3   M in acetonitrile) by tetra-n-butyl-ammonium 
pyrophosphate. 
The binding constant is determined by non-linear curve fitting. The following general 
equation (Eq. 11)[174] is applied for both fluorescence and UV titration: 
Iobs  =  IH  +o
(IHG - IH  )o
2[Ho]
( [Ho] + [Go] + 1K -[Ho] + [Go] +( )
2 4[Ho][Go] ) (11)
 
In Eq. 11, I refers to the intensity of UV absorption or fluorescence emission; H is the 
host molecule (36) and G is the guest molecule (i.e. PPi or V2); HG is the 1:1 
complex of host and guest; K refers to binding constant which need to be fitted. This 
equation describes the relationship of the observed spectroscopic data (Iobs) from the 
host entity with total amount of guest molecule being added (G0). In principle, Eq. 11 
can be applied to any supramolecular system for the formation of 1:1 complex 
coupled with continuously observable spectroscopic change. Applying Eq.11 on 
experimental data obtained from the UV titration (see Fig. 36) gave a very good fit 
(Fig 38), from which the binding constant of 1.5 × 107 mol-1 was calculated. 
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Figure 38.  UV titration data of 36 (3   M in acetonitrile) by pyrophosphate monitoring at 
343 nm, and the calculated binding curve (in red) with Ka = 1.5 × 107 mol-1. 
The complex of 36 and PPi also shows low solubility in most of the organic solvents 
and water. Therefore, the NMR titration was performed in DMSO-d6. Since the 31P 
NMR chemical shift PPi is not sensitive in terms of formation of hydrogen bonds, 
only 1H-NMR spectra of 36 were measured to follow the changes upon the binding 
with PPi. As expected, broadening of 1H resonances was observed (Fig. 39), similar 
as for the titration with vanadate.  
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Figure 39.  Part of the 1H-NMR spectra of 0.5 mM 36 in DMSO-d6 with different ratio of PPi. 
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Using parameters from the X-ray structure of 1, the molecular structure of complex 
formed by 36 and PPi was calculated with program Titan® at the AM1 level. It is 
important to note that although the size of PPi is much larger than chloride, the 
binding pocket of 36 can still accommodate PPi by self-adjusting the geometry of the 
binding site inside the basket. 
   
Figure 40.  The proposed structure of complex of 36 and PPi (right) based on the X-ray 
structure of 1 (left). The molecular modeling is calculated at AM1 level with program Titan®.  
For comparison, the binding of phosphate to 36 was investigated by UV, fluorescence 
and NMR titration. Changes, similar to PPi-binding were observed, such as red 
shifting and broadening of UV bands, quenching of fluorescent emissions and 
broadening of 1H-NMR signals, however, the changes observed with all these 
methods were less significant, indicating the lower affinity of phosphate to 36. Further, 
no clear stoichiometry can be deduced from the titration data, suggesting the 
formation of different complexes between host and guest molecules. For example, the 
1H-NMR titration curve following the chemical shift change of the benzyl protons of 
36 at different ratios of phosphate shows a very complicated tendency (Fig. 41), 
revealing equilibria between several multi-components complexes. Apparently, 36 is 
not an optimal receptor for phosphate. 
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Figure 41.  1H-NMR titration curve of 36 in DMSO-d6 by phosphate, monitoring the 
chemical shift of proton at benzyl position of 36.  
 
3. 3. 7. Comparison of 36 and the Thiourea-Analogue 53 as Anion Receptor 
The thiourea precursor 53 is a close structural analogue of guanidinium receptor 36, 
but carries no positive charge for coulomb interaction with a guest molecule, the 
capacity to bind any kind of vanadate or phosphate hence can only originate from the 
formation of hydrogen bonds. For direct comparison, the same solvent and vanadate 
stock solution were used for the UV and fluorescent titration. Almost no influence to 
the UV spectrum was observed when vanadate was added portionwise to the 
acetonitrile solution of 53, except for the background absorption caused by vanadate 
itself. However, quenching of fluorescent emission was obtained. It is interesting to 
note that the quenching is mainly observed for the excimer emission, while the 
monomer fluorescence intensity decreased only to a small extent compared to the 
excimer (Fig. 42). Clear stoichiometry has not been possible to be determined since 
the Job plot from fluorescent profile gave two maxima (Fig. 42), indicating that more 
than one complex was generated between 53 and vanadate. If the main change of 
fluorescence intensity is associated with the formation of 1:1 complex with V1, the 
binding constant about 1.4 × 105 mol-1 can be estamated. This assumption is based on 
the non-linear fitting results with 2 = 0.984. Therefore, it is reasonable to conclude 
that the binding constant of 53 to vanadate is at least two orders magnitude lower than 
that for 36, due to the lack of positive charge for electrostatic interaction. 
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Figure 42.  Fluorescent titration of 53 (3   M in acetonitrile) by vanadate (the total 
equivalent was counted as V1), and the related Job plot.   
All the titration studies with phosphate and pyrophosphate showed that both anions 
influenced the UV-, fluorescence- and 1H-NMR spectra of 53, however, none of the 
experiment gave any clear stoichiometry between host and guest molecules. 
Apparently, 53 is not an optimal receptor for these anions. 
It is worth to note that during the 1H-NMR titration, significant change of chemical 
shift to higher field was observed for the signals from the counter cation, nBu4N+, 
which is normally believed to be innocent for binding due to its non-coordinative 
nature. The N-CH2 is the most shifted signal, with the maximum downfield shift of 
about 1 ppm at the ratio of 53 : nBu4+NH2PO4- = 1:1 (Fig. 43).  
This observation can be associated with the ion-pair formation. When the neutral 
receptor 53 binds the anion by hydrogen bonds, the resulting complex 57 is negatively 
charged. Therefore, the counter cation is attracted closer to form ion-pairs such as 58 
(Scheme 15). Due to the shielding effect from the large conjugated  electron system 
of pyrenes, proton signals of nBu4N+ shift to higher field. Understandably the 
positively charged 36 displayed almost no change of chemical shift of nBu4N+ part 
and has much higher affinity to anions. The possibility that 53 alone may bind nBu4N+ 
by -cation interaction can be excluded, because no influence on the chemical shift 
was observed when 53 was titrated with nBu4N+BPh4-, of which the anion BPh4- is 
non-coordinative, and hence, does not form a complex with 53 by hydrogen bonding. 
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Figure 43.  Partial 1H-NMR spectra of n-Bu4N+H2PO4- with different ratio of 53. Signals 
marked belong to N-CH2 of n-Bu4N+. 
It is possible that the formation of the ion-pairs also has an influence on the UV and 
fluorescence spectra, especially if nBu4N+ is embedded within the three pyrenes, 
which will enlarge the distance between pyrenes and reduce the ratio of excimer 
formation. This may explain why the UV and fluorescence titration data did not fit the 
simple 1:1 complex mode. More experiments are needed in order to verify the 
modified mode shown in Scheme 15, which taken the ion pair formation into the 
account of the overall equilibriums. Nevertheless, the neutral receptor 53 opens the 
possibility to probe the process of ion-pair formation, which is potentially helpful to 
interpret many phenomena in supramolecular chemistry especially in low dielectric 
constant solvents, but only attracts little attention nowadays.[231, 232] 
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Scheme 15.  The equilibriums of anion binding of 53 coupled with ion-pair formation. 
 
3. 3. 8. Summary of Part 3. 3. 
Introducing pyrene-CH2- to the N-terminal of the all three guanidinium arms of 1 
leads to a new class of vanadate and phosphate receptors distinct from 1. 36 can be 
synthesized from its thiourea analogy 53. The pyrene chromophores of both 36 and 53 
couple the UV and fluorescence responds to anion binding,  i.e. excimer formation 
and the PET type fluorescence quenching can be observed. The pyrenes of 36 hold the 
three arms together by -  interaction, preorganizing itself to bind vanadate. In 
addition, compared to 1, 36 is more soluble in organic solvent. Therefore, deduced 
from the UV, fluorescence and 51V-NMR titration, 36 exhibits an association constant 
>> 3 × 107 mol-1 with pyrovanadate (V2O74-) in acetonitrile, which is at least 4 orders 
of magnitude higher than that of 1 to HVO42-. The preference of 36 binding V2 over 
V1 was also confirmed by comparison with titration studies of pyrophosphate and 
phosphate, the structural analogues of pyrovanadate and vanadate. The neutral 
thiourea receptor 53 shows much smaller binding constant and almost no preference 
to any vanadate or phosphate species mentioned above, revealing the importance of 
positive charges on the affinity and selectivity for anion binding. 
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3. 4.  Catalytic Activity: Functional Model of V-HPO 
3. 4. 1. Activity of Vanadate alone in Acetonitrile: Solvent Effect 
As already mentioned in chapter 1.6.2., Butler first reported that simple vanadate can 
mimic the function of V-HPO in acidic aqueous solution; namely, it can catalyze the 
oxidation of Br- in the presence of H2O2 to Br+ and the subsequent bromination 
organic substrates.[124, 125] The active species of the system was proposed as 
V2O2(O2)3.[125, 129] The catalyst was later applied in a two-phase system (H2O-CHCl3 or 
H2O-CH2Cl2) by other group.[131, 132] However, it has never been tried in homogenous 
pure organic solvent in which the inorganic vanadate is not soluble. As described 
previously, using nBu4N+ as counter cation, it has been able to prepare vanadate stock 
solution in organic solvent. Therefore we first investigated the catalytic activity of 
vanadate alone in acetonitrile to compare the solvent influence on bromide oxidation 
and bromination of organic substrate. 
Since “Br+” exists as the equilibrium mixture (i.e. HOBr Br2  Br3– in water), the 
oxidation of Br- to “Br+” can be followed by UV-vis, monitoring the increasing of 
absorption at 268 nm, which is a characteristic band of Br3- (Fig. 44). It is worth to 
note this absorption maximum in acetonitrile is slightly red shifted compared to that 
in water ( max = 267 nm). The catalytic reaction is dramatically accelerated by 
changing solvent from water to acetonitrile. However, the exact turn over rate is 
difficult to be obtained for this reaction, because the equilibrium constants of “Br+” 
Br2  Br3– have not been established in this solvent. 
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Figure 44.  Vanadate catalyzed oxidation of Br- to “Br+” as followed by UV-vis spectroscopy 
at 268 nm. Reaction conditions are 6   M vanadate (counted as V1), 0.48 mM H2O2, 1.2 mM 
n-Bu4NBr and 0.24 mM HClO4. The reaction is initiated by addition of HClO4. 
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Monochlorodimedone (MCD) and phenol red have been used as standard substrates 
for the catalytic bromination of organic compounds since these reactions can be 
followed by UV-vis spectroscopy.[110, 127] Phenol red (59) is tetra-brominated to give 
bromophenol blue (60). The significant difference of the absorption maxima between 
59 ( max = 429 nm;  = 21.4 mM-1 cm-1) and 60 ( max = 598 nm;  = 70.4 mM-1 cm-1) 
in water buffer solution renders phenol red one of the most favorite bromination 
substrates for catalytic analysis.  As one can judge from the compounds’ names, the 
distinct colors of educts and product make it possible to visualize the reaction process 
even by the naked eyes (Scheme 16). However, since phenol red can be tetra-
brominated, and every single step of bromination is coupled with different extend of 
color change, accurate quantification of the kinetic data from UV measurement is 
very difficult. Surprisingly, this source of errors has been ignored by most authors.[137, 
233-236]
 In addition, unlike the situation in water buffer solution, 59 and 60 show only 
small difference of UV in acetonitrile, because they mainly exist in the form of yellow 
-sultones (61 and 62) in organic solvents (Scheme 16)[234, 237]. Pecararo studied the 
kinetics of catalytic bromination of phenol red in acetonitrile spectrophotometrically, 
however, the reaction aliquot had to be diluted in water buffer solution for UV 
measurement from time to time. In our system, the reaction is too fast; hence a 
quantitative analysis is not possible if following this way. 
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Scheme 16.  The catalytic bromination of phenol red to bromophenol blue and their 
tautomerization equilibriums in acetonitrile.  
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MCD has maximum absorption at 258 nm in acetonitrile with the extinction 
coefficient of 11.8 mM-1 cm-1, which is different from that in water ( max = 290 nm,  
= 20 mM-1cm-1)[11]. The bromination of MCD can be quantitatively followed at loss of 
UV intensity at 258 nm (Scheme 17). The overall reaction needs one equivalent of 
both H+ and Br-, which can derive from HClO4 and n-Bu4NBr separately or HBr 
directly. No significant influence on reaction rate was observed when different H+ and 
Br- sources were used. The latter is preferred for convenience and more economic 
especially in preparative scale. 
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Scheme 17.  The catalytic bromination of MCD in acetonitrile. 
The bromination of MCD catalyzed by vanadate is rapid and stoichiometric on each 
H2O2, H+ and Br- consumption. About 10 turnovers were achieved within 7 minutes, 
which is half-life of the reaction. As shown in Fig. 44, the increase of absorption at 
258 nm at the beginning of reaction time is due to the formation of Br3- ( max = 268 
nm), which disturbs the measurement of initial rate. Therefore, the rate could only be 
determined after ca. 120 seconds. Compared with the reported reaction rate in 
water[124], similar value of (d[MCD]/dt) can be obtained at much lower concentration 
of both catalyst and reactants in acetonitrile, i.e., [vanadate] was 30 times lower than 
that in water, while [H2O2], [H+] and [Br-] were 20, 400 and 1000 times lower 
respectively, indicating the over all rate constant in acetonitrile is several orders of 
magnitude higher than that in water. 
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Figure 44.  Vanadate catalyzed bromination of MCD as followed by UV-vis spectroscopy at 
258 nm. Reaction conditions are 6   M vanadate (counted as V1), 0.12 mM MCD, 0.3 mM 
H2O2, 0.12 mM HBr. The reaction is initiated by addition of HBr. 
The rate of bromination depends on the reactivity of organic substrates. Due to the 
electrophilic nature of the Br+, electron rich substrates are brominated much faster, for 
example, 100 turnovers were achieved within less than 10 minutes for the 
bromination of 1,3,5-tri-methoxy-benzene (TMB, 65), which is about 50 times higher 
than that reported in water.[124] The dramatic rate enhancement by simply changing 
solvent can be reasoned to the mimicry of hydrophobic environment at the active site 
of enzyme. It is becoming especially clear in the field of bioinorganic chemistry that 
the metallic enzyme normally has a less polar active site interiorly which is provided 
by protein folding. More specifically, as Pecoraro proposed for his functional 
models,[128, 129] using acetonitrile as solvent might facilitate the protonation of 
peroxovanadate by increasing the pKa value of its conjugated acid, since the 
protonation is key step of the catalytic cycle. 
If stoichiometric HBr or H2O2 was used, bromination of TMB quantitatively yields 
mono-brominated product 66. If both reactants were added in excess, further 
brominated product could be obtained. This bromination reaction can be readily 
scaled up for preparative use. Several aromatic substrates were brominated in gram 
scale (Scheme 18). Notably, the first bromination step of activated aromatic 
compounds is exclusively para selective (see 68 and 70), indicating the active-
brominating species may be vanadate-bounded, rather than freely diffusible “Br+”, 
since the bromination by Br2 alone leads to the mixture of regio-isomers[238]. With 
excess of HBr or H2O2, the second bromination happened in ortho position (i.e., 71). 
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Chlorination of TMB was also achieved in a preparative scale, and a second 
chlorination is possible if an excess of reactants was used. Although oxidation of 
chloride catalyzed by simple vanadate was observed in water, no detail was reported 
presumably because the reaction is too slow in aqueous solution[124]. However, the 
chlorination highly depends on substrate reactivity, i.e., even in acetonitrile, 
chlorination of MCD can not be observed. The reason of apparent rate determination 
by the reactivity of organic substrate is not obvious, which need further in depth 
kinetic investigation.  
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Scheme 18.  The halogenations of organic substrates catalyzed by vanadate in acetonitrile. 
It is interesting to note that a bromination coupled cyclization has been achieved for a 
mono-protected phytyl-hydroquinone 74, yielding a brominated -tocopherol 
derivative 75. The -tocopherol belongs to vitamin E family which is of industrial 
interest as important food and cosmetic additive, as well as therapeutic drug. The 
acid-promoted cyclization of phytyl-hydroquinone is the key step in the biosynthesis 
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of -tocopherol. It has been discovered by Woggon’s group that this enzyme-
catalyzed ring closure proceeds by Si protonation of the double bond and 
concomittant Re attack of the phenolic oxygen atom via a carbon-cation transition 
state[239, 240]. Therefore, the cyclization of 74 suggests a cationic nature of the active 
brominating species. However, although the cyclized product is exclusively the 6-
membered chromane, a side product 76 from the oxidative cleavage of the protecting 
group by H2O2 diminishes the yield of 75 to only 41%. 
 
3. 4. 2. Catalytic Activity of Vanadate-36 Complex 
To investigate the vanadate catalyzed bromination by the vanadate-bound 
supramolecular receptor which mimics the protein part of V-HPO is the final goal of 
this study. As already mentioned in the introduction, coordination of hydrogen 
peroxide to vanadate to form peroxovanadate is the common first step of catalytical 
cycle for both the V-HPO and some of the reported functional models. Therefore, the 
affinity of the supramolecular receptor 36 to peroxovanadate was first studied in order 
to confirm that vanadate keeps being bounded during the whole process. It is known 
that peroxoxvanadates apparently do not oligomerize beyond the formation of dimers, 
but their solution chemistry is easily as complex as simple vanadate because of their 
ability to bind between 1-4 peroxides[116]. The equilibria of peroxoxvanadates in 
acetonitrile and acetonitrile/water mixture have been studied by 51V-NMR at mM 
concentration by Pecoraro. HxV2O3(O2)4x-4, which is a dimer of diperoxovanadate 
VO(O2)2-, becomes the predominate species at low water concentrated acetonitrile 
solution at the presence of excess of H2O2[129]. 
 
The binding of peroxoxvanadates to 36 was studied by UV and fluorescence titration 
as the way described previously. Peroxovanadate was prepared by addition of 10 
equivalent excess of H2O2 to the 5.4 mM vanadate solution in acetonitrile. Addition of 
this peroxovanadate to the acetonitrile solution of 36 caused the broadening of UV 
bands, indicating that complexation occurred. The change became saturated after the 
addition of 2.5 equivalents of peroxovanadate (counted as V1). It is important to note 
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that the final state of the UV spectrum of the 36-peroxovanadate complex is different 
to that of the 36-vanadate mixture (Fig. 45), reflecting their structural difference. The 
same final UV spectrum can also be obtained by forming 36-vanadate complex first, 
then adding excess of H2O2 later. 
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Figure 45.  Comparison of UV spectra of 36 alone (blue solid line) and at the presence of 
vanadate (violet dash line) or peroxovanadate (red dotted line). 
Similar as that observed with vanadate or pyrophosphate binding to 36, the 
peroxovanadate induced UV change was also accompanied by fluorescence 
quenching. After addition of 1.5 equivalents of peroxovanadate (counted as V1) to 36, 
the quenching of both the excimer and monomer emissions were almost complete. 
(Fig. 46). The elusive break points of UV and fluorescent titration are not consistent 
to each other, which suggest that more than one peroxovanadate species may be 
involved in complexation with 36 simultaneously. As reported by Pecoraro, two 
minor species of unknown structures are detectable in the 51V-NMR spectrum of 
peroxovanadate in acetonitrile solution together with the main species, HxV2O3(O2)4x-. 
[129]
 It is possible that these unknown species may be involved in the complexation 
with 36. Details are not clear yet because no suitable solvent is available which can 
well dissolve both 36 and vanadate while is innocent to peroxide. Nevertheless, the 
sharp binding curve clearly indicates that the major peroxovanadate species is tightly 
bound to 36. 
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Figure 46.  Fluorescent spectra of 36 (3   M in acetonitrile) at the presence of the different 
equivalents of peroxovanadate (counted as V1) and the related titration curve (inlet). 
Since the peroxovanadate complex with receptor 36 could be prepared, the catalytic 
activity for bromination of organic substrate was subsequently investigated. MCD 
was the first organic substrate being tested. As shown in Fig. 47, the bromination of 
MCD was followed by UV spectrum at loss of intensity at 258 nm, which reveals that 
the presence of 36 accelerated the bromination almost twice, as the slope of the curve 
in the presence of 36 is sharper than that at the absence of 36. The half lifetime of 
MCD bromination (t1/2) is almost doubled without 36 compared that with 36. 
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Figure 47.  Comparison of catalytic bromination of MCD with or without 3   M 36. Reaction 
is followed by UV-vis spectroscopy at 258 nm. Reaction conditions are 6   M vanadate 
(counted as V1), 0.12 mM MCD, 0.3 mM H2O2, 0.12 mM HBr. The reaction is initiated by 
addition of HBr. 
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Whether this enhancement of catalytic activity is also applicable for the bromination 
of other organic substrates is of interests, particularly for electron rich aromatics. 
However, since little UV change is coupled with the bromination for most of the 
aromatics substrates, a kinetic study is difficult. To overcome this obstacle, a 
competitive bromination experiment was designed using both TMB and MCD as 
substrates in one reaction at the same time. Since TMB is much more reactive than 
MCD due to its electron rich characteristic, the former should be preferentially 
brominated over the latter. Little change of UV at 258 nm should be observed during 
the bromination of TMB. However, as soon as the bromination of TMB is completed, 
MCD will start to be brominated which will initiate the decreasing of UV intensity at 
258 nm. Hence, the period of UV-insensitive time is corresponding to the total 
reaction time of TMB bromination. Fig. 48 shows that in the absence of 36 the UV 
absorption at 258 nm is almost constant during 480 seconds, in the course of this time 
gap TMB is totally consumed. The following increase of UV absorption refers to a 
small amount of free Br3- being generated. After ca. 580 seconds, the absorption at 
258 nm decreases steadily within about 1000 seconds due to the bromination of MCD. 
The overall reaction is 100% complete for both substrates and stoichiometric with the 
consumption of HBr. All of the individual steps discussed above were significantly 
accelerated when receptor 36 was added into the reaction system. The reaction time 
for TMB is shorten to about 150 seconds, indicating that TMB bromination is > 3 
times faster than without 36. In addition, the following steps including generation of 
Br3- and bromination of MCD also become faster, which is seen from the sharper 
slope of the curve. 
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Figure 48.  Comparison of competitive catalytic bromination of TMB/ MCD with or without 3 
  M 36. Reaction is followed by UV-vis spectroscopy at 258 nm. Reaction conditions are 6   M 
vanadate (counted as V1), 0.12 mM MCD, 0.12 mM TMB, 0.5 mM H2O2, 0.24 mM HBr. The 
reaction is initiated by addition of HBr. 
Two possible reasons are proposed here to explain the catalytic effect of 36.  Firstly, 
the formation of hydrogen bonds with positively charged guanidinium may increase 
the Lewis acidity of vanadate, as has been proposed for the enzyme of V-CPO[28]. 
Indeed replacement of these positively charged residues (Arg 360, and Arg 490, Lys 
353) to alanine significantly decreases the activityof V-CPO[36]. Secondly, 36 may 
facilitate the protonation of peroxovanadate as a nearby acid base catalyst. As already 
described in the introduction, peroxovanadate must be protonated prior to halide 
oxidation both for V-HPO enzyme and the reported functional models. For V-CPO, 
the amino acid residue Lys 353 is proposed to play such a role. The X-ray structure of 
the peroxide-form of V-CPO reveals that Lys 353 is the only residue that forms direct 
hydrogen bond with the peroxo-oxygen atom via the ammonium group[30]. 
Additionally and more importantly, site directed mutagenesis of replacement of Lys 
353 by alanine leads to more drastic loss of activity as compared to the replacement of 
Arg 360, and Arg 490. For the model systems, the pKa value of the conjugated acid of 
ligand bounded peroxovanadate was estimated in the range of 5.5-6.0 (Eq. 12) by 
studying the rate dependence on acid.[128]  
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The guanidinium groups of 36 are not adequate to have efficient proton exchange 
with peroxovanadate due to the too higher pKa in acetonitrile (pKa of tetramethyl-
guanidinium is 23.3 in acetonitrile and 13.2 in water[241]), however the central 
nitrogen atom is a reasonable candidate as one can expect based on the uncommonly 
low pKBH value of central nitrogen of its structural analogy 1 in water (pKa = 2.58). 
 
3. 4. 3. Summary of Part 3. 4. 
Using n-Bu4N+ as counter cation makes vanadate soluble in organic solvents. 
Preliminary studies reveals that simple vanadate in acetonitrile is a more efficient 
functional model than in water. The rate acceleration of acetonitrile can be compared 
to an enzyme-like hydrophobic environment in vanadate catalytic center of V-CPO. In 
addition, solvents also influence the pKBH value for peroxovanadate, facilitating the 
proton transfer from the acid to it. UV and fluorescent titration shows that 
supramolecular receptor 36 exhibits a high affinity to the peroxovanadate. A 
competitive catalytic bromination experiment was designed and successfully 
demonstrated the kinetic process for the catalytic bromination of TMB/MCD mixtures. 
The addition of 36 to the reaction system significantly enhances the catalytic 
efficiency. The rate enhancement by 36 was discussed and reasoned to the increasing 
of Lewis acidity of vanadate by forming hydrogen bonds with positively charged 
guanidiniums of 36. In addition, the central nitrogen atom of 36 may play as an acid 
base catalyst, facilitating the protonation of peroxovanadate. All together, 36 is an 
effective functional model for V-HPO due to the structural fidelity to the 
supramolecular binding fashion of the enzyme. 
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4. Summary and Conclusions 
V-HPOs are enzymes catalyzing the halogenation of a variety of organic substrates 
using hydrogen peroxide and halide ions at slightly acidic condition[17, 21, 50]. The X-
ray structure of V-HPO from Curvularia inaequalis[29, 30] reveals that the positively 
charged residues at the active site bind orthovanadate (HVO42-) through electrostatic 
interaction and hydrogen bonds, together with one coordinating bond from the 
nitrogen (N 2) of His496 to vanadium, which is the only direct bond from protein to 
metal center. Accordingly the coordination sphere at vanadium is trigonal-
bipyramidal, resembling the transition state of SN2-type reactions involving 
phosphates[65]. Apart from that, vanadate and phosphate are also very similar in the 
tetrahedral ground state. Thus, it is no surprise that vanadate is an inhibitor of various 
phosphate metabolizing enzymes[73]. Since the structural assignment and reaction 
mechanism of V-HPOs are still under debate, and no structural model reported so far 
shows high fidelity concerning the non-covalent binding fashion, we decided to 
prepare supramolecular models structurally related to the binding mode of HVO42- in 
the enzyme, and study the influence of the binding sphere of vanadate to its catalytic 
activity. 
The vanadate receptor tris-(2-guanidinium-ethyl)amine 1 was rationally designed and 
conveniently synthesized from tris-(2-aminoethyl)amine via single step. Its three 
guanidinium-arms can provide not only positive charges but also several hydrogen 
bond donor sites. The central nitrogen with pKa=2.48 for its conjugated acid, allows 
the V-N coordination to occur within a broad pH window. The X-ray structure of 1 
reveals that it is already preorganized in a basket shape before binding vanadate, 
which verifies our design. 
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Scheme 19.  Binding of vanadate to supramolecular receptor 1 and the proposed structure 
of complex 5. 
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NMR titration data from 51V of vanadate and 1H of the ligand give complementary 
results. The ligand 1 binds vanadate as 1/1 complex 5 (Scheme 19) at pH 10.21 in 
water solution, with Ka = 103 Mol-1. The complex 5 was also detected by ESI-MS. 
The absorption at 306 nm observed in UV difference spectrum is an indication of a V-
N bond formation in agreement with coordination in V-HPO. The time dependent 
DFT calculation both for enzyme and model system 5 provided in-depth evidence that 
V-N coordination is responsible for this UV band.  
5 is the first supramolecular structural model V-HPO. These model studies provided 
for the first time evidence that the V-N bond of V-HPO is coordinative and not 
covalent as original proposed[242]. 
A series of more rigid novel guanidinium-cryptands containing the key scaffold of 1 
were synthesized (Scheme 20), the preorganization was expected to provide higher 
affinity to vanadate. A general flexible synthetic strategy was developed which allows 
the preparation of the guanidinium cryptands with different size and geometry. 
However, spectroscopic studies failed to demonstrate any enhancement of binding 
constant for encapsulating vanadate. The association of vanadate most likely occurres 
not interior but outside of the cavity even for the largest cage receptor 35. 
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Scheme 20.  Guanidinium cryptands: cage shaped receptors for vanadate.  
Three pyrene moieties introduced to the terminal-N atoms of 1 not only improved the 
solubility of the receptor in unpolar solvent, but also served as UV and fluorescence 
sensor for vanadate recognition (see Scheme 21). In addition, the -  stacking 
interaction within pyrenes holds three arms together to further preorganize itself 
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favoring the binding of vanadate. This preorganization was demonstrated by 
observing the pyrene excimer emission, which can be also observed for the neutral 
analogue 53.  
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Scheme 21.  More preorganized receptor and fluorescent sensor 36 and its structure 
analogy and synthetic precursor 53. 
The binding of vanadate to 36 and 53 is coupled with the significant UV and 
fluorescence response in acetonitrile. Upon the addition of vanadate, the UV bands of 
36 became broader and red shifted, together with a PET-type fluorescence quenching. 
Therefore, deduced from the UV, fluorescence titration and additional 51V-NMR data, 
36 exhibits an association constant >> 3 × 107 mol-1 with pyrovanadate (V2O74-, V2) 
(Scheme 22) in acetonitrile, which is at least 4 times magnitude higher than that of 1 
to vanadate (HVO42-, V1). The preference of 36 to bind V2 over V1 was also 
confirmed in titration studies with the pyrophosphate and phosphate, the structure 
analogue of V2 and V1 respectively.  
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Scheme 22.  The proposed complex of 36 and pyrovanadate. 
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The neutral thiourea receptor 53 shows much lower binding constant and almost no 
preference to any vanadate or phosphate species mentioned above, revealing the 
importance of positive charge on the affinity and selectivity for anion binding. 
Kinetic studies reveal that simple vanadate in acetonitrile is a more efficient 
functional model than in water. The rate acceleration in acetonitrile is thought to be 
originated from an enzyme-like hydrophobic environment for the catalytic species. 
UV and fluorescence titration shows that the supramolecular receptor 36 exhibits high 
affinity to the peroxovanadate as well, which verifies that vanadium core keeps being 
bounded in the catalytical cycle. A competitive catalytic bromination experiment was 
designed and successfully demonstrated the kinetic process for the catalytic 
bromination of 1,3,5-tri-methoxy-benzene (TMB) and monochlorodimedone (MCD) 
mixture substrates. The addition of 36 to the reaction system significantly enhances 
the catalytic efficiency. The rate enhancement by 36 may be reasoned to the 
increasing of Lewis acidity of vanadate by forming hydrogen bonds with positively 
charged guanidiniums of 36. In addition, the central nitrogen atom of 36 may act as an 
acid base catalyst, facilitating the protonation of peroxovanadate. All together, 36 is 
an effective functional model for V-HPO based on the structural fidelity to the 
supramolecular binding fashion of the enzyme. 
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5. Experimental Part 
5. 1. General Remarks 
5. 1. 1. Solvents and Reagents 
Reagents were used as received from Fluka AG (Buchs, Switzerland), Merck AG 
(Darmstadt, Germany) and Aldrich (Buchs, Switzerland) unless otherwise stated. 
Chemicals of the quality purum, purum p. a. or >98% were used without further 
purification. 
Solvents for chromatography and extractions were distilled prior to use. As solvent of  
reaction, dry dichloromethane (CH2Cl2) was distilled from CaH2, Et2O and THF from 
Na/benzophenone. All freshly dried solvents were used immediately. Further solvents 
used for reactions corresponded to the quality puriss p. a., abs., over Molecular Sieves 
from Fluka AG. Degassed solvents for reactions under oxygen-free condition (e.g. in 
the glove box) were obtained by at least four freeze-pump-thaw cycles. Nano-pure 
water was used if necessary. 
For an inert atmosphere Argon 56 (< 4 ppm other gases) from Carbagas AG 
(Lenzburg, Switzerland) was used. 
 
5. 1. 2. Materials & Instruments 
Solvents were removed with a Büchi (Switzerland) rotary evaporator (Waterbath B-
480, Rotavapor R 114 and Vacuum Controller 168) and a MZ 2C membrane pump 
(Vacuubrand). For cooling a mixture of EtOH and water was kept at 4° with a UKW 
300 thermostat (Vacuubrand).  
For weighing compounds and reagents Mettler (Switzerland) balances P1200 (> 1 g), 
AE163 (< 1 g), and AX205 (< 100 mg) were used.  
A high-vacuum pump D5E from Trivac (Köln, Germany) or Edwards from Edwards 
High Vacuum International (west Sussex, England) was used for drying compounds 
and reagents.  
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Lyophilization was performed with Lyolab B from LSL Secfroid (Aclens, 
Switzerland).    
Magnetic stirrers were MR3001K with thermo-controller EKT 3001 from Heidolph 
(Schwabach, Germany) and IKA-Combimag RCT from Janke & Kunkel Gmbh & Co. 
KG (Staufen, Germany). 
For all non-aqueous reactions glassware were flame dried either under vacuum or 
argon overpressure, and the atmosphere was exchanged by three cycles of evacuating 
and flushing with argon.  
5. 1. 3. Chromatographic Methods 
Analytical thin layer chromatography (TLC) was performed on 0.25 mm precoated 
glass plates (5×10 cm, silica gel 60 F254, Merck AG, Darmstadt, Germany) or on 0.2 
mm precoated plastic plates (5×10 cm, ALUGRAM® aluminum oxide N/UV254, 
Macherey-Nagel, Germany). Reverse phase TLC was performed on precoated glass 
plates (5×10 cm, RP-18 F254s, Merck AG, Darmstadt, Germany). Compounds were 
detected at 254 nm (UV) or at 366 nm (fluorescence), or visualized by iodine vapor or 
spray reagents, i.e. Ninhydrin spray reagent. Description: TLC (solvent): Rf.  
Preparative thin layer chromatography was conducted on 0.25 mm precoated glass 
plates (20×20 cm, silica gel 60 F254, Merck AG, Darmstadt, Germany).  
For normal phase column chromatography silica gel 60 from Merck (0.043-0.06 
mm, 230-400 mesh) or aluminum oxide 90 from Merck (standardized (activity II-III), 
0.063-0.2 mm, 70-230 mesh) were used and for eluting the compounds pressure (0.3–
0.5 bar N2) was applied (flash chromatography).  
5. 1. 4. Spectroscopic and Characterization Methods  
Ultra violet – visible absorption spectra (UV/Vis) were recorded on a Hewlett-
Packard 8452A Diode Array spectrophotometer and a Agilent 8453 Diode Array 
spectrophotometer using optical 110-OS Hellma cuvettes (10 mm light path). For 
kinetic UV measurement, internal software was used to fit the reaction rate. 
Description: UV/Vis (solvent): wavelength of maxima ( max) in nm.  
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Fluorescence spectra were recorded on an ISA Jobin Yvon-Spex FluoroMax-2 
spectrometer which was fitted with a magnetic stirrer and thermostatic cell housing 
controlled by external water bath, and using 10 mm path length quartz cuvettes 
(Hellma) which were fitted with an appropriate magnetic stir bar. If not otherwise 
stated all spectra were recorded at 23 ˚C. For kinetic measurement, the software 
OriginPro was used to fit the reaction rate. 
Infrared spectra (IR) were measured on a Perkin-Elmer 1600 series FTIR 
spectrometer in KBr (1% w/w) or neat between NaCl-plates. Description: IR 
(medium): wavenumbers of transmission maxima in cm-1, intensity (s = strong, m = 
middle, w = weak, br = broad).  
1H-Nuclear magnetic resonance spectroscopy (1H-NMR) was performed using 
either a Bruker av250 (250 MHz), Varian Gemini 300 (300 MHz), Bruker DPX-NMR 
(400 MHz), Bruker DRX-500 (500 MHz) or a Bruker DRX-600 (600 MHz) 
spectrometer. Solvents for NMR were obtained from Dr. Glaser AG (Basel, 
Switzerland) and Cambridge Isotope Laboratories (Andover, MA, USA). CDCl3 was 
filtered through basic alumina prior to use. If not otherwise stated all spectra were 
recorded at room temperature. If necessary for the interpretation correlated spectra 
like COSY, TOCSY, NOESY and ROESY were recorded also. Description: 1H-NMR 
(frequency, solvent): δ H in ppm relative to residual solvent peaks or internal TMS 
peak (peak multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
b = broad; coupling constants J in Hertz).  
13C-Nuclear magnetic resonance spectra (13C-NMR) were 1H-decoupled and 
recorded on a Bruker DPX-NMR (100 MHz), Bruker DRX-500 (125 MHz) and 
Varian Gemini 300 (75 MHz) spectrometer. For the assignment of carbons APT, 
DEPT, HETCOR, HMQC and HMBC experiments were carried out if essential. 
Description: 13C-NMR (frequency, solvent): δ C in ppm relative to residual solvent 
peaks.  
51V-Nuclear magnetic resonance spectra (51V-NMR) were recorded on a Bruker 
DPX-600 (157.8 MHz), chemical shift is given in ppm, with VOCl3 (δ v = 0.0 ppm) as 
external reference; line broadening = 0-100 Hz, sweep width ~ 100 000 Hz, no 
relaxation delay. 
 86 
31P-Nuclear magnetic resonance spectra (31P-NMR) were recorded on a Bruker 
DPX-600 (242.94 MHz) and Bruker DPX-NMR (161.97 MHz); chemical shift is 
given in ppm relative to inorganic phosphate (δ v = 0.0 ppm). 
Electron impact mass spectra (EI-MS) and fast atom bombardment mass spectra 
(FAB-MS) were measured by Dr. H. Nadig on a Varian double focusing VG-70-250 
spectrometer in the mass spectrometry laboratory of the institute. As matrix for FAB-
MS nitrobenzyl alcohol was used and, if necessary KCl added. Electron spray 
ionization mass spectra (ESI-MS) were recorded on a Finnigan Mat LCQ-700 or a 
Bruker Esquire 3000plus. Description: MS (solvent): mass peaks in m/z (relative 
intensity in %). Peaks with an intensity of less than 5% were not considered.  
Single crystal X-ray structures were determined by Dr. Markus Neuburger and Dr. 
Silvia Schaffner. Data collection was carried out on a Nonius KappaCCD 
diffractometer using the COLLECT software suite. The usual corrections were 
applied. No absorption correction was determined. The structures were solved by 
direct methods using the program SIR92. Anisotropic least-squares refinement was 
carried out on all non-hydrogen atoms using the program CRYSTALS. Hydrogen 
atoms are in calculated positions. 
Melting points (mp) were determined on a Büchi 510 apparatus and are uncorrected.  
Elemental analysis (EA) was carried out by Mr. H. Kirsch at the institute with a 
Perkin-Elmer 240 Analyzer. Description: EA calculated (calc.) for (chemical formula, 
molecular weight): abundance of C, H, O in %; found abundance of C, H, O in %. 
5. 1. 5. Non-linear data fit  
Non-linear data fit used the program proFit 5.1 (proFit® QuantumSoft)  performed on 
Mac or Origin 7.0 SR0 (Origin® OriginLab Corporation) performed on PC. The 
following general equation was applied for NMR, UV and fluorescent titration 
titration of 1:1 binding mode: 
Iobs  =  IH  +o
(IHG - IH  )o
2[Ho]
( [Ho] + [Go] + 1K -[Ho] + [Go] +( )
2 4[Ho][Go] )
 
“I” refers to the chemical shift or UV/fluorescent intensity of specie H. 
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5. 2. Syntheses 
5. 2. 1. The serial of first generation Tris- openarmed-guanidiniums 
Tris(2-guanidinoethyl)amine trihydochloride (1) 
300 l tris-(2-aminoethyl)amine (2, 2 mmol) and 1.03 ml  
N,N-di-isopropyl-ethylamine (DIEA, 6 mmol) were 
dissolved in 6 ml DMF to get a clear solution. White solid 
precipitated when the solution of 903 mg (6.16 mmol) of 
1H-pyrazole-1-carboxamidine monohydrochloride (3) in 6 
ml DMF was added in. This white solid is the hydrochloride salt of 2. The reaction 
was stirred by ultrasound bath for 3 hours under argon atmospheres below 50 ˚C and 
most of the solid was dissolved. The reaction was continued at room temperature with 
normal magnetic stirrer over night. The reaction system was filtrated and washed with 
8 ml 1:1 solution of DMF/t-butyl-methylether (TBME), and. 14 ml TBME was added 
to precipitate the white solid. The solution and stirred slowly at room temperature for 
2 hours, then filtrated. The solid was washed with TBME to yield 762.2 mg (99.8%) 
crude 1 as pale yellow solid. Yield of the recrystallization (MeOH/CH2Cl2) was 72%. 
 
1H-NMR (400 MHz, DMSO-d6): 2.57 (t, 6H, J = 5.55 Hz, 3×CH2-N); 3.25 (td, 6H, J 
= 5.31, 5.55 Hz, 3×CH2-NH); 7.25 & 7.54 (br, 12H, 3× NH2-C- NH2); 7.64 (t, 3H, J 
= 5.18, 3×NH). 
13C-NMR (100 MHz, DMSO-d6): 39.07 (3C, 3×CH2-NH); 52.06 (3C, 3×CH2-N); 
157.99 (3C, 3×C=NH).  
ESI-MS (MeOH): Positive ion mode: 273.3 (M+H+) 
IR (KBr cm-1): 3331 (s); 3158 (s); 1656 (s). 
EA: calc. for C9H27Cl3N10: C 28.32, H 7.13, Cl 27.86, N 36.69; found: C 28.30, H 
7.10, N 36.58, Cl 27.84. 
X-ray structure: The single crystal for X-ray structure determination was obtained 
by vapor diffusion of CH2Cl2 into the solution of 1 in methanol. 1 was cocrystallized 
with one molar MeOH. The structural details see chapter 5.5. 
 
NH
N
HNN
H
NH2
H2N
NH2
NH2
NH2H2N
++
+
3. Cl-
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Tris(2-guanidinopropyl)amine trihydochloride (6)  
Compound 6 was synthesized via the similar manner as 1 
from tris-(3-aminopropyl)amine. However, 6 can not be 
precipitated as solid by adding TBME to the final reaction 
solution. Instead, the crude product was precipitated as 
yellow oil under this condition. Decant the up layer 
solution and the oil was soaked by 1:1 mixture of 
DMF/TBME, then by pure TBME and diethyl ether subsequently. Accurate yield was 
not able to be obtained due to the high hydroscopic nature of 6. 
1H-NMR (400 MHz, DMSO-d6): 1.63 (tt, 6H, J = 6.57, 6.82 Hz, 3×N-CH2CH2CH2-
NH); 2.44 (t, 6H, J = 6.82 Hz, 3×CH2-N); 3.16 (t, 6H, J = 6.56 Hz, 3×CH2-NH); 6.8-
8.9 (br m, 15 H, 3×gunidinium-H). 
13C-NMR (100 MHz, DMSO-d6): 26.71 (3C, 3×N-CH2CH2CH2-NH);39.79 (3C, 
3×CH2-NH); 50.96 (3C, 3×CH2-N);157.96 (3C, 3×C=NH). 
ESI-MS (MeOH): Positive ion mode: 315.2 (M+H+); Negative ion mode: 349.8 
(M+Cl-). 
 
 
Tris(2-guanidinoethyl)amine tri-tetraphenylborate (7) 
38.17 mg compound 1 (0.1 mmol) was dissolved 
in 2 ml water and this clear solution was heated 
up to 45 ˚C by oil bath. The 3 ml aqueous 
solution of 131.51 mg NaBPh4 (0.38 mmol) was 
added in and white solid started to precipitate. 
The system continued to be stirred at 45-50 ˚C for 30 minutes and at rt for overnight. 
After filtration and washing with water, the solid was dried under vacuum to afford 
113.09 mg 7 as white powder (91.7%). 
1H-NMR (400 MHz, CD3CN): 2.62 (t, 6H, J = 6.32 Hz, 3×CH2-N); 3.10 (t, 6H, J = 
6.32 Hz, 3×CH2-NH); 6.01 (br m, 15H, 3×5-gunidinium-H); 6.87 (t, 12H, J = 7.07 Hz, 
12×Ar-CHp); 7.02 (t, 24H, J = 7.33 Hz, 24×Ar-CHm); 7.30 (m, 24H, 24×Ar-CHo). 
N
N
H
HN
NH
NH2
H2N
NH2
NH2
H2N NH2
3. Cl
6
N
HNNH
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NH2H2N
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13C-NMR (100 MHz, CD3CN): 39.50 (3C, 3×CH2-NH); 51.85 (3C, 3×CH2-N); 
122.24 (12C, 12×Ar-CHp); 126.02, 126.05, 126.08, 126.11 (q, coupling with B, 24C, 
24×Ar-CHo); 136.15 (24C, 24×Ar-CHm); 157.99 (3C, 3×C=NH); 163.48, 163.96, 
164.46, 164.96 (q, coupling with B, 12C, 12×Ar-C-B). 
 
 
Tris(2-guanidinopropyl)amine tri-tetraphenylborate (8) 
 
Compound 8 was prepared in a same 
way as for 7, albeit directly from the 
final reaction mixture for preparation of 
6 with overall yield of 87.0% according 
to tris-(2-aminopropyl)amine. 
 
1H-NMR (400 MHz, CD3CN): 1.62 (tt, 6H, J = 6.82, 7.07 Hz, 3×N-CH2CH2CH2-
NH); 2.42 (t, 6H, J = 7.07 Hz, 3×CH2-N); 3.03 (t, 6H, J = 6.82 Hz, 3×CH2-NH); 6.87 
(t, 12H, J = 7.16 Hz, 12×Ar-CHp); 7.02 (t, 24H, J = 7.41 Hz, 24×Ar-CHm); 7.30 (m, 
24H, 24×Ar-CHo). 
13C-NMR (100 MHz, CD3CN): 25.09 (3C, 3×N-CH2CH2CH2-NH); 40.28 (3C, 
3×CH2-NH); 49.76 (3C, 3×CH2-N); 122.25 (12C, 12×Ar-CHp); 126.03, 126.06, 
126.09, 126.11 (q, coupling with B, 24C, 24×Ar-CHo), 136.15 ((24C, 12×Ar-CHm); 
157.14 (3C, 3×C=NH); 163.47, 163.96, 164.45, 164.94 (q, 12C, 12×Ar-C-B). 
 
 
5. 2. 2. Guanidinium cryptands 
N,N-bis(4-phthalimidobutyl)benzylamine (11) 
 
4.55 g N-(4-bromobutyl)-phthalimide (9) (16.1 
mmol), 0.88 ml benzylamine (8.05 mmol) and 
2.80 g KF-545-Celite* were mixed in 27 ml 
acetonitrile. The reaction was carried under argon 
atmosphere at rt over night. The KF-545-Celite 
NN
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was removed by filtration and washed with fresh acetonitrile. The filtrate was 
concentrated by evaporator and subsequently purified by flash chromatography (silica 
gel, toluene/acetone = 20:1) to afford 1.99 g (48.0%) product 11 as white solid. 
 
*) The catalyst KF-545-Celite was prepared by mixing 125 ml aqueous solution of 5 g potassium 
fluoride with 5 g of Celite 353. Water was removed and the resulting solid was washed with 25 ml 
acetonitrile then dried under vacuum. 
 
TLC (toluene/acetone = 7: 1): Rf = 0.35. 
mp: 105-7 ˚C. 
1H-NMR (400 MHz, CDCl3): 1.49 (tt, 4H, J = 7.2, 7.3 Hz, 2×CH2-2); 1.66 (tt, 4H, J 
= 7.4, 7.5 Hz, 2×CH2-3); 2.43 (t, 4H, 2×CH2-1); 3.51 (s, 2H, PhCH2); 3.63 (t, 4H, J = 
7.2 Hz, 2×CH2-4); 7.16-7.29 (m, 5H, Ph-CH); 7.70 (m, 4H, 4×Ph-CH); 7.80 (m, 4H, 
4×Ph-CH). 
13C-NMR (100 MHz, CDCl3): 24.8 (2C, 2×CH2-3); 26.8 (2C, 2×CH2-2); 38.3 (2C, 
2×CH2-4); 53.6 (2C, 2×CH2-1); 59.1 (PhCH2), 123.5, 127.1, 128.5, 129.2, 132.6, 
134.2, 140.3 (18C, Ph-C, CH); 168.8 (4C, 4×C=O). 
MS (ESI, m/z):  510.6 (M+H+), 532.4 (M+Na+).       
EA: calc. for C31H31N3O4: C 73.06, H 6.13, N 8.25, O 12.56; found: C 72.85, H 6.05, 
N 8.21, O 12.90. 
IR (KBr, cm-1): 3062 (w
.
), 2933 (m), 2788 (m), 1708 (s). 
 
 
N,N-bis(5-phthalimidopentyl)benzylamine (12) 
 
12 was prepared in similar way as 11 from N-(5-
bromopentyl)-phthalimide (10). 
 
TLC (CH2Cl2/MeOH = 20:1.5): Rf = 0.45. 
1H-NMR (400 MHz, CDCl3): 1.30 (m, 4H, 
2×CH2-3); 1.48 (t, 4H, J = 6.52 Hz, 2×CH2-2); 
1.63 (tt, 4H, J = 7.45, 7.54 Hz, 2×CH2-4); 2.36 (t, 
N
O
O
N
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O
O
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4H, J = 6.37 Hz, 2×CH2-1); 3.50 (s, 2H, PhCH2); 3.65 (t, 4H, J = 7.25 Hz, 2×CH2-5); 
7.16-7.26 (m, 5H, Ph-CH); 7.69 (AA’ of AA’BB’, 4H, J = 3.04, 5.44 Hz, 4×Ph-CH); 
7.82 (BB’ of AA’BB’, 4H, J = 3.03, 5.46 Hz, 4×Ph-CH). 
13C-NMR (100 MHz, CDCl3): 25.05, 26.97, 28.88 (6C, 2×C-2, 2×C-3, 2×C-4); 38.38 
(2C, 2×C-5); 53.89 (2C, 2×C-1); 58.96 (PhCH2); 123.55, 127.01, 128.48, 128.63, 
129.15, 132.58, 134.23 (18C, 3×Ph-C, CH); 168.83 (4C, 4×C=O). 
MS (ESI, m/z):  538.1 (M+H+). 
 
 
N,N-Bis-(4-phthalimidobutyl)amine (13) 
 
1.81 g compound 11 (3.6 mmol) was dissolved in 10 
ml acetic acid and 100 mg 10% Pd/C was added in. 
The inner atmosphere of the reaction system was 
exchanged three times with argon and another three 
times with H2. The reaction was performed at 70 ˚C 
under H2 balloon overnight then cooled down to rt. 
The catalyst was removed by filtration over Celite. The acetic acid was removed 
under vacuum, and then 20 ml CHCl3 and 20 ml 4N ammonia aqueous solution were 
added in together. The organic phase was washed with brine and dried over Na2SO4. 
Solvent was removed and dried under vacuum to get 1.66 g 13 (91.0%) which was 
enough pure for next step. 
 
TLC (CH2Cl2/MeOH/NEt3 = 20:1:0.1): Rf = 0.23 
1H-NMR (400 MHz, CDCl3): 1.55 – 1.78 (m, 8H, 2×CH2-2 + 2×CH2-3); 2.71 (t, 4H, 
J = 7.2 Hz, 2×CH2-1); 3.70 (t, 4H, J = 7.2 Hz, 2×CH2-4); 7.69 (AA’ of AA’BB’, 4H, 
J = 3.0, 5.5 Hz, 4×Ph-CH); 7.82 (BB’ of AA’BB’, 4H, J = 3.0, 5.5 Hz, 4×Ph-CH). 
13C-NMR (100 MHz, CDCl3): 25.3, 26.8, (4C, 2×C-2, 2×C-3); 38.0 (2C, 2×C-4); 
49.1 (2C, 2×C-1); 123.6, 132.5, 134.3 (12C, Ph-C and -CH); 168.8 (4C, 4×C=O). 
ESI-MS (m/z):  420.5 (M+H+). 
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Tris-(4-phthalimidobutyl)amine (15)  
 
1.20 g KF-545-Celite was added into the 5.0 
ml acetonitrile solution of N-(4-bromobutyl)-
phthalimide (9, 422 mg, 1.49 mmol) and 482 
mg compound 13 (1.15 mmol). The mixture 
was stirred under argon atmosphere over night; 
then the catalyst was removed by flirtation and 
washed with fresh acetonitrile. The filtrate was 
concentrated in vacuo and purified by flash 
chromatography (silica gel, toluene/acetone = 
20:1) to afford 196 mg (27.0%) 15 as white solid. 
 
TLC (toluene/acetone = 5:1): Rf = 0.12. 
mp: 122.5-123.5 ˚C. 
1H-NMR (400 MHz, CD3CN): 1.39 (tt, 6H, J = 7.3 Hz, J = 7.3 Hz, 3×CH2-2); 1.61 (tt, 
6H, J = 7.3 Hz, J = 7.3 Hz, 3×CH2-3); 2.33 (t, 6H, J = 6.9 Hz, 3×CH2-1); 3.56 (t, 6H, 
J = 7.1 Hz, 3×CH2-4); 7.72 - 7.74 (m, 12×Ph-CH). 
13C-NMR (100 MHz, CD3CN): 24.7, 26.5 (6C, 2×C-2, 2×C-3); 38.0 (3C, 2×C-4); 
53.4 (3C, 2×C-1); 123.1, 132.7, 134.3 (18C, Ph-C and -CH); 168.7 (6C, 6×C=O). 
ESI-MS (m/z):  621.7 (M+H +); 
EA: calc. for C36H36N4O6: C 69.66, H 5.85, N 9.03, O 15.47; found: C 69.42, H 5.92, 
N 8.42, O 15.76. 
 
 
Tris-(4-aminobutyl)amine tetrahydrochloride (17) 
0.17 ml hydrazine monohydrate (3.56 mmol) was added to 
the solution of 245 mg Tris-(4-phthalimidobutyl)amine (15) 
in 4.6 ml ethanol. The reaction was stirred at room 
temperature for two hours and white solid precipitated 
during this procedure. All the volatile was removed in 
vacuo and 5.0 ml 2 M HCl aqueous solution was added in. 
The mixture was filtrated and the solution was dried under vacuum. The residue was 
dissolved in 1 ml water and loaded to ion exchange resin (Amberlite IR-120, H+ form, 
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6.56 g, pre-wash with 3M HCl and then water to pH neutral). 3 M HCl was used as 
eluent and the Ninhydrin positive fragments were collected and lyophilized to afford 
77.3 mg compound 17 (52.0%) as white solid. 
 
1H-NMR (400 MHz, D2O): 1.60 – 1.80 (12H, 3×CH2-2 + 2×CH2-3); 2.96 (t, 6H, 
2×CH2-1); 3.15 (br, 6H, 2×CH2-4). 
13C-NMR (100 MHz, D2O): 21.1 (3C, 3×C-2); 24.4 (3C, 3×C-3); 39.3 (3C, 3×C-4); 
52.8 (3C, 3×C-1). 
ESI-MS (m/z):  231.3 (M+H+) 
 
 
N-(4-iodobutyl)-phthalimide (19) 
 
5.64 g N-(4-bromobutyl)-phthalimide (9) (20 mmol) 
and 7.20 g fine powdered sodium iodide (48 mmol) 
were mixed with 40 ml acetone and refluxed under 
argon atmosphere for 24 hours. Another 7.20 g fine 
powdered sodium iodide was added in and continue to reflux for 24 hours more. The 
volatiles were removed in vacuo; then 100 ml CH2Cl2 and 100 ml water were added 
to the residue and the two phases were separated. The water layer was extracted again 
with 2×100 ml CH2Cl2. All the organic layers were combined and wash with 10% 
NaS2O3 aqueous solution, water and brine, then dried over Na2SO4 anhydrite. After 
filtration, the solvent was removed and resulting solid was dried under vacuum to 
afford 6.22 g 19 (94.5%) which is already pure enough for next step reaction.  
 
TLC (toluene/acetone = 20:3): Rf = 0.58; (hexane/ethyl acetate = 4:1): Rf = 0.35; 
(CH2Cl2): Rf = 0.41. 
mp: 88-89 ˚C 
1H-NMR (400 MHz, CDCl3): 1.83 (m, 4H, CH2-2 + CH2-3); 3.21 (t, 2H, J = 6.53 Hz, 
CH2-1); 3.70 (t, 2H, J = 6.59 Hz, CH2-4); 7.71 (AA’ of AA’BB’, 2H, J = 3.06, 5.42 
Hz, 2×Ph-CH); 7.83 (BB’ of AA’BB’, 2H, J=3.03, 5.46 Hz, 2×Ph-CH). 
13C-NMR (100 MHz, CDCl3): 5.99 (C-3); 29.93 (C-2); 30.94 (C-1); 37.13 (C-4); 
123.68, 132.43, 134.41 (6C, Ph-C, CH); 168.77 (2C, 2×C=O). 
IR (CHCl3, cm-1): 1765, 1703 
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N-(5-iodopentyl)-phthalimide (20) 
 
Compound 20 was prepared in a same way as 19 
from N-(5-bromopentyl)-phthalimide (10) with a 
yield of 96.5%. 
 
TLC (hexane/ethyl acetate = 4:1): Rf = 0.29, (toluene/acetone = 20:3): Rf = 0.60 
mp: 73-75 ˚C 
1H-NMR (400 MHz, CDCl3): 1.45 (tt, 2H, J = 7.33, 8.08 Hz, CH2-3); 1.70 (tt, 2H, J = 
7.33, 7.58 Hz, CH2-2); 1.87 (tt, 2H, J = 7.08, 7.33 Hz, CH2-4); 3.17 (t, 2H, J = 6.95 
Hz, CH2-1); 3.68 (t, 2H, J = 7.21 Hz, CH2-5); 7.71 (AA’ of AA’BB’, 2H, J = 3.03, 
5.56 Hz, 2×Ph-CH); 7.83 (BB’ of AA’BB’, 2H, J=3.03, 5.56 Hz, 2×Ph-CH). 
13C-NMR (100 MHz, CDCl3): 6.82 (C-3); 27.91, 28.11 (C-2, C-4); 33.30 (C-1); 38.05 
(C-5); 123.64, 132.51, 134.34 (6C, Ph-C, CH); 168.81 (2C, 2×C=O). 
EI-MS (70 ev, m/z): 343 (3.8 M +), 261.1 (49.2), 160 (100); ESI-MS (m/z):  365.9 
(M+Na+). 
EA: calc. for C13H14INO2: C 45.50, H 4.11, N 4.08, O 9.32; found: C 45.92, H 4.27, 
N 4.03; 
 
 
Benzyl-tris-(4-phthalimidobutyl)-ammonium iodide (21) 
 
1.50 g KF-545-Celite was added into the 15.0 
ml solution of 1.645 g N-(4-iodobutyl)-
phthalimide (19) (5 mmol) and 110 l 
benzylamine (1.0 mmol) in acetonitrile. The 
mixture was refluxed under argon atmosphere 
for 48 hours; then the KF-545-Celite was 
removed by flirtation and washed with fresh acetonitrile. The filtrate was concentrated 
in vacuo and the residue was soaked in benzene. The reaction flask stood in ultra 
sonic bath for 30 minutes and was cooled down in ice bath for one hour; then the 
benzene up-layer was decanted. The residue was repeated this washing procedure by 
benzene once more to remove the excess of 19 and the bis- alkylated side product. 10 
ml CH2Cl2 was added to the residue, and the mixture was filtrated to remove small 
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amount of white inorganic salts. The solution was dried under vacuum to give 516 mg 
(60.8%) 21 as yellow solid which can be used directly for next step reaction. However, 
all the NMR signals of 21 shows more than two group of signals which did not 
improve after flash chromatography (silica gel, CH2Cl2/MeOH gradient from 100:1 to 
10:1), and the reason is not clear yet. Only the main signal is listed bellow. 
 
TLC (CH2Cl2/MeOH = 40:3): Rf = 0.26, 
1H-NMR (400 MHz, CDCl3): 1.78 – 1.91 (m, 12H, CH2-2  CH2-3); 3.47 – 3.50 (m, 
6H, Hz, CH2-1); 3.69 – 3.71 (m, 2H, J = 6.95 Hz, CH2-4); 4.87 (s, 2H, PhCH2); 7.26 – 
7.81 (m, 17H, Ph-H). 
13C-NMR (100 MHz, CDCl3): 20.05, 25.70 (6C, 3×C-2, 3×C-3); 32.26 (3C, 3×C-1); 
59.01 (3C, 3×C-4); 63.87 (PhCH2); 123.39, 127.00, 129.56, 130.95, 131.89, 132.50, 
134.19 (24C, 4×Ph-C, CH); 168.51 (6C, 6×C=O). 
ESI-MS (m/z):  711.2 (M +). 
 
 
Benzyl-tris-(5-phthalimidopentyl)-ammonium iodide (22) 
Compound 25 was obtained from 
N-(5-iodopentyl)-phthalimide (20) 
via the same way as 21., Yield: 
66.0%. 
 
TLC (CH2Cl2/MeOH = 40:3): Rf = 
0.53; 
1H-NMR (400 MHz, CDCl3): 1.43 
(tt, 6H, J = 7.43 Hz, 3×CH2-3); 1.83 (tt, 6H, J = 6.87 Hz, 3×CH2-2); 1.97 (m, 6H, 
3×CH2-4); 3.32 (t, 6H, J = 8.31 Hz, 3×CH2-1); 3.73 (t, 6H, J = 6.59 Hz, 3×CH2-5); 
4.86 (s, 2H, PhCH2); 7.44-7.56 (m, 5H, Ph-CH); 7.71 (AA’ of AA’BB’, 6H, J = 3.03, 
5.47 Hz, 6×Ph-CH); 7.82 (BB’ of AA’BB’, 6H, J = 3.03, 5.49 Hz, 6×Ph-CH). 
13C-NMR (100 MHz, CDCl3): 22.23, 23.65, 28.28 (9C, 3×C-2, 3×C-3, 3×C-4); 32.26 
(3C, 3×C-1); 37.17 (3C, 3×C-5); 59.27 (PhCH2); 123.72, 128.74, 132.39, 132.94, 
134.47 (24C, 4×Ph-C, CH); 168.92 (6C, 6×C=O). 
ESI-MS (m/z):  753.2 (M +). 
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Benzyl-tris-(4-aminobutyl)-ammonium iodide (23) 
 
167.7 mg Benzyl-tris-(4-phthalimidobutyl)-
ammonium iodide (21) (0.2 mmol) and 159 l 
hydrazine monohydrate were added to 2 ml 
ethanol. The reaction mixture was refluxed under 
argon atmosphere for two hours and white solid 
precipitated. Subsequently the system was cooled 
down and stirred at room temperature for over night, then stored at 4 ˚C fridge for two 
hours. Keep the system cool and the white solid was removed by filtration. All the 
volatiles were removed under high vacuum to afford the crude product 23 as yellow 
gum which contain small amount of N,N’-phthaloyl hydrazine. Though it can be 
further purified by reverse phase chromatography (RP18, CH3CN/H2O), the crude 
product was used directly for next step. 
 
1H-NMR (400 MHz, CD3OD): 1.64 (tt, 6H, J = 7.40 Hz, J = 7. 64 Hz, 3×CH2-2); 
1.93 (tt, 6H, J = 5.30 Hz, J = 10.59 Hz, 3×CH2-2); 2.99 (t, 6H, J = 7.27 Hz, CH2-4); 
3.14 (t, 6H, J = 8.32 Hz, CH2-1); 7.50 (m, 5×Ph-H). 
ESI-MS (m/z):  321.3 (M +) 
 
 
Benzyl-tris-(5-aminopentyl)-ammonium iodide (24) 
 
Compound 24 was prepared from 22 in a 
same way as 23.  
 
TLC (RP18, H2O/acetonitrile = 3:1): Rf = 
0.85; 
1H-NMR (400 MHz, CDCl3): 1.42 (m, 6H, 
3×CH2-3); 1.61 (tt, 6H, J = 7.42 Hz, 3×CH2-2); 1.87 (m, 6H, 3× CH2-4); 2.73 (t, 6H, J 
= 7.16 Hz, 3×CH2-5); 3.21 (t, 6H, J = 7.37 Hz, 3×CH2-1); 4.59 (s, 2H, Ph-CH2); 7.53 
(m, 5H, Ph-CH). 
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13C-NMR (100 MHz, CDCl3): 22.20, 23.68, 31.25 (12C, 3×C-1, 3×C-2, 3×C-3, 3×C-
4); 40.94 (3C, 3×C-5); 58.60 (Ph-CH2); 126.05, 127.89, 129.59, 130.93, 131.85, 
132.75 (6C, Ph-C, CH). 
ESI-MS (m/z):  363.3 (M +) 
 
 
Tris-(2-isothiocyanate-ethyl)amine (26) 
(2-Aminoethyl) amine 2 (0.29g, 2.00mmol) dissolved in 8.0 
ml of THF was added dropwise to a solution of DCC (1.65g, 
8mmol) and 3.2ml of CS2 (large excess) in 8.0 ml of THF at -
10ºC. The reaction was warm up to room temperature slowly 
and stirred overnight. 5ml of ether was added in to precipitate 
the solid of N,N’-dicyclohexyl-thiourea, then filtrate and wash with 5ml ether. The 
filtrate was evaporated and the resulting solid was washed with hexane. Purification 
by chromatography on silica gel (chloroform) gave 0.42g (76%) titled compound as 
yellow solid.  
 
TLC (CH2Cl2) Rf = 0.68; 
mp: 48-49 ˚C; 
1H NMR (400 MHz, CDCl3): 2.97 (t, J = 6.2 Hz, 6H, N-CH2); 3.60 (t, J = 6.2 Hz, 6H, 
CH2-NCS).   
13C NMR (100 MHz, CDCl3): 44.7 (N-CH2); 54.9 (CH2-NCS); 133.5 (NCS). 
FAB-MS (m/z): 273 (M+, 25.8); 200 (100).  
EA. calc. for C9H12N4S3: C 39.68, H 4.44, N 20.57; found: C 39.88, H 4.41, N 20.66.  
IR (KBr): 2201, 2120 cm-1.  
 
 
Tris-(3-isothiocyanate-propyl)amine (27) 
 
27 was prepared similarly as 26 from (3-aminopropyl) 
amine (25). Yield: 74.1%. 
 
TLC (CH2Cl2) Rf = 0.28; 
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mp: 43-44 ˚C; 
1H-NMR (400 MHz, CDCl3): 1.84 (tt, 6H, J = 6.31, 6.57 Hz, 3×CH2CH2CH2); 2.52 (t, 
6H, J = 6.57 Hz, 3×CH2-N); 3.61 (t, 6H, J = 6.31 Hz, 3×CH2-N=C=S). 
13C-NMR (100 MHz, CDCl3): 27.96 (3C, 3×CH2CH2CH2); 43.23 (3C, 3×CH2-
N=C=S); 50.56 (3C, 3×CH2-N); 130.90 (3C, 3×N=C=S). 
ESI-MS (m/z):  315.5 (M+H +) 
EA: calc. for C12H18N4S3: C 45.83, H 5.77, N 17.81; found: C 46.03, H 5.78, N 17.89. 
IR (KBr): 2200, 2123 cm-1. 
 
 
1,4,6,9,12,14,19,21 –Octaaza –bicyclo[7,7,7]tricosane-5,13,20 –trithione (28) 
 
A solution of Tris-(2-isothiocyanate-ethyl)amine (26) 
(272.4 mg, 1.0mmol) in 200 ml of CHCl3 and a solution of 
2 (146.1 mg, 1.0 mmol) were added dropwise 
simultaneously to 100ml of CHCl3 at 60 ºC. The mixture 
was refluxed for 30 min and stirred at room temperature 
overnight. The solvent was removed to dryness to give 422mg 3 (100%) as white 
solid. 
 
mp: >300˚C (decomposed). 
1H NMR (400 MHz, CDCl3): 2.441 (br., 6H, CH2-N); 2.803 (br., 6H, CH2-N); 3.019 
(br., 6H, NH-CH2); 4.621 (br., 6H, NH-CH2); 6.685 (br., 6H, NH). 
1H NMR (400 MHz, DMSO-d6): 7.068 (broad s, 6H, NH); 3.448 (broad s, 12H, NH-
CH2); 2.530 (t, 12H, J = 5.32 Hz, CH2-N).  
13C-NMR (100 MHz, DMSO-d6): 42.15 (6C, 6 × CH2NH2); 51.26 (6C, 6 × CH2N); 
182.70 (3C, 3 × C=S). 
FAB-MS (m/z): 419 (M+1+, 100), 129 (48.3); ESI-MS positive ion mode (m/z): 419.3 
(M+H+), negative ion mode (m/z): 417.1 (M-1-, 100), 383.1 (70.8). 
IR (KBr): 3304, 3250, 1570, 1361 cm-1.  
EA calc. for C15H30N8S3: C 43.03, H 7.22, N 26.77, S 22.98; Found: C 42.87, H 7.03, 
N 25.81.  
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X-ray structure: The single crystal suitable for X-ray structure determination was 
obtained by slow evaporation of solvent of the solution of 28 in CH2Cl2. The 
structural details chapter 5.4. 
 
3-2H+-bis-picrate 
16.7 mg (0.04mmol) of 3 and 33.6mg (0.09mmol) of picric acid (containing 40% 
water) were dissolved in 40 ml acetone. The solution was opened to the air to allow 
the slow evaporation of solvent. Yellow crystals grew and were collected by filtration 
one week later. The structure was characterized by X-ray crystallography and one 
acetone molecule was observed as cocrystallized solvent. For the structural details see 
chapter 5.5. 
  
1,4,6,10,14,16,21,23 –Octaaza –bicyclo[8,8,8]hexacosane-5,15,22 –trithione (29) 
 
Compound 29 was prepared similarly as 28. However 29 
is almost insoluble in CHCl3, therefore it can be obtained 
by filtration without removing solvent. This 
unsymmetrical thiourea cryptand was able to be obtained 
from different starting materials. Both the condensation 
of Tris-(2-isothiocyanate-ethyl)amine (26) with Tris-(3-
aminopropyl)amine (25) (yield = 93%) , or Tris-(3-isothiocyanate-propyl)amine (27) 
with Tris-(2-aminoethyl)amine (2) (yield = 84%) gave the identical product. 
 
mp: >300˚C (decomposed); 
1H-NMR (400 MHz, DMSO-d6): 1.65 (m, 6H, 3×CH2-2’); 2.28 (m, 6H, 3×CH2-1’); 
2.60 (m, 6H, 3×CH2-1); 3.03 (bs, 6H, 3×CH2-3’); 3.49 (bs, 6H, 3×CH2-2); 6.35 (bs, 
3H, 3×NH-C-2); 7.55 (bs, 3H, 3×NH-C-3’). 
13C-NMR (100 MHz, DMSO): 23.60 (3C, 3×C-2’); 39.33 (3C, 3×C-3’); 42.00 (3C, 
3×C-2); 48.40 (3C, 3×C-1’); 51.47 (3C, 3×C-1); 181.96 (3C, 3×C=S). 
ESI-MS positive ion mode (m/z): 461.3 (M+H+); negative ion mode (m/z): 459.5 (M-
1-, 100), 495.5 & 497.4 (M+Cl-, 81.5 & 39.6). 
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X-ray structure: The single crystal suitable for X-ray structure determination was 
obtained by vapor diffusion of water into the solution of 28 in DMSO. The structural 
details chapter 5.4. 
 
 
1,5,7,11,15,17,24,26 –Octaaza –bicyclo[9,9,9]nonacosane-6,16,25 –trithione (30) 
 
Compound 30 was prepared from 25 and 27 in a same 
way as for 29 (87%). 
 
TLC (CH2Cl2/MeOH/NEt3 = 20:2:1) Rf = 0.33; 
mp: >300˚C (decomposed); 
1H-NMR (400 MHz, DMSO-d6): 1.61 (bs, 12H, 6×N-
CH2CH2CH2-NH); 2.38 (bs, 12H, 6×CH2-N); 3.35 (bs, 
12H, 6×CH2-NH); 7.62 (bs, 6H, 6×NH). 
13C-NMR (100 MHz, DMSO-d6): 26.79 (6C, 6×N-CH2CH2CH2-NH); 40.41 (6C, 
6×CH2-NH); 52.66 (6C, 6×CH2-N); 181.48 (3C, 3×C=S). 
ESI-MS positive ion mode (m/z): 503.6 (M+H+), 525.6 (M+Na+); negative ion mode 
(m/z): 501.7 (M-1-), 537.6 (M+Cl-). 
IR (KBr): 3222, 1222 cm-1. 
 
 
1,5,7,12,17,19,28,28 –Octaaza –bicyclo[10,10,10]dotriacontane-6,18,27 –trithione 
(31) 
 
Similar as 30, compound 31 was prepared from 17 
and 27(60.1%). Its 1H-NMR spectrum was too 
broad to be assigned at room temperature, therefore, 
the 1H chemical shifts and all the 2D spectra were 
obtained at 340 K. The 13C-NMR chemical shift can 
not be obtained due to the broadness. 
 
TLC (CH2Cl2/MeOH/NEt3 = 20:4:1) Rf = 0.77. 
mp: >300˚C (decomposed). 
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1H-NMR (400 MHz, DMSO-d6, 340K): 1.34 (bs, 6H, 3×CH2-2’); 1.47 (bs, 6H, 
3×CH2-3’); 1.64 (bs, 6H, 3×CH2-2); 2.24 (bs, 6H, 3×CH2-1’); 2.40 (bs, 6H, 3×CH2-1); 
3.26 (bs, 6H, 3×CH2-4’); 3.39 (bs, 6H, 3×CH2-3); 7.44 (bs, 3H, 3×NH-C-4’); 7.55 (bs, 
3H, 3×NH-C-3). 
ESI-MS (MeOH+CH3COOH) positive ion mode (m/z): 545.5 (M+H+), 567.5 
(M+Na+); negative ion mode (m/z): 543.7 (M-1-), 603.4 (M+CH3COO-). 
 
 
5,15,22,-Tris-methylimino-1,4,6,10,14,16,21,23 –octaaza –bicyclo[8,8,8]hexacosane 
(32) 
23.0 mg 1,4,6,10,14,16,21,23 –Octaaza –
bicyclo[8,8,8]hexacosane-5,15,22 –trithione (29) 
(0.05 mmol) was suspended in 7.5 ml fresh 
distilled THF. 25 l MeI was injected in and the 
system was slightly warmed up to 38 ˚C and 
stirred for 24 hours, then another 25 l MeI was 
added. The reaction was continued for 24 hours 
more till the starting material was no more detectable by ESI-MS. All the volatiles 
were evaporated and the residue was dried in vacuo to afford 37.13 mg crude S-
methyl-isothiourea derivative of 29 as dark yellow solid. Without purification, 9.80 
mg of this intermediate was suspended in 2 ml 8 mol/l solution of MeNH2 in ethanol. 
The reaction was stirred 70 ˚C for 72 hours and followed by ESI-MS. The mixture 
was filtrated and washed with ethanol to remove the insoluble impurity. All the 
volatiles were removed and the remaining solid was dried under high vacuum to 
afford 11.07 mg product, presumably as tris-iodide salt. 
 
1H-NMR (500 MHz, CD3OD): 1.90 (t, 6H, J = 4.95 Hz, 3×CH2-2’); 2.50 (m, 6H, 
3×CH2-1’); 2.87 (t, 6H, J = 5.09 Hz, 3×CH2-1); 2.91 (s, 9H, 3×CH3); 3.30 (t, 6H, J = 
6.25 Hz, 3×CH2-3’); 3.37 (bs, 6H, 3×CH2-2). 
ESI-MS (CD3OD): positive ion mode (m/z): 452.4 (M+H+), 226.6 (M+2H+)/2; 
negative ion mode (m/z): 450.4 (M-1-), 486.3 (M+ Cl-). 
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6,16,25-Tris-benzylimino-1,5,7,11,15,17,24,26 –octaaza –bicyclo[9,9,9]nonacosane- 
(33) 
The pre-dried thiourea cryptand 30 
(209.2 mg, 0.417 mmol) and 375.6 mg 
2-Chloro-1-methylpyridinium iodide 
(Mukaiyama reagent) (1.47 mmol) 
were mixed with 400 l triethylamine 
and 32 ml acetonitrile. The system was 
refluxed under argon atmosphere for 5 hours and most solid got soluble during the 
refluxing; the solution became more deeply colored. ESI indicated that all the thiourea 
groups converted to carbodiimide (Caution: this intermediate is unstable to moisture.). 
157 l benzylamine was injected in and the color quickly changed to orange. The 
reaction continued to reflux for 36 hours more, then cool down to room temperature 
and stirred for another 12 hours. The liquid part was carefully decanted and the sticky 
solid was washed 3 times by fresh acetonitrile. 10 ml methanol was added to this 
crude mixture and then the insoluble impurity was removed by filtration. The solution 
was concentrated in vacuo and the remaining 267 mg yellow solid was purified by 
fresh chromatography (silica gel, CH2Cl2/MeOH = 1:1) to give 162.6 mg yellow solid 
(35.3%). 
 
1H-NMR (400 MHz, MeOD): 1.68 (bs, 12H, 6×N-CH2CH2CH2-NH); 2.44 (bs, 12H, 
6×CH2-N); 3.30 (bs, 12H, 6×CH2-NH); 4.49 (s, 6H, 3×PhCH2); 7.26-7.39 (m, 15H, 
3×Ph-CH). 
13C-NMR (100 MHz, MeOD): 26.66 (6C, 6×N-CH2CH2CH2-NH); 40.32 (6C, 
6×CH2-NH); 44.79 (3C, 3×PhCH2); 51.15 (6C, 6×CH2-N); 127.57, 128.04, 128.95, 
137.08 (6C, 6×Ph-C, CH); 155.31 (3C, 3×C=N). 
ESI-MS (MeOH): positive ion mode (m/z): 722.47 (M+H+), 361.81 (M+2H+)/2; 
negative ion mode (m/z): 720.74 (M-1-), 756.73 (M+ Cl-). 
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12-Benzyl -1,4,6,12,18,20,25,27 –octaaza –bicyclo[10,10,10]dotriacontane -5,19,26,-
trithione (34) 
 
A super diluted condition is required for synthesis of 34 
due to the relatively long and flexible chain of the 
starting material 24. A six liter three necked flask was 
installed with two dropping funnels. One liter DMF and 
one liter chloroform were mixed in the flask and heated 
up to reflux. The solution of 462 mg 24 (0.846 mmol) in 
one liter DMF and another solution of 243.6 mg 26 
(0.894 mmol) in one liter chloroform were dropped into 
the refluxing system from dropping funnels slowly and 
simultaneously at same speed. The adding was finished 
within 5 hours. After stirring under reflux for another 
1.5 hours,  the reaction was cooled down to room temperature and stirred over night. 
The solution was concentrated in vacuo then 20 ml DMF was re-added in. The first 
part white solid was collected by filtration and washed by methanol. 30 ml methanol 
was added to the filtrate and the mixture stood in fridge for overnight. The second part 
solid was again collected by filtration and wash with methanol, which is of almost the 
same purity as the first part. The two parts white solid was dried under high vacuum 
to give the totally 157.34 mg product (24.4%). Similar as 31, the 1H-NMR signals of 
34 are very broad and overlapped at room temperature. The 1H-NMR chemical shifts 
and 2D spectra were collected at 325 K. 
 
TLC (CH2Cl2/MeOH/NEt3 = 20:2:0.5) Rf = 0.56. 
mp: >300˚C (decomposed). 
1H-NMR (600 MHz, DMSO-d6, 325 K): 1.53 (bs, 6H, 3×CH2-3’); 1.58 (bs, 6H, 
3×CH2-4’); 1.87 (bs, 6H, 3×CH2-2’); 2.51 (bs, 6H, 3×CH2-1); 3.41 (bs, 6H, 3×CH2-
1’); 3.50 (bs, 6H, 3×CH2-5’); 3.55 (bs, 6H, 3×CH2-2); 4.48 (s, 2H, PhCH2); 7.49-7.51 
(m, 5H, Ph-CH); 7.77 (bs, 3H, 3×NH); 7.86 (bs, 3H, 3×NH’); 
ESI-MS (MeOH): positive ion mode (m/z): 635.3 (M+); negative ion mode (m/z): 
633.4 (M-2H) -, 669.3 (M-H + Cl-). 
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12-Benzyl-5,19,26-tris-methylimino-1,4,6,12,18,20,25,27–octaaza–bicyclo[10,10,10] 
dotriacontane (35) 
50.69 mg compound 34 (0.066 mmol) was suspended in 
6 ml acetonitrile, and 600 l MeI was added in. The 
reaction was heated up to reflux and the solid was 
dissolved. The reaction was followed by ESI-MS, and 
after 6 hours, all the thiourea groups were converted to 
S-methyl-isothiourea. The system was cooled down to 
room temperature. Then all the volatiles were removed 
and the residue was dried under high vacuum. 6.0 ml 8 
mol/l MeNH2 ethanol solution was added in and the 
mixture was stirred under reflux for 60 hours. The 
insoluble impurity was removed by filtration and the filtrate was concentrated then 
dried in vacuo to give 89.6 mg crude product as colorless gum which was then 
purified by flash chromatography (silica gel, MeOH). The iodide salt of 35 was 
converted to free base by passing through strong basic ion exchange resin (Dowex 
1×2, OH- form) to afford 39.50 mg base form of 35 (95%) as colorless gum after dried 
under high vacuum. After being loaded to acidic ion exchange resin (Amberlite CG-
50, H+ form), the compound was washed down by HCl aqueous solution (gradient 
from 1 mM to 50 mM). The positive fragments of iodine vapor test were collected and 
dried in vacuo; the hydrochloride salt of 35 was finally obtained as white powder after 
lyophilization. 
 
TLC (H2O/MeOH/HCOOH = 16:8:1) Rf = 0.22. 
1H-NMR of free base form (600 MHz, D2O): 1.28 (t, 6H, J = 6.67 Hz, 3×CH2-3’); 
1.49 (t, 6H, J = 6.44 Hz, 3×CH2-4’); 1.62 (m, 6H, 3×CH2-2’); 2.60 (s, 9H, 3×CH3); 
2.66 (t, 6H, J = 5.90 Hz, 3×CH2-1); 3.00 (t, 6H, J = 7.50 Hz, 3×CH2-1’); 3.03 (t, 6H, J 
= 6.55 Hz, 3×CH2-5’); 3.15 (m, 6H, 3×CH2-2); 4.31 (s, 2H, PhCH2); 7.30-7.39 (m, 5H, 
Ph-CH). 
13C-NMR of free base form (150 MHz, D2O): 20.87 (3C, 3×CH2-2’); 22.46 (3C, 
3×CH2-3’); 26.79 (3C, 3×CH2-4’); 27.52 (3C, 3×CH3); 40.08 (3C, 3×CH2-5’); 48.77 
(3C, 3×CH2-2); 51.72 (3C, 3×CH2-1); 58.39 (3C, 3×CH2-1’); 63.40 (1C, PhCH2); 
126.63, 129.24, 130.80, 132.52 (6C, Ph-C, CH); 155.61 (3C, 3×C=NH). 
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1H-NMR of HCl salt form (500 MHz, MeOD): 1.54 (bs, 6H, 3×CH2-3’); 1.81 (bs, 6H, 
3×CH2-4’); 1.97 (bs, 6H, 3×CH2-2’); 2.88 (s, 9H, 3×CH3); 3.01-3.44 (m, 12H, 
3×CH2-5’, 3×CH2-1’); 3.63 (bs, 6H, 3×CH2-1); 3.87 (bs, 6H, 3×CH2-2); 4.52 (s, 2H, 
PhCH2); 7.50-7.54 (m, 5H, Ph-CH). 
13C-NMR of HCl salt form (125 MHz, MeOD): 21.45 (3C, 3×CH2-2’); 22.99 (3C, 
3×CH2-3’); 27.49 (6C, 3×CH2-4’, 3×CH3); 36.73 (3C, 3×CH2-2); 41.14 (3C, 3×CH2-
5’); 54.16 (3C, 3×CH2-1); 59.20 (3C, 3×CH2-1’); 63.77 (1C, PhCH2); 127.64, 129.01, 
129.19, 130.38, 132.34, 132.64 (6C, Ph-C, CH); 155.16 (3C, 3×C=NH). 
ESI-MS (MeOH): positive ion mode (m/z): 626.5 (M+), 313.8 (M++H+)/2; negative 
ion mode (m/z): 624.5 (M-2H) -. 
 
 
5. 2. 3 The Pyrene Modified Receptors 
 
Tris-(2- (N’-pyren-1yl-methyl-thiourea)-ethyl)- amine (53)  
 
Tris-(2-isothiocyanate-ethyl)amine (26) (210 mg, 
0.77 mmol), 1-pyrenemethylamine hydrochloride 
(606.3 mg 2.27 mmol) and 330 l triethylamine 
were mixed in 30 ml CH2Cl2 and stirred under 
argon atmosphere for one week. All the volatiles 
were removed in vacuo then the residue was 
purified by flash chromatography (silica gel, 
CH2Cl2/MeOH gradient from 100:0 to 100:2) to afford 619.5 mg product (83.2%) as 
yellow solid. 
 
TLC (CH2Cl2/MeOH = 20:0.5) Rf = 0.40. 
1H-NMR (600MHz, CD2Cl2): 2.65 (m, 6H, 3×CH2-N); 3.67 (bs, 6H, 3×CH2-NH); 
5.05 (bs, 6H, 3×CH2-Pyrene); 7.68-8.11 (m, 27H, 27×Pyrene-CH). 
ESI-MS (MeOH): positive ion mode (m/z): 966.2 (M+H+); negative ion mode (m/z): 
964.2 (M-H)-, 1000.2 (M+Cl-). 
UV (3 M in CH3CN): 242 nm (0.4517), 266 nm (0.178047), 277 nm (0.244112), 315 
nm (sh, 0.088458), 328 nm (0.196298), 344 nm (0.251476). 
Fluorescence (3 M in CH3CN, ex = 344 nm): 377 nm (77510), 397 nm (109970), 
477 nm (846610). 
N
NH HN
NH
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 106 
Tris-(2- (N’-pyren-1yl-methyl-guanidinium)-ethyl)- amine tri-chloride (36)  
 
Compound 53 (477.4 mg, 0.494 mmol) was 
dissolved in 5 ml CH2Cl2 and 128 l HI aqueous 
solution (56%) was added in. The mixture was 
stirred at room temperature for 30 minutes then 10 
ml ethanol was added in. The system stood in 
ultrasonic bath for another 30 minutes and then 
was filtrated, washed with fresh Et2O. The 
resulting hydroiodide salt of 53 (530.6 mg) was dried under high vacuum, and then 
was suspended in 20 ml CH2Cl2/MeOH (3:1) mixture. 850 l MeI was added in and 
the reaction was stirred under sealed condition at room temperature and followed by 
ESI-MS. After 70 hours, all the thiourea groups were converted completely to S-
methyl isothiourea. All the volatiles were removed in vacuo then the resulting residue 
was dried under high vacuum. 622 mg out of 645.44 mg of the S-methyl-isothiourea 
intermediate was transferred into a grass tube equipped with a J-Young valve, 10 ml 
ammonia solution (7N in MeOH) was added in and the tube was sealed and the 
reaction was stirred at 55 ˚C over night. Most of the solid became soluble during the 
reaction procedure. The system was concentrated in vacuo then the residue (670 mg) 
was purified by flash chromatography (silica gel, CH2Cl2/MeOH gradient from 
490:10 to 300:200) to afford 290 mg pale yellow solid (47% for three steps) as 
triiodide salt. The counter anion was able to be exchanged to chloride by ion 
exchange resin (Dowex 1×2, Cl- form, eluent: MeOH/CH3CN = 4:1).  
 
TLC (CH2Cl2/MeOH = 2:1) Rf = 0.29. 
1H-NMR (400MHz, CDCl3): 2.69 (t, 6H, J = 5.33 Hz, 3×CH2-N); 3.37 (t, 6H, J = 
5.50 Hz, 3×CH2-NH); 4.79 (bs, 6H, 3×CH2-Pyrene); 7.71-7.91 (m, 27H, 27×Pyrene-
CH). 
13C-NMR (500MHz, CDCl3): 39.07 (3C, 3×CH2-N); 43.52 (3C, 3×CH2-Pyrene); 
52.39 (3C, 3×CH2-NH); 121.87, 124.23, 124.62, 124.67, 125.35, 125.47, 126.06, 
127.08, 127.54, 127.75, 128.25, 130.37, 131.00, 131.18 (48C, 48×Pyrene-C, CH); 
155.88 (3C, 3×C=NH). 
ESI-MS (MeOH): positive ion mode (m/z): 915.3 (M+H+), 458.2 (M+2H+)/2, 1043.2 
(M+2H++I-); negative ion mode (m/z): 913.3 (M-H)-, 949.3 (M+Cl-) 1041.2 (M+I-). 
N
NH HN
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UV (3 M in CH3CN): 242 nm (0.416618), 265 nm (0.160328), 276 nm (0.266125), 
314 nm (sh, 0.079722), 327 nm (0.17845), 343 nm (0.231993). 
Fluorescence (3 M in CH3CN, ex = 343 nm): 376 nm (335250), 396 nm (316140), 
474 nm (1896021). 
 
 
5. 2. 4 The Catalytic Bromination in Preparative Scale 
 
The preparation of vanadate catalyst stock solution 
The 0.2 M (n-Bu4N)2HVO4 aqueous solution was prepared according to the following 
equation: 
V2O5 + 4 × n-Bu4N·OH  2 × (n-Bu4N)2·HVO4 + H2O 
A 5 ml volumetric flask was added with 90.94 mg V2O5 (0.5 mmol) and 1.5999 g n-
Bu4N·OH.30H2O (2 mmol), then 1 ml nano-pure water was added in. The flask stood 
in ultra sonic bath for 30 minutes till the solid was soluble and the solution became 
clear and colorless. The whole volume was adjusted to 5 ml by adding water. The 
solution is ready to use and can be diluted to the concentration wanted in acetonitrile 
or water for binding titration or catalytic reaction. This solution can be store in dark at 
room temperature under argon for one month. Caution: since this solution is readily 
frozen ( ≤  4 ˚C), proper flask is needed if the sample would like to be stored in fridge, 
in order to avoid the grass container being destroyed due to swell of volume. 
 
 
The general procedure for preparative catalytic bromination: 
The reaction flask equipped with two dropping funnels was added with organic 
substrate (2 mmol), 80 ml acetonitrile and 100 l 0.2 M vanadate stock solution (0.02 
mmol). The solution of 225 l 48% HBraq* (2 mmol) ** in 30 ml acetonitrile and the 
solution of 217 l 30% H2O2 (2 mmol)** in 30 ml acetonitrile were dropped in 
separately and simultaneously within one hour. The reaction was continued to stir at 
room temperature and followed by TLC till all the starting material disappeared. 20 
ml sodium hydrogen sulfite solution (38-40%) was added in and stirred for 30 
minutes. The most of organic solvent was removed in vacuo then CH2Cl2 was used to 
extract the product. The organic layer was washed with water and brine, dried over 
Na2SO4 then purified with flash chromatography. 
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*) Equal amount of n-Bu4N·Br and HClO4 combination can be used instead. In case of chlorination, 
HCl aqueous solution was used. 
**) Excess amount of HBr (or HCl) and H2O2 were needed for bis- halogenations. 
 
 
Physical properties of the brominated products 
The flowing data were compared with literature value or authentic samples. 
 
2,4,6-(Trimethoxy)bromobenzene (66) 
TLC (hexane/EtOAc = 20:7) Rf = 0.39. 
1H-NMR (400 MHz, CDCl3): 3.77 (s, 3H, OCH3-C-4); 3.86 (s, 6H, 
OCH3-C-2, OCH3-C-6); 6.13 (s, 2H, CH-3, CH-5). 
13C-NMR (100 MHz, CDCl3): 55.97 (OCH3-C-4); 56.78 (2C, 
OCH3-C-2, OCH3-C-6); 92.06 (2C, C-3, C-5); 92.26 (C-1); 157.83, 
160.91 (3C, C-2, C-4, C-6). 
 
 
4-bromoanisole (68) 
TLC (hexane/EtOAc = 20:1) Rf = 0.41. 
1H-NMR (400 MHz, CDCl3): 3.77 (s, 3H, OCH3); 6.78 (d, 2H, J = 9.10 Hz, 
CH-3, CH-5); 7.37 (d, 2H, J = 9.10 Hz, CH-2, CH-6). 
13C-NMR (100 MHz, CDCl3): 55.83 (OCH3); 113.20 (C-1); 116.15 (2C, C-2, 
C-6); 132.64 (2C, C-3, C-5); 159.11 (C-4). 
 
 
4-bromo-N,N-dimethylaniline (70) 
TLC (hexane/EtOAc = 20:4) Rf = 0.46. 
1H-NMR (400 MHz, CDCl3); 2.92 (s, 6H, 2×CH3); 6.69 (d, 2H, J = 9.09 Hz, 
CH-2, CH-6); 7.30 (d, 2H, J = 8.84 Hz, CH-3, CH-5). 
13C-NMR (100 MHz, CDCl3): 40.98 (2C, 2×CH3); 108.91 (C-4); 114.50 (2C, 
C-2, C-6); 132.08 (2C, C-3, C-5); 149.92 (C-1). 
ESI-MS (MeOH): (m/z): 199.9 & 201.9 (relative intensity  1:1 M+H+). 
 
 
O O
O
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2,4-Dibromo-N,N-dimethylaniline (71) 
TLC (hexane/EtOAc = 20:1) Rf = 0.53. 
1H-NMR (400 MHz, CDCl3): 2.78 (s, 6H, 2×CH3); 6.94 (d, 1H, J = 8.6 
Hz, CH-6); 7.36 (dd, 1H, J = 2.0, 8.6 Hz, CH-5); 7.68 (d, 1H, J = 2.0 Hz, 
CH-3). 
13C-NMR (100 MHz, CDCl3): 44.49 (2C, 2×CH3); 115.75 (C-2); 120.08 (C-4); 
122.03, 131.40, 136.44 (C-3, C-5, C-6); 151.55 (C-1). 
ESI-MS (MeOH): m/z): 277.8, 279.8 & 281.8 (relative intensity  1:2:1 M+H+). 
 
 
2-Chloro-1,3,5-trimethoxybenzene (72) 
TLC (hexane/EtOAc = 20:7) Rf = 0.36. 
1H-NMR (400 MHz, CDCl3): 3.80 (s, 3H, OCH3-C-5); 3.87 (s, 6H, 
OCH3-C-1, OCH3-C-3); 6.17 (s, 2H, CH-4, CH-6). 
13C-NMR (100 MHz, CDCl3): 55.93 (OCH3-C-5); 56.69 (2C, 
OCH3-C-1, OCH3-C-3); 91.95 (2C, C-4, C-6); 103.00 (C-2); 156.93 (C-5); 159.82 
(2C, C-1, C-3). 
EI-MS (70 ev, m/z): 202.0 (100 M +), 204.0 (32.28 37Cl-M +), 159.0 (26.85), 161.0 
(8.23). 
 
 
2,4-Dichloro-1,3,5-trimethoxybenzene (73) 
TLC (hexane/EtOAc = 20:7) Rf = 0.31. 
1H-NMR (400 MHz, CDCl3): 3.88 (s, 3H, OCH3-C-3); 3.90 (s, 6H, 
OCH3-C-1, OCH3-C-5); 6.35 (s, 1H, CH-6). 
13C-NMR (100 MHz, CDCl3): 56.93 (OCH3-C-3); 61.01 (2C, 
OCH3-C-1, OCH3-C-5); 93.63 (C-6); 110.19 (2C, C-2, C-4); 154.30 (2C, C-1, C-5); 
155.22 (C-3). 
EI-MS (70 ev, m/z): 236.0 (100 M +), 238.0 (63.56 37Clbis-M +), 240.0 (10.37 37Clmono-
M +). 
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(1S, 2RS, 4R, 4R, 8R)-4,7,7-Trimethyl-3-oxo-2-oxa-bicyclo-[2.2.1]heptane-1-
carboxylate 8-bromo-2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-tridecyl)-chroman-6-
yl-ester (75) 
 
18.5 l vanadate 
stock solution (5.4 
mM in acetonitrile) 
(0.1 mol) was 
added into the solution of 5 mg compound 74 (8.38 mol) in 5 ml acetonitrile. Then 
200 l 54 mM HBr and 100 l 108 mM H2O2 were added in. The solution became 
yellow colored and the reaction was followed by TLC. After stirring at room 
temperature overnight and the starting material disappeared completely in TLC, 2 ml 
NaHSO3 (38-40%) was added in and stirred for 30 minutes. The most of organic 
solvent was removed in vacuo then CH2Cl2 was used to extract the product. The 
organic layer was washed with water and brine, dried over Na2SO4 then purified with 
preparative TLC. It’s important to note that the final product containing two 
diastereomers (see 13C signal of CH3 at position 9) which is very well separate by 
HPLC. 
 
TLC (hexane/EtOAc = 20:8) Rf = 0.38; (toluene/acetone = 20:0.7) Rf = 0.46.  
1H-NMR (400 MHz, CDCl3): 0.836, 0.854, 0.871 (3s, 12H, CH3-13, 17, 22, 22), 
1.00-1.55 (m, 19H, alky-H), 1.12, 1,16, 1.17 (3s, 9H, 3×CH3-Cam27,29,29), 1.346/1.350 
(s, 3H, CH3-9), 1.71-1.87 (m, 3H, 1H26 and CH2-10), 1.95-2.01 (m, 1H, H26), 2.05 (s, 
3H, CH3-3), 2.11 (s, 3H, CH3-2), 2.15-2.24 (m, 1H, H25), 2.52-2.59 (ddd, 1H, = 14.15 
Hz, 10.10 Hz, 4.22 Hz, H25), 3.20-3.36 (m, 2H-7), 4.29 (dd, 1H, J = 8.97 Hz, 5.93 Hz 
1H-8),  6.55 (s, 1H, Ar-H). 
ESI-MS (MeOH): 697.1/699.1 (1:1, M+Na+). 
UV (detected during HPLC run): 206 nm ( max), 225 nm (sh), 287 nm (w). 
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5. 3. Determination of Binding Mode and Binding Constants 
5. 3. 1. NMR Titration 
General procedure 
The stock solution of 2 mM (n-Bu4N)2HVO4 in D2O was prepared according to the 
procedure previously described in chapter 5.2.4. and the pD was adjusted to 10.21 by 
n-Bu4N.OH. The stock solution shows a single peak at – 536.5 ppm in 51V-NMR 
spectrum. The first point solution was obtained by adding 38.17 mg of receptor 1 (10 
eq.) to 5 ml of vanadate stock solution and the pD was carefully adjusted to about 10.2 
by n-Bu4N.OH/HCl. The ratio of ligand 1 and vanadate (V1) was 10:1 in this first 
point solution. Different ratio of 1/vanadate from 0 to 10 were systemically obtained 
by mixing the different volumes of stock solution and first point solution. Importantly, 
the total concentration of vanadate was kept constantly at 2 mM for all these points 
and pD was controlled within 10.2±0.1. Both 51V and 1H-NMR were measured at 
different 1/vanadate ratio.  
 
For binding study with phosphate and pyrophosphate, the commercial available n-
Bu4N.H2PO4 and (n-Bu4N)3HP2O7 were used. 
 
 
Determination of the Binding Mode 
The stoichiometry of complex formed between of host and guest molecules was 
determined by Job plot, which was made by plotting molecular fraction  ([host]total/ 
([host]total+[guest]total) ) against the relative chemical shift change (  × ( obs- host) ). 
The position of maximum value of relative chemical shift change is corresponding for 
the stoichiometry of the complex formation. For example, maximum at  = 0.5 means 
1:1 complex, since at that point, [host]total = [guest]total; on contrast, for 2:1 mode, the 
maximum should appear at 1/3 when 2× [host]total = [guest]total. For sharp binding 
curve, the stoichiometry can also be judged from the position of break point. 
 
Binding Constants 
The chemical shift values were plotted against the value of 1/vanadate ratio and the 
data were fitted to the appropriate function using proFit 5.1 (proFit® QuantumSoft) or 
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Origin 7.0 SR0 (Origin® OriginLab Corporation). The binding constant was obtained 
from the fitting if the systemic error was acceptable. 
 
 
5. 3. 2. UV-vis and Fluorescent Titration 
General procedure 
The titration experiments were performed on a 3.6 ml scale in 1-cm path quartz 
fluorescence cuvettes. The stock solution of 1.08 mM (A) and 5.4 mM (B) vanadate 
were prepared by dilution of 0.2 M (n-Bu4N)2·HVO4 water solution in acetonitrile. 
The proportional addition of the stock solution by syringe to 3.6 ml 3 M solution of 
receptor 36 or 53 in a fluorescent cuvette gave rise to different ratio of vanadate to 
receptor at 0:1, 0.25:1, 0.5:1, 1:1, 1.5:1, 2:1, 3:1, 5:1, 8:1, 13:1, 23:1, and 43:1. The 
solution stirred for 5 minutes to be equilibrated for every step. Before reached the 
ratio of 3:1, solution (A) was used, and solution (B) was used after this point in order 
to minimize the total volume of vanadate solution added. Therefore, the concentration 
of receptor can be approximately treated as constant by this manner. Both UV-vis and 
fluorescence spectra were recorded for every single step. 2 nm slid was adopted for 
both excitation and emission for fluorescence spectra. 
 
For binding study with phosphate and pyrophosphate were performed in a similar way, 
and the commercial available n-Bu4N.H2PO4 and (n-Bu4N)3HP2O7 were used for 
making stock solution. 
 
The stoichiometry and binding constants were determined similarly as for NMR 
titration. 
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5. 4. Kinetic Study of Catalytic Bromination  
The kinetic of catalytic experiments were performed on a 3.6 ml scale in 1-cm path 
quartz cuvettes. Spectra were collected primarily on an Agilent 8453 Diode Array 
spectrophotometer under “kinetic mode” and cycle time was 2 seconds for all 
measurements. Tribromide (Br3-) formation was measured at 268 nm; the bromination 
of phenol red was followed at 391, 395 and 415 nm and the bromination of MCD was 
monitored at decreasing of intensity at 258 nm (  = 11.8 mM-1 cm-1). The stock 
solution of the reagents in acetonitrile were 54 mM HBr (or n-Bu4N.Br and HClO4), 
H2O2, MCD, TMB, 5.4 mM Phenol red and 5.4 mM vanadate. 
 
 
General procedure 
A typical procedure for bromination of MCD is given bellow: 
The blank UV spectrum of 3.6 ml acetonitrile in a 1-cm path quartz cuvette was 
measured prior to the addition of reagents. The stock solutions of vanadate (4 l), 
MCD (8 l), H2O2 (20 l) were added in subsequently by syringe. The kinetic UV 
measurement monitoring the intensity at 258 and 268 nm started as soon as 8 l HBr 
stock solution was injected in. The measurement lasted for 10 minutes and UV 
intensity of the targeted wavelength was plotted against time. The rate was 
determined by the internal software of instrument. 
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5. 5. Detailed Parameters of X-ray Structures 
Crystallographic data for compounds 1, 28, 28-bis picrate and 29. 
 
Compound 1 28 28.2H+-2Picrate 29 
Molecular 
formula 
C10H31Cl3N10O1 C15H30N8S3 C30H42N14O15S3 C20H42N8O1S4 
Formula 
weight 
413.78 418.66 934.95 538.87 
Color colorless colorless paleyellow colourless 
Temperature 
(K) 
173 173 173 173 
Crystal size 
(mm3) 
0.16×0.20×0.26 0.10×0.16×0.34 0.30×0.36×0.37 0.10×0.20×0.30 
Crystal system Monoclinic Orthorhombic Monoclinic Monoclinic 
Space group P  21/c  P c 21 n P 21/n P 21/n 
a (Å) 8.82200(10) 7.5935(2) 10.6325(2) 11.5701(3) 
b (Å) 20.7240(4) 10.8892(3) 23.0332(3) 13.6077(4) 
c (Å) 11.77740(10) 24.1172(5) 16.7530(5) 17.5134(5) 
α
 (˚) 90 90 90 90 
β
 (˚) 105.1454(9) 90 108.0013(18) 91.961(2) 
γ
 (˚) 90 90 90 90 
Volume (Å3) 2078.44(5) 1994.2 3902.0 2755.7 
Z 4 4 4 4 
Density (calc.) 
(g cm-3) 
1.322 1.394 1.591 1.299 

 (Mo K α ) 
(mm-1) 
0.461 0.390 0.280 0.374 
Scan type  and  scans  scans  and  scans  and  scans 
F(000) 880 897.661 1954.425 1162.247 
θ
 range for 
data collection 
(˚) 
1.965-27.486 4.11-32.49 4.08 - 29.20 4.14 - 30.81 
Completeness 
to max 
θ
  
1.000 1.00 0.999 1.000 
Reflection 
measured 
16065 37873 79708 69442 
Independent 
reflections 
4772 7214 10558 8647 
Reflection 
used 
2952 3959 6110 4867 
Number of 
parameters 
281 259 560 323 
R  0.0337 
(I > 3 (I)) 
0.0386  
(I > 2 (I)) 
0.0384 
(I > 2 (I)) 
0.0652 
(I > 4 (I)) 
wR 0.0380 0.0423 0.0243 0.0530 
Goodness of 
fit on F 
1.0760 1.0462 1.0585 0.9633 
Recidual 
density (e- Å-3) 
-0.23  0.74  -0.94 0.83 -0.44  0.35 -0.55  0.93 
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Structure(ORTEP view) and atoms coordination for compound 1 
 
Atom X Y Z Uiso 
N1 0.48181(19) 0.15815(8) 0.91931(14) 0.0242 
N4 0.2400(2) 0.20862(9) 1.00742(17) 0.0321 
N6 0.0985(2) 0.28904(9) 1.06926(17) 0.0329 
N7 0.0954(3) 0.18575(10) 1.13805(19) 0.0393 
N10 0.5809(2) 0.11133(10) 1.16422(16) 0.0368 
N12 0.7038(3) 0.15811(10) 1.34363(17) 0.0392 
N13 0.4857(3) 0.09465(12) 1.32478(19) 0.0430 
N16 0.2788(2) 0.05661(9) 0.80558(15) 0.0316 
N18 0.1381(2) 0.00263(10) 0.64022(16) 0.0354 
N19 0.0646(2) -0.00473(10) 0.81261(17) 0.0367 
C2 0.3858(3) 0.21199(11) 0.8587(2) 0.0379 
C3 0.3111(3) 0.25118(11) 0.9371(2) 0.0340 
C5 0.1437(2) 0.22793(10) 1.07004(18) 0.0291 
C8 0.6227(3) 0.18154(12) 1.0078(2) 0.0377 
C9 0.6914(3) 0.13166(12) 1.09900(19) 0.0365 
C11 0.5917(3) 0.12246(11) 1.27690(19) 0.0317 
C14 0.5283(3) 0.11512(12) 0.8359(2) 0.0376 
C15 0.3929(3) 0.08318(11) 0.74817(19) 0.0330 
C17 0.1603(2) 0.01887(10) 0.75254(18) 0.0288 
C21 0.7300(4) 0.42188(13) 1.1072(2) 0.0486 
O20 0.6652(2) 0.35947(8) 1.07648(14) 0.0409 
Cl1 0.23919(6) 0.04583(3) 1.07739(5) 0.0333 
Cl2 0.16744(7) 0.41232(3) 0.91486(5) 0.0364 
Cl3 0.88935(7) 0.27660(3) 1.26261(5) 0.0395 
H41 0.265(3) 0.1683(6) 1.013(2) 0.037(7) 
H61 0.118(3) 0.3170(10) 1.0206(19) 0.039(7) 
H62 0.036(2) 0.2971(12) 1.1130(19) 0.037(7) 
H71 0.127(3) 0.1465(6) 1.137(2) 0.043(7) 
H72 0.035(3) 0.1991(13) 1.179(2) 0.042(7) 
H101 0.497(2) 0.0915(12) 1.125(2) 0.044(7) 
H121 0.706(3) 0.1590(13) 1.4173(10) 0.037(7) 
H122 0.762(3) 0.1832(12) 1.315(2) 0.050(8) 
H131 0.485(3) 0.1060(14) 1.3953(13) 0.049(8) 
H132 0.407(2) 0.0737(13) 1.281(2) 0.053(9) 
H161 0.288(3) 0.0667(12) 0.8775(11) 0.036(7) 
H181 0.180(3) 0.0253(12) 0.594(2) 0.045(7) 
 116 
H182 0.067(3) -0.0259(11) 0.610(2) 0.048(8) 
H191 -0.019(2) -0.0256(11) 0.776(2) 0.037(7) 
H192 0.078(3) 0.0072(12) 0.8844(11) 0.038(7) 
H201 0.715(3) 0.3315(12) 1.127(2) 0.056(9) 
H211 0.7514 0.4319 1.1901 0.0603 
H212 0.8299 0.4257 1.0853 0.0609 
H213 0.6602 0.4546 1.0644 0.0610 
H21 0.4515 0.2399 0.8273 0.0469 
H22 0.3039 0.1948 0.7955 0.0469 
H31 0.3899 0.2773 0.9885 0.0423 
H32 0.2316 0.2785 0.8896 0.0423 
H81 0.5941 0.2186 1.0464 0.0457 
H82 0.7007 0.1936 0.9681 0.0457 
H91 0.7826 0.1494 1.1531 0.0440 
H92 0.7212 0.0947 1.0606 0.0440 
H141 0.5940 0.0819 0.8798 0.0472 
H142 0.5871 0.1398 0.7930 0.0472 
H151 0.4329 0.0489 0.7093 0.0411 
H152 0.3417 0.1146 0.6911 0.0411 
 
 
 
Structure (ORTEP view)and atoms coordination for compound 28 
 
Atom X Y Z Uiso 
S1 0.81134(7) -0.27261(9) 0.08290(2) 0.0224 
S2 0.30610(8) -0.25049(8) 0.25523(2) 0.0216 
S3 0.13781(9) -0.28450(9) -0.04675(3) 0.0309 
N1 0.3239(3) -0.54274(19) 0.12832(9) 0.0197 
N2 0.3450(3) 0.0090(2) 0.11356(9) 0.0185 
N3 0.5954(4) -0.3657(2) 0.16002(11) 0.0238 
N4 0.6091(4) -0.1579(2) 0.1571(1) 0.0208 
N6 0.1000(3) -0.1536(2) 0.1766(1) 0.0220 
N5 0.0914(4) -0.3599(2) 0.1824(1) 0.0229 
N7 0.2925(4) -0.3807(2) 0.0424(1) 0.0248 
N8 0.2998(4) -0.1740(2) 0.0372(1) 0.0257 
C1 0.4845(4) -0.5755(2) 0.15825(12) 0.0222 
C2 0.6362(4) -0.4910(2) 0.14424(12) 0.0230 
 117 
C3 0.6654(3) -0.2643(3) 0.13605(8) 0.0170 
C4 0.6562(4) -0.0368(3) 0.13627(14) 0.0250 
C5 0.5027(4) 0.0516(2) 0.14211(12) 0.0222 
C10 0.1819(4) 0.0485(2) 0.14035(11) 0.0209 
C9 0.1395(4) -0.0272(2) 0.19107(11) 0.0209 
C8 0.1580(3) -0.2545(3) 0.20216(9) 0.0178 
C7 0.1229(4) -0.4817(2) 0.20416(11) 0.0219 
C6 0.1633(4) -0.5725(2) 0.15849(12) 0.0223 
C11 0.3216(4) -0.5894(2) 0.07124(11) 0.0237 
C12 0.2202(4) -0.5018(3) 0.03380(11) 0.0258 
C13 0.2467(3) -0.2791(3) 0.01404(8) 0.0205 
C14 0.2392(4) -0.0534(3) 0.02181(11) 0.0260 
C15 0.3471(4) 0.0388(2) 0.05413(11) 0.0247 
H3 0.513(4) -0.347(3) 0.1874(12) 0.028(7) 
H4 0.538(4) -0.160(3) 0.1880(11) 0.029(7) 
H6 0.029(4) -0.168(3) 0.146(1) 0.017(6) 
H5 0.007(4) -0.355(3) 0.1548(11) 0.023(7) 
H7 0.317(5) -0.368(3) 0.0801(8) 0.029(7) 
H8 0.354(4) -0.183(3) 0.0720(9) 0.018(6) 
H11 0.5166(4) -0.6581(2) 0.14872(12) 0.0270 
H12 0.4620(4) -0.5705(2) 0.19735(12) 0.0270 
H21 0.7395(4) -0.5177(2) 0.16378(12) 0.0276 
H22 0.6577(4) -0.4943(2) 0.10504(12) 0.0276 
H41 0.7547(4) -0.0060(3) 0.15699(14) 0.0300 
H42 0.6878(4) -0.0431(3) 0.09783(14) 0.0300 
H51 0.4762(4) 0.0609(2) 0.18080(12) 0.0270 
H52 0.5364(4) 0.1297(2) 0.12692(12) 0.0270 
H61 0.2575(4) -0.6304(2) 0.16310(12) 0.0269 
H62 0.0682(4) -0.6108(2) 0.13873(12) 0.0269 
H71 0.2210(4) -0.4788(2) 0.22922(11) 0.0262 
H72 0.0197(4) -0.5085(2) 0.22376(11) 0.0262 
H91 0.2388(4) -0.0257(2) 0.21572(11) 0.0250 
H92 0.0391(4) 0.0079(2) 0.20934(11) 0.0250 
H101 0.2799(4) 0.1041(2) 0.14114(11) 0.0251 
H102 0.0880(4) 0.0839(2) 0.11902(11) 0.0251 
H111 0.2663(4) -0.6687(2) 0.07063(11) 0.0284 
H112 0.4404(4) -0.5966(2) 0.05797(11) 0.0284 
H121 0.2336(4) -0.5257(3) -0.00428(11) 0.0310 
H122 0.0976(4) -0.5026(3) 0.04348(11) 0.0310 
H141 0.2551(4) -0.0408(3) -0.01727(11) 0.0312 
H142 0.1168(4) -0.0447(3) 0.03097(11) 0.0312 
H151 0.4664(4) 0.0371(2) 0.04097(11) 0.0299 
H152 0.2988(4) 0.1194(2) 0.04870(11) 0.0299 
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Structure (ORTEP) and atoms coordination for compound 28-bis picrates 
(a) The view from the top of  cryptand 
 
(b) The side view for cryptand. Picrate and acetone molecules are omitted for clarity. 
 
 
Atom X Y Z Uiso 
N1 0.95841(16) 0.17649(7) 0.9156(1) 0.0178 
N2 1.28070(16) 0.20045(7) 0.7534(1) 0.0186 
N3 1.13482(16) 0.05983(7) 0.9059(1) 0.0179 
N4 1.27864(17) 0.06991(7) 0.8314(1) 0.0199 
N5 0.82455(16) 0.21203(7) 0.7187(1) 0.0191 
N6 0.97232(16) 0.22062(7) 0.6466(1) 0.0195 
N7 1.18277(18) 0.27623(8) 0.98766(11) 0.0258 
N8 1.33979(18) 0.28644(8) 0.92258(11) 0.0261 
C1 0.9948(2) 0.12200(9) 0.96810(12) 0.0214 
C2 1.0101(2) 0.06650(9) 0.92247(13) 0.0202 
C3 1.1553(2) 0.07674(8) 0.83471(12) 0.0171 
C4 1.3221(2) 0.08985(9) 0.76222(13) 0.0228 
 119 
C5 1.3788(2) 0.15106(9) 0.77286(13) 0.0227 
C6 0.81955(19) 0.17064(9) 0.85597(13) 0.0208 
C7 0.7758(2) 0.21814(9) 0.78974(13) 0.0221 
C8 0.93576(19) 0.23678(8) 0.71334(12) 0.0181 
C9 1.0896(2) 0.24130(9) 0.62981(13) 0.0245 
C10 1.2090(2) 0.2017(1) 0.65991(13) 0.0241 
C11 0.9651(2) 0.22807(9) 0.97263(13) 0.0252 
C12 1.1018(2) 0.2455(1) 1.02906(13) 0.0276 
C13 1.2705(2) 0.25102(9) 0.95630(13) 0.0223 
C14 1.4226(2) 0.26694(9) 0.87385(13) 0.0270 
C15 1.3514(2) 0.25760(9) 0.78025(13) 0.0251 
S1 1.03346(5) 0.10583(2) 0.75513(3) 0.0218 
S2 1.02408(6) 0.28434(2) 0.78576(4) 0.0275 
S3 1.29277(6) 0.17864(2) 0.95876(4) 0.0255 
C16 0.7617(2) 0.07346(9) 0.58809(11) 0.0181 
C17 0.6468(2) 0.04637(9) 0.60090(12) 0.0204 
C18 0.6191(2) -0.01204(9) 0.58969(12) 0.0243 
C19 0.7110(2) -0.04819(9) 0.57365(13) 0.0265 
C20 0.8306(2) -0.02739(9) 0.56789(13) 0.0256 
C21 0.8529(2) 0.03104(9) 0.57430(12) 0.0205 
N9 0.55221(18) 0.08187(8) 0.62482(11) 0.0238 
N10 0.6815(2) -0.10949(9) 0.56139(13) 0.0370 
N11 0.97916(18) 0.05074(8) 0.56732(11) 0.0244 
O1 0.78006(14) 0.12697(6) 0.58903(9) 0.0200 
O2 0.58581(17) 0.12981(7) 0.65650(11) 0.0348 
O3 0.44120(16) 0.06184(8) 0.6149(1) 0.0332 
O4 0.5683(2) -0.12578(7) 0.55359(12) 0.0458 
O5 0.7705(2) -0.14272(8) 0.55885(16) 0.0629 
O6 1.07368(16) 0.01772(7) 0.59188(11) 0.0341 
O7 0.98629(16) 0.09889(7) 0.5376(1) 0.0307 
C22 0.97193(19) 0.44681(8) 0.56856(12) 0.0170 
C23 1.0938(2) 0.41448(9) 0.58538(12) 0.0187 
C24 1.17907(19) 0.40367(8) 0.66434(12) 0.0191 
C25 1.1479(2) 0.42494(9) 0.73330(12) 0.0204 
C26 1.0334(2) 0.45550(8) 0.72475(12) 0.0194 
C27 0.94898(19) 0.46587(9) 0.64560(12) 0.0181 
N12 1.12897(17) 0.38842(8) 0.51626(11) 0.0238 
N13 1.23364(18) 0.41218(8) 0.81659(11) 0.0245 
N14 0.83021(17) 0.49813(8) 0.64072(11) 0.0250 
O8 0.89551(14) 0.45761(6) 0.49793(8) 0.0217 
O9 1.08064(16) 0.40703(7) 0.44497(9) 0.0312 
O10 1.20559(19) 0.34679(8) 0.53192(11) 0.0449 
O11 1.34320(16) 0.39147(7) 0.8237(1) 0.0309 
O12 1.19286(17) 0.42057(8) 0.8764(1) 0.0372 
O13 0.83245(16) 0.53163(7) 0.6982(1) 0.0341 
O14 0.73148(16) 0.49003(9) 0.5809(1) 0.0412 
C28 0.9263(3) -0.1198(1) 0.80196(14) 0.0317 
C29 0.9680(3) -0.05902(11) 0.7925(2) 0.0472 
C30 0.7836(3) -0.12989(12) 0.78951(19) 0.0477 
O15 1.0056(2) -0.15903(9) 0.82147(15) 0.0576 
H1 1.01903(16) 0.18201(7) 0.8840(1) 0.0217 
H2 1.21821(16) 0.19479(7) 0.7836(1) 0.0223 
H3 1.20693(16) 0.04226(7) 0.9485(1) 0.0204 
H4 1.34183(17) 0.05070(7) 0.8774(1) 0.0233 
H5 0.77406(16) 0.18873(7) 0.6724(1) 0.0216 
H6 0.91683(16) 0.19363(7) 0.6077(1) 0.0223 
H7 1.17279(18) 0.31760(8) 0.98235(11) 0.0289 
H8 1.33421(18) 0.32744(8) 0.93128(11) 0.0292 
H11 1.0774(2) 0.12913(9) 1.01080(12) 0.0258 
H12 0.9270(2) 0.11530(9) 0.99386(12) 0.0258 
 120 
H21 0.9999(2) 0.03416(9) 0.95606(13) 0.0238 
H22 0.9410(2) 0.06575(9) 0.86963(13) 0.0238 
H41 1.3891(2) 0.06374(9) 0.75637(13) 0.0283 
H42 1.2477(2) 0.08892(9) 0.71206(13) 0.0283 
H51 1.4330(2) 0.15519(9) 0.83018(13) 0.0275 
H52 1.4327(2) 0.15486(9) 0.73654(13) 0.0275 
H61 0.75967(19) 0.17069(9) 0.88869(13) 0.0250 
H62 0.81366(19) 0.13414(9) 0.82739(13) 0.0250 
H71 0.8062(2) 0.25471(9) 0.81618(13) 0.0259 
H72 0.6809(2) 0.21808(9) 0.76922(13) 0.0259 
H91 1.1128(2) 0.27823(9) 0.65693(13) 0.0286 
H92 1.0693(2) 0.24605(9) 0.57024(13) 0.0286 
H101 1.2715(2) 0.2136(1) 0.63230(13) 0.0294 
H102 1.1797(2) 0.1629(1) 0.64303(13) 0.0294 
H111 0.9120(2) 0.21925(9) 1.00810(13) 0.0300 
H112 0.9282(2) 0.26082(9) 0.93784(13) 0.0300 
H121 1.0906(2) 0.2700(1) 1.07271(13) 0.0319 
H122 1.1479(2) 0.2108(1) 1.05342(13) 0.0319 
H141 1.4905(2) 0.29545(9) 0.87904(13) 0.0298 
H142 1.4622(2) 0.23077(9) 0.89704(13) 0.0298 
H151 1.4163(2) 0.26137(9) 0.75146(13) 0.0295 
H152 1.2868(2) 0.28790(9) 0.76235(13) 0.0295 
H181 0.5368(2) -0.02723(9) 0.59306(12) 0.0295 
H201 0.8959(2) -0.05347(9) 0.55961(13) 0.0306 
H241 1.25867(19) 0.38179(8) 0.67155(12) 0.0229 
H261 1.0128(2) 0.46936(8) 0.77331(12) 0.0235 
H291 0.8917(3) -0.03421(11) 0.7768(2) 0.0587 
H292 1.0284(3) -0.04599(11) 0.8447(2) 0.0587 
H293 1.0108(3) -0.05775(11) 0.7497(2) 0.0587 
H301 0.7690(3) -0.17035(12) 0.79719(19) 0.0542 
H302 0.7564(3) -0.10743(12) 0.82957(19) 0.0542 
H303 0.7331(3) -0.11839(12) 0.73372(19) 0.0542 
 
 
 
Structure (ORTEP view) and atoms coordination for compound 29 
(a) The view from side of  cryptand 
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(b) The view from top of  cryptand, hydrogen atoms were omitted for clarity 
 
Atom X Y Z Uiso 
S1 1.16867(5) 0.10687(4) 0.64481(3) 0.0240 
S2 0.69811(5) -0.07548(5) 0.57669(3) 0.0287 
S3 0.94006(9) 0.47959(8) 0.61644(4) 0.0593 
N1 0.73271(16) 0.20452(14) 0.6801(1) 0.0221 
N2 0.80883(16) 0.23366(14) 0.3381(1) 0.0215 
N3 0.94515(17) 0.13451(17) 0.61949(11) 0.0282 
N4 1.05493(16) 0.13340(16) 0.5139(1) 0.0254 
N5 0.58781(17) 0.09710(14) 0.56790(11) 0.0230 
N6 0.65685(17) 0.03874(14) 0.45656(11) 0.0237 
N7 0.7369(2) 0.39222(15) 0.59186(12) 0.0301 
N8 0.8357(2) 0.42910(17) 0.48551(12) 0.0337 
C1 0.7996(2) 0.12455(19) 0.71527(13) 0.0267 
C2 0.9275(2) 0.1284(2) 0.70105(13) 0.0308 
C3 1.04863(18) 0.12613(16) 0.58916(12) 0.0213 
C4 0.95694(19) 0.14816(19) 0.46038(12) 0.0253 
C5 1.0000(2) 0.16500(19) 0.38083(12) 0.0264 
C6 0.9012(2) 0.16493(18) 0.32100(12) 0.0248 
C7 0.61019(19) 0.18797(17) 0.68937(12) 0.0240 
C8 0.56194(19) 0.09728(17) 0.64825(13) 0.0244 
C9 0.64366(18) 0.02640(16) 0.53166(12) 0.0215 
C10 0.6206(2) 0.12412(17) 0.41396(14) 0.0272 
C11 0.64523(19) 0.11506(17) 0.32917(13) 0.0245 
C12 0.70125(19) 0.20715(17) 0.29718(12) 0.0229 
C13 0.7683(2) 0.29901(19) 0.71291(13) 0.0328 
C14 0.7159(3) 0.38882(18) 0.67303(15) 0.0338 
C15 0.8316(2) 0.42997(19) 0.56186(15) 0.0331 
C16 0.7396(2) 0.40095(18) 0.43511(14) 0.0278 
C17 0.7658(2) 0.41297(18) 0.35178(14) 0.0295 
C18 0.84524(19) 0.33402(17) 0.32132(12) 0.0236 
S4 0.42338(6) 0.37060(4) 0.51817(4) 0.0307 
O1 0.52371(16) 0.30288(14) 0.53266(11) 0.0346 
C19 0.3037(3) 0.3129(3) 0.5587(2) 0.0570 
C20 0.3802(4) 0.3540(3) 0.42099(19) 0.0600 
H1 0.8862(16) 0.150(2) 0.5913(14) 0.024(6) 
H2 1.1185(17) 0.118(2) 0.4936(18) 0.036(6) 
H3 0.570(2) 0.1499(13) 0.5438(14) 0.020(6) 
H4 0.7003(18) -0.0036(14) 0.4360(13) 0.012(5) 
H5 0.684(2) 0.368(2) 0.5623(16) 0.036(6) 
 122 
H6 0.8947(19) 0.457(2) 0.4671(18) 0.039(7) 
H11 0.7894 0.1264 0.7693 0.0321 
H12 0.7698 0.0635 0.6950 0.0321 
H21 0.9607 0.1853 0.7259 0.0373 
H22 0.9643 0.0703 0.7213 0.0373 
H41 0.9133 0.2043 0.4760 0.0306 
H42 0.9083 0.0909 0.4603 0.0306 
H51 1.0386 0.2276 0.3795 0.0328 
H52 1.0537 0.1140 0.3689 0.0328 
H61 0.9318 0.1822 0.2726 0.0298 
H62 0.8693 0.0999 0.3183 0.0298 
H71 0.5969 0.1811 0.7429 0.0290 
H72 0.5689 0.2446 0.6699 0.0290 
H81 0.5961 0.0399 0.6717 0.0296 
H82 0.4799 0.0957 0.6532 0.0296 
H101 0.6605 0.1804 0.4343 0.0325 
H102 0.5386 0.1325 0.4192 0.0325 
H111 0.6963 0.0602 0.3224 0.0295 
H112 0.5736 0.1033 0.3013 0.0295 
H121 0.6482 0.2609 0.3011 0.0275 
H122 0.7176 0.1959 0.2447 0.0275 
H131 0.7468 0.3000 0.7654 0.0398 
H132 0.8511 0.3038 0.7107 0.0398 
H141 0.7480 0.4470 0.6965 0.0412 
H142 0.6334 0.3881 0.6798 0.0412 
H161 0.6743 0.4417 0.4463 0.0334 
H162 0.7211 0.3336 0.4445 0.0334 
H171 0.8023 0.4757 0.3452 0.0354 
H172 0.6942 0.4113 0.3225 0.0354 
H181 0.9212 0.3436 0.3435 0.0283 
H182 0.8474 0.3410 0.2668 0.0283 
H191 0.2362 0.3539 0.5512 0.0684 
H192 0.3187 0.3040 0.6126 0.0684 
H193 0.2901 0.2506 0.5349 0.0684 
H120 0.3155 0.3959 0.4086 0.0715 
H121 0.4432 0.3699 0.3892 0.0715 
H122 0.3580 0.2866 0.4128 0.0715 
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7.  
 
Slow Down the Proton Exchange Rate: A New Approach To 
Measure Absolute Acidity. 
 
The main difficulty for directly measuring proton concentration in solution is due to 
the high speed of proton exchange between different species. A rigid hydrophobic 
microenvironment and formation of hydrogen bond (HB) can slow down this 
procedure, in certain cases dramatically, such as the situation of interior part of a 
folded protein. We found such a phenomenon can also be achieved in a very small 
synthetic molecule and the proton exchange rate can reach the level below NMR 
timescale. Therefore, it can be utilized to determine the absolute proton concentration, 
and further the pKa of acid by NMR spectrum. 
 
A novel thiourea-cryptand 1 has been synthesized. The protonation behavior was 
studied by solution NMR (Figure 1) and X-ray crystallography (Figure 2), both 
indicate a rigid conformation of the cavity and the involvement of intramolecular HB 
for the central-ammonium-protons and S-atoms. The proton exchange is thus slowed 
down to the NMR time scale, even within short distance of intramolecular exchange 
between two central nitrogen atoms in MP-1. Intramolecular HB also leads an 
unusual negatively cooperative protonation effect, namely, pKa2> pKa1, in contrast 
most of other polyamine compounds for which the second protonation is usually more 
difficult than the first1. 
 131 
 
Figure 1. TOCSY 1H-NMR of BP-1 bis-picrate and assignment of peaks of 1, MP-1 and BP-
1. 
 
 
Figure 2. ORTEP drawing of the X-ray structure of neutral 1 (top) and BP-1 (bottom); left: 
side view; right: top view. -CH2- hydrogen atoms were omitted for clarity. 
 
 132 
Since the low proton exchange rate allows to distinguish all the different protonated 
states of 1 in the 1H-NMR spectrum (Figure 1), the absolute concentration of the 
individual species can be obtained from the integral. Therefore, [H+] and pKa of the 
acid used can then be deduced from the population of each species by following 
equations (eq.1-5), although certain error exists due to the ion pair formation 
(Samples of pKa measurement see Table 1).  
 
[HA]Ka=
[MP-1]K1= [H+][1]
[BP-1]
K2= [H+][MP-1]
[HA] + [A-] = Ca
[A-] = [MP-1] + [H+] + 2[BP-1]
........................................1
........................................2
........................................3
........................................4
..........................5
[H+][A-]
 
*  Ca is total concentration of acid used. 
 
Table 1: The pKa of selected acids determined by our new method and the literature values. 
 
Acid MeSO3H CF3SO3H TsOH MeSO3H CF3COOH HCl 
Solvent 
(all-d) 
DMSO DMSO DMSO 5%H2O/ 
DMSO 
5%H2O/ 
DMSO 
5%H2O/ 
DMSO 
Ka 0.0885 2.7118 0.0332 0.3130 0.0467 0.4296 
pKa-Exp 1.053 -0.433 1.479 0.504 1.331 0.367 
litDMSO 1.6 0.3  1.6 3.45 1.8 
litH2O -2.6 -14  -2.6 0.23(-0.26) -8.0 
 
Accordingly it is possible to measure the acidity using the phenomenon of slow 
proton exchange. The modification of structure 3 should decrease the error and 
broaden the scope of pKa measurement, which sheds light on its potential role as bio-
sensor.  
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